id	sid	tid	token	lemma	pos
fnp-2639	1	1	neuronal	neuronal	ADJ
fnp-2639	1	2	intermediate	intermediate	ADJ
fnp-2639	1	3	filament	filament	NOUN
fnp-2639	1	4	inclusion	inclusion	NOUN
fnp-2639	1	5	disease	disease	NOUN
fnp-2639	1	6	may	may	AUX
fnp-2639	1	7	be	be	AUX
fnp-2639	1	8	incorrectly	incorrectly	ADV
fnp-2639	1	9	classified	classify	VERB
fnp-2639	1	10	as	as	ADP
fnp-2639	1	11	a	a	DET
fnp-2639	1	12	subtype	subtype	NOUN
fnp-2639	1	13	of	of	ADP
fnp-2639	1	14	ftld	ftld	ADJ
fnp-2639	1	15	-	-	PUNCT
fnp-2639	1	16	fus	fus	NOUN
fnp-2639	1	17	feel	feel	VERB
fnp-2639	1	18	free	free	ADJ
fnp-2639	1	19	to	to	PART
fnp-2639	1	20	add	add	VERB
fnp-2639	1	21	comments	comment	NOUN
fnp-2639	1	22	by	by	ADP
fnp-2639	1	23	clicking	click	VERB
fnp-2639	1	24	these	these	DET
fnp-2639	1	25	icons	icon	NOUN
fnp-2639	1	26	on	on	ADP
fnp-2639	1	27	the	the	DET
fnp-2639	1	28	sidebar	sidebar	NOUN
fnp-2639	1	29	free	free	ADJ
fnp-2639	1	30	neuropathology	neuropathology	PROPN
fnp-2639	1	31	1:9	1:9	NUM
fnp-2639	1	32	(	(	PUNCT
fnp-2639	1	33	2020	2020	NUM
fnp-2639	1	34	)	)	PUNCT
fnp-2639	1	35	original	original	ADJ
fnp-2639	1	36	paper	paper	NOUN
fnp-2639	1	37	neuronal	neuronal	ADJ
fnp-2639	1	38	intermediate	intermediate	ADJ
fnp-2639	1	39	filament	filament	NOUN
fnp-2639	1	40	inclusion	inclusion	NOUN
fnp-2639	1	41	disease	disease	NOUN
fnp-2639	1	42	may	may	AUX
fnp-2639	1	43	be	be	AUX
fnp-2639	1	44	incorrectly	incorrectly	ADV
fnp-2639	1	45	classified	classify	VERB
fnp-2639	1	46	as	as	ADP
fnp-2639	1	47	a	a	DET
fnp-2639	1	48	subtype	subtype	NOUN
fnp-2639	1	49	of	of	ADP
fnp-2639	1	50	ftld	ftld	ADJ
fnp-2639	1	51	-	-	PUNCT
fnp-2639	1	52	fus	fus	PROPN
fnp-2639	1	53	kevin	kevin	PROPN
fnp-2639	1	54	f.	f.	PROPN
fnp-2639	1	55	bieniek1	bieniek1	PROPN
fnp-2639	1	56	,	,	PUNCT
fnp-2639	1	57	keith	keith	PROPN
fnp-2639	1	58	a.	a.	PROPN
fnp-2639	1	59	josephs2	josephs2	PROPN
fnp-2639	1	60	,	,	PUNCT
fnp-2639	1	61	wen	wen	PROPN
fnp-2639	1	62	-	-	PROPN
fnp-2639	1	63	lang	lang	PROPN
fnp-2639	1	64	lin3	lin3	PROPN
fnp-2639	1	65	,	,	PUNCT
fnp-2639	1	66	dennis	dennis	PROPN
fnp-2639	1	67	w.	w.	PROPN
fnp-2639	1	68	dickson3	dickson3	PROPN
fnp-2639	1	69	1	1	NUM
fnp-2639	1	70	department	department	NOUN
fnp-2639	1	71	of	of	ADP
fnp-2639	1	72	pathology	pathology	PROPN
fnp-2639	1	73	&	&	CCONJ
fnp-2639	1	74	laboratory	laboratory	PROPN
fnp-2639	1	75	medicine	medicine	NOUN
fnp-2639	1	76	,	,	PUNCT
fnp-2639	1	77	university	university	PROPN
fnp-2639	1	78	of	of	ADP
fnp-2639	1	79	texas	texas	PROPN
fnp-2639	1	80	health	health	PROPN
fnp-2639	1	81	science	science	PROPN
fnp-2639	1	82	center	center	PROPN
fnp-2639	1	83	,	,	PUNCT
fnp-2639	1	84	san	san	PROPN
fnp-2639	1	85	antonio	antonio	PROPN
fnp-2639	1	86	,	,	PUNCT
fnp-2639	1	87	tx	tx	PROPN
fnp-2639	1	88	,	,	PUNCT
fnp-2639	1	89	usa	usa	PROPN
fnp-2639	1	90	2	2	NUM
fnp-2639	1	91	department	department	NOUN
fnp-2639	1	92	of	of	ADP
fnp-2639	1	93	neurology	neurology	NOUN
fnp-2639	1	94	(	(	PUNCT
fnp-2639	1	95	behavioral	behavioral	ADJ
fnp-2639	1	96	neurology	neurology	NOUN
fnp-2639	1	97	&	&	CCONJ
fnp-2639	1	98	movement	movement	PROPN
fnp-2639	1	99	disorders	disorder	NOUN
fnp-2639	1	100	)	)	PUNCT
fnp-2639	1	101	mayo	mayo	NOUN
fnp-2639	1	102	clinic	clinic	PROPN
fnp-2639	1	103	,	,	PUNCT
fnp-2639	1	104	rochester	rochester	PROPN
fnp-2639	1	105	,	,	PUNCT
fnp-2639	1	106	mn	mn	PROPN
fnp-2639	1	107	,	,	PUNCT
fnp-2639	1	108	usa	usa	PROPN
fnp-2639	1	109	3	3	NUM
fnp-2639	1	110	department	department	NOUN
fnp-2639	1	111	of	of	ADP
fnp-2639	1	112	neuroscience	neuroscience	NOUN
fnp-2639	1	113	(	(	PUNCT
fnp-2639	1	114	neuropathology	neuropathology	NOUN
fnp-2639	1	115	)	)	PUNCT
fnp-2639	1	116	,	,	PUNCT
fnp-2639	1	117	mayo	mayo	NOUN
fnp-2639	1	118	clinic	clinic	PROPN
fnp-2639	1	119	,	,	PUNCT
fnp-2639	1	120	jacksonville	jacksonville	PROPN
fnp-2639	1	121	,	,	PUNCT
fnp-2639	1	122	fl	fl	PROPN
fnp-2639	1	123	,	,	PUNCT
fnp-2639	1	124	usa	usa	PROPN
fnp-2639	1	125	corresponding	corresponding	PROPN
fnp-2639	1	126	author	author	NOUN
fnp-2639	1	127	:	:	PUNCT
fnp-2639	1	128	keith	keith	PROPN
fnp-2639	1	129	a	a	PROPN
fnp-2639	1	130	josephs	josephs	PROPN
fnp-2639	1	131	,	,	PUNCT
fnp-2639	1	132	md	md	PROPN
fnp-2639	1	133	,	,	PUNCT
fnp-2639	1	134	mst	mst	PROPN
fnp-2639	1	135	,	,	PUNCT
fnp-2639	1	136	msc	msc	PROPN
fnp-2639	1	137	·	·	PUNCT
fnp-2639	1	138	mayo	mayo	PROPN
fnp-2639	1	139	clinic	clinic	PROPN
fnp-2639	1	140	·	·	PUNCT
fnp-2639	1	141	200	200	NUM
fnp-2639	1	142	1st	1st	ADJ
fnp-2639	1	143	street	street	NOUN
fnp-2639	1	144	s.w	s.w	PROPN
fnp-2639	1	145	.	.	PROPN
fnp-2639	1	146	·	·	PUNCT
fnp-2639	1	147	rochester	rochester	PROPN
fnp-2639	1	148	,	,	PUNCT
fnp-2639	1	149	mn	mn	PROPN
fnp-2639	1	150	,	,	PUNCT
fnp-2639	1	151	55902	55902	NUM
fnp-2639	1	152	·	·	PUNCT
fnp-2639	1	153	usa	usa	PROPN
fnp-2639	1	154	·	·	PUNCT
fnp-2639	1	155	tel	tel	PROPN
fnp-2639	1	156	:	:	PUNCT
fnp-2639	1	157	+1	+1	ADJ
fnp-2639	1	158	-	-	PUNCT
fnp-2639	1	159	507	507	NUM
fnp-2639	1	160	-	-	PUNCT
fnp-2639	1	161	538	538	NUM
fnp-2639	1	162	-	-	PUNCT
fnp-2639	1	163	1038	1038	NUM
fnp-2639	1	164	·	·	PUNCT
fnp-2639	1	165	fax	fax	NOUN
fnp-2639	1	166	:	:	PUNCT
fnp-2639	1	167	+1	+1	ADJ
fnp-2639	1	168	-	-	PUNCT
fnp-2639	1	169	507	507	NUM
fnp-2639	1	170	-	-	PUNCT
fnp-2639	1	171	538	538	NUM
fnp-2639	1	172	-	-	PUNCT
fnp-2639	1	173	6012	6012	NUM
fnp-2639	1	174	josephs.keith@mayo.edu	josephs.keith@mayo.edu	NOUN
fnp-2639	1	175	submitted	submit	VERB
fnp-2639	1	176	:	:	PUNCT
fnp-2639	1	177	02	02	NUM
fnp-2639	1	178	february	february	NOUN
fnp-2639	1	179	2020	2020	NUM
fnp-2639	1	180	accepted	accept	VERB
fnp-2639	1	181	:	:	PUNCT
fnp-2639	1	182	05	05	NUM
fnp-2639	1	183	march	march	PROPN
fnp-2639	1	184	2020	2020	NUM
fnp-2639	1	185	copyedited	copyedit	VERB
fnp-2639	1	186	by	by	ADP
fnp-2639	1	187	:	:	PUNCT
fnp-2639	1	188	aivi	aivi	PROPN
fnp-2639	1	189	t.	t.	PROPN
fnp-2639	1	190	nguyen	nguyen	PROPN
fnp-2639	1	191	published	publish	VERB
fnp-2639	1	192	:	:	PUNCT
fnp-2639	1	193	11	11	NUM
fnp-2639	1	194	march	march	NOUN
fnp-2639	1	195	2020	2020	NUM
fnp-2639	1	196	https://doi.org/10.17879/freeneuropathology-2020-2639	https://doi.org/10.17879/freeneuropathology-2020-2639	PROPN
fnp-2639	1	197	keywords	keyword	NOUN
fnp-2639	1	198	:	:	PUNCT
fnp-2639	1	199	fus	fus	PROPN
fnp-2639	1	200	,	,	PUNCT
fnp-2639	1	201	tdp-43	tdp-43	PROPN
fnp-2639	1	202	,	,	PUNCT
fnp-2639	1	203	atypical	atypical	ADJ
fnp-2639	1	204	frontotemporal	frontotemporal	ADJ
fnp-2639	1	205	lobar	lobar	ADJ
fnp-2639	1	206	degeneration	degeneration	NOUN
fnp-2639	1	207	,	,	PUNCT
fnp-2639	2	1	nifid	nifid	ADJ
fnp-2639	2	2	,	,	PUNCT
fnp-2639	2	3	electron	electron	NOUN
fnp-2639	2	4	microscope	microscope	NOUN
fnp-2639	2	5	abstract	abstract	ADJ
fnp-2639	2	6	background	background	NOUN
fnp-2639	2	7	:	:	PUNCT
fnp-2639	2	8	the	the	DET
fnp-2639	2	9	majority	majority	NOUN
fnp-2639	2	10	of	of	ADP
fnp-2639	2	11	cases	case	NOUN
fnp-2639	2	12	of	of	ADP
fnp-2639	2	13	frontotemporal	frontotemporal	ADJ
fnp-2639	2	14	lobar	lobar	ADJ
fnp-2639	2	15	degeneration	degeneration	NOUN
fnp-2639	2	16	(	(	PUNCT
fnp-2639	2	17	ftld	ftld	ADJ
fnp-2639	2	18	)	)	PUNCT
fnp-2639	2	19	are	be	AUX
fnp-2639	2	20	characterized	characterize	VERB
fnp-2639	2	21	by	by	ADP
fnp-2639	2	22	focal	focal	ADJ
fnp-2639	2	23	cortical	cortical	ADJ
fnp-2639	2	24	atrophy	atrophy	NOUN
fnp-2639	2	25	with	with	ADP
fnp-2639	2	26	an	an	DET
fnp-2639	2	27	underlying	underlying	ADJ
fnp-2639	2	28	tau	tau	NOUN
fnp-2639	2	29	or	or	CCONJ
fnp-2639	2	30	tdp-43	tdp-43	NOUN
fnp-2639	2	31	proteinopathy	proteinopathy	ADJ
fnp-2639	2	32	.	.	PUNCT
fnp-2639	3	1	a	a	DET
fnp-2639	3	2	subset	subset	NOUN
fnp-2639	3	3	of	of	ADP
fnp-2639	3	4	ftld	ftld	ADJ
fnp-2639	3	5	cases	case	NOUN
fnp-2639	3	6	,	,	PUNCT
fnp-2639	3	7	however	however	ADV
fnp-2639	3	8	,	,	PUNCT
fnp-2639	3	9	lack	lack	VERB
fnp-2639	3	10	tau	tau	PROPN
fnp-2639	3	11	and	and	CCONJ
fnp-2639	3	12	tdp-43	tdp-43	PROPN
fnp-2639	3	13	immunoreactivity	immunoreactivity	PROPN
fnp-2639	3	14	,	,	PUNCT
fnp-2639	3	15	but	but	CCONJ
fnp-2639	3	16	have	have	VERB
fnp-2639	3	17	neuronal	neuronal	ADJ
fnp-2639	3	18	inclusions	inclusion	NOUN
fnp-2639	3	19	positive	positive	ADJ
fnp-2639	3	20	for	for	ADP
fnp-2639	3	21	ubiquitin	ubiquitin	NOUN
fnp-2639	3	22	,	,	PUNCT
fnp-2639	3	23	referred	refer	VERB
fnp-2639	3	24	to	to	ADP
fnp-2639	3	25	as	as	ADP
fnp-2639	3	26	atypical	atypical	ADJ
fnp-2639	3	27	ftld	ftld	NOUN
fnp-2639	3	28	(	(	PUNCT
fnp-2639	3	29	aftld	aftld	PROPN
fnp-2639	3	30	-	-	PUNCT
fnp-2639	3	31	u	u	NOUN
fnp-2639	3	32	)	)	PUNCT
fnp-2639	3	33	.	.	PUNCT
fnp-2639	4	1	studies	study	NOUN
fnp-2639	4	2	have	have	AUX
fnp-2639	4	3	demonstrated	demonstrate	VERB
fnp-2639	4	4	that	that	SCONJ
fnp-2639	4	5	ubiquitin	ubiquitin	ADJ
fnp-2639	4	6	-	-	PUNCT
fnp-2639	4	7	positive	positive	ADJ
fnp-2639	4	8	inclusions	inclusion	NOUN
fnp-2639	4	9	in	in	ADP
fnp-2639	4	10	aftld	aftld	ADJ
fnp-2639	4	11	-	-	PUNCT
fnp-2639	4	12	u	u	NOUN
fnp-2639	4	13	are	be	AUX
fnp-2639	4	14	immunoreactive	immunoreactive	ADJ
fnp-2639	4	15	for	for	ADP
fnp-2639	4	16	fused	fuse	VERB
fnp-2639	4	17	in	in	ADP
fnp-2639	4	18	sarcoma	sarcoma	NOUN
fnp-2639	4	19	(	(	PUNCT
fnp-2639	4	20	fus	fus	PROPN
fnp-2639	4	21	)	)	PUNCT
fnp-2639	4	22	.	.	PUNCT
fnp-2639	5	1	as	as	ADP
fnp-2639	5	2	such	such	ADJ
fnp-2639	5	3	,	,	PUNCT
fnp-2639	5	4	the	the	DET
fnp-2639	5	5	current	current	ADJ
fnp-2639	5	6	nosology	nosology	NOUN
fnp-2639	5	7	for	for	ADP
fnp-2639	5	8	this	this	DET
fnp-2639	5	9	entity	entity	NOUN
fnp-2639	5	10	is	be	AUX
fnp-2639	5	11	ftld	ftld	ADJ
fnp-2639	5	12	-	-	PUNCT
fnp-2639	5	13	fus	fus	NOUN
fnp-2639	5	14	,	,	PUNCT
fnp-2639	5	15	which	which	PRON
fnp-2639	5	16	is	be	AUX
fnp-2639	5	17	thought	think	VERB
fnp-2639	5	18	to	to	PART
fnp-2639	5	19	include	include	VERB
fnp-2639	5	20	not	not	PART
fnp-2639	5	21	only	only	ADV
fnp-2639	5	22	aftld	aftld	ADJ
fnp-2639	5	23	-	-	PUNCT
fnp-2639	5	24	u	u	NOUN
fnp-2639	5	25	but	but	CCONJ
fnp-2639	5	26	also	also	ADV
fnp-2639	5	27	neuronal	neuronal	ADJ
fnp-2639	5	28	intermediate	intermediate	ADJ
fnp-2639	5	29	filament	filament	NOUN
fnp-2639	5	30	inclusion	inclusion	NOUN
fnp-2639	5	31	disease	disease	NOUN
fnp-2639	5	32	(	(	PUNCT
fnp-2639	5	33	nifid	nifid	ADJ
fnp-2639	5	34	)	)	PUNCT
fnp-2639	5	35	and	and	CCONJ
fnp-2639	5	36	basophilic	basophilic	ADJ
fnp-2639	5	37	inclusion	inclusion	NOUN
fnp-2639	5	38	body	body	NOUN
fnp-2639	5	39	disease	disease	NOUN
fnp-2639	5	40	.	.	PUNCT
fnp-2639	6	1	objective	objective	NOUN
fnp-2639	6	2	:	:	PUNCT
fnp-2639	6	3	to	to	PART
fnp-2639	6	4	compare	compare	VERB
fnp-2639	6	5	pathological	pathological	ADJ
fnp-2639	6	6	features	feature	NOUN
fnp-2639	6	7	of	of	ADP
fnp-2639	6	8	cases	case	NOUN
fnp-2639	6	9	of	of	ADP
fnp-2639	6	10	aftld	aftld	ADJ
fnp-2639	6	11	-	-	PUNCT
fnp-2639	6	12	u	u	NOUN
fnp-2639	6	13	and	and	CCONJ
fnp-2639	6	14	nifid	nifid	ADJ
fnp-2639	6	15	.	.	PUNCT
fnp-2639	7	1	methods	method	NOUN
fnp-2639	7	2	:	:	PUNCT
fnp-2639	7	3	we	we	PRON
fnp-2639	7	4	reviewed	review	VERB
fnp-2639	7	5	the	the	DET
fnp-2639	7	6	neuropathology	neuropathology	NOUN
fnp-2639	7	7	of	of	ADP
fnp-2639	7	8	15	15	NUM
fnp-2639	7	9	patients	patient	NOUN
fnp-2639	7	10	(	(	PUNCT
fnp-2639	7	11	10	10	NUM
fnp-2639	7	12	males	male	NOUN
fnp-2639	7	13	and	and	CCONJ
fnp-2639	7	14	5	5	NUM
fnp-2639	7	15	females	female	NOUN
fnp-2639	7	16	;	;	PUNCT
fnp-2639	7	17	average	average	ADJ
fnp-2639	7	18	age	age	NOUN
fnp-2639	7	19	at	at	ADP
fnp-2639	7	20	death	death	NOUN
fnp-2639	7	21	54	54	NUM
fnp-2639	7	22	years	year	NOUN
fnp-2639	7	23	(	(	PUNCT
fnp-2639	7	24	range	range	NOUN
fnp-2639	7	25	41	41	NUM
fnp-2639	7	26	-	-	SYM
fnp-2639	7	27	69	69	NUM
fnp-2639	7	28	years	year	NOUN
fnp-2639	7	29	)	)	PUNCT
fnp-2639	7	30	)	)	PUNCT
fnp-2639	7	31	with	with	ADP
fnp-2639	7	32	an	an	DET
fnp-2639	7	33	antemortem	antemortem	NOUN
fnp-2639	7	34	clinical	clinical	ADJ
fnp-2639	7	35	diagnosis	diagnosis	NOUN
fnp-2639	7	36	of	of	ADP
fnp-2639	7	37	a	a	DET
fnp-2639	7	38	frontotemporal	frontotemporal	ADJ
fnp-2639	7	39	dementia	dementia	NOUN
fnp-2639	7	40	and	and	CCONJ
fnp-2639	7	41	pathological	pathological	ADJ
fnp-2639	7	42	diagnosis	diagnosis	NOUN
fnp-2639	7	43	of	of	ADP
fnp-2639	7	44	aftld	aftld	ADJ
fnp-2639	7	45	-	-	PUNCT
fnp-2639	7	46	u	u	NOUN
fnp-2639	7	47	(	(	PUNCT
fnp-2639	7	48	n=8	n=8	NUM
fnp-2639	7	49	)	)	PUNCT
fnp-2639	7	50	or	or	CCONJ
fnp-2639	7	51	nifid	nifid	ADJ
fnp-2639	7	52	(	(	PUNCT
fnp-2639	7	53	n=7	n=7	PROPN
fnp-2639	7	54	)	)	PUNCT
fnp-2639	7	55	.	.	PUNCT
fnp-2639	8	1	sections	section	NOUN
fnp-2639	8	2	were	be	AUX
fnp-2639	8	3	processed	process	VERB
fnp-2639	8	4	for	for	ADP
fnp-2639	8	5	immunohistochemistry	immunohistochemistry	NOUN
fnp-2639	8	6	and	and	CCONJ
fnp-2639	8	7	immunoelectron	immunoelectron	ADJ
fnp-2639	8	8	microscopy	microscopy	NOUN
fnp-2639	8	9	with	with	ADP
fnp-2639	8	10	fus	fus	PROPN
fnp-2639	8	11	,	,	PUNCT
fnp-2639	8	12	tdp-43	tdp-43	PROPN
fnp-2639	8	13	,	,	PUNCT
fnp-2639	8	14	and	and	CCONJ
fnp-2639	8	15	α	α	X
fnp-2639	8	16	-	-	NOUN
fnp-2639	8	17	internexin	internexin	NOUN
fnp-2639	8	18	(	(	PUNCT
fnp-2639	8	19	αinx	αinx	NOUN
fnp-2639	8	20	)	)	PUNCT
fnp-2639	8	21	antibodies	antibodie	VERB
fnp-2639	8	22	.	.	PUNCT
fnp-2639	9	1	results	result	NOUN
fnp-2639	9	2	:	:	PUNCT
fnp-2639	9	3	eight	eight	NUM
fnp-2639	9	4	cases	case	NOUN
fnp-2639	9	5	had	have	VERB
fnp-2639	9	6	pathologic	pathologic	ADJ
fnp-2639	9	7	features	feature	NOUN
fnp-2639	9	8	consistent	consistent	ADJ
fnp-2639	9	9	with	with	ADP
fnp-2639	9	10	ftld	ftld	ADJ
fnp-2639	9	11	-	-	PUNCT
fnp-2639	9	12	fus	fus	NOUN
fnp-2639	9	13	,	,	PUNCT
fnp-2639	9	14	with	with	ADP
fnp-2639	9	15	severe	severe	ADJ
fnp-2639	9	16	striatal	striatal	ADJ
fnp-2639	9	17	atrophy	atrophy	NOUN
fnp-2639	9	18	(	(	PUNCT
fnp-2639	9	19	7/8	7/8	NUM
fnp-2639	9	20	cases	case	NOUN
fnp-2639	9	21	)	)	PUNCT
fnp-2639	9	22	,	,	PUNCT
fnp-2639	9	23	as	as	ADV
fnp-2639	9	24	well	well	ADV
fnp-2639	9	25	as	as	ADP
fnp-2639	9	26	fus	fus	ADJ
fnp-2639	9	27	-	-	PUNCT
fnp-2639	9	28	positive	positive	ADJ
fnp-2639	9	29	neuronal	neuronal	ADJ
fnp-2639	9	30	cytoplasmic	cytoplasmic	ADJ
fnp-2639	9	31	and	and	CCONJ
fnp-2639	9	32	vermiform	vermiform	ADJ
fnp-2639	9	33	intranuclear	intranuclear	NOUN
fnp-2639	9	34	inclusions	inclusion	NOUN
fnp-2639	9	35	,	,	PUNCT
fnp-2639	9	36	but	but	CCONJ
fnp-2639	9	37	no	no	DET
fnp-2639	9	38	αinx	αinx	NOUN
fnp-2639	9	39	immunoreactivity	immunoreactivity	NOUN
fnp-2639	9	40	.	.	PUNCT
fnp-2639	10	1	five	five	NUM
fnp-2639	10	2	cases	case	NOUN
fnp-2639	10	3	had	have	VERB
fnp-2639	10	4	features	feature	NOUN
fnp-2639	10	5	consistent	consistent	ADJ
fnp-2639	10	6	with	with	ADP
fnp-2639	10	7	nifid	nifid	ADJ
fnp-2639	10	8	,	,	PUNCT
fnp-2639	10	9	with	with	ADP
fnp-2639	10	10	neuronal	neuronal	ADJ
fnp-2639	10	11	inclusions	inclusion	NOUN
fnp-2639	10	12	positive	positive	ADJ
fnp-2639	10	13	for	for	ADP
fnp-2639	10	14	both	both	DET
fnp-2639	10	15	fus	fus	NOUN
fnp-2639	10	16	and	and	CCONJ
fnp-2639	10	17	αinx	αinx	NOUN
fnp-2639	10	18	.	.	PUNCT
fnp-2639	11	1	striatal	striatal	ADJ
fnp-2639	11	2	atrophy	atrophy	NOUN
fnp-2639	11	3	was	be	AUX
fnp-2639	11	4	present	present	ADJ
fnp-2639	11	5	in	in	ADP
fnp-2639	11	6	only	only	ADV
fnp-2639	11	7	two	two	NUM
fnp-2639	11	8	of	of	ADP
fnp-2639	11	9	the	the	DET
fnp-2639	11	10	nifid	nifid	ADJ
fnp-2639	11	11	cases	case	NOUN
fnp-2639	11	12	.	.	PUNCT
fnp-2639	12	1	two	two	NUM
fnp-2639	12	2	cases	case	NOUN
fnp-2639	12	3	had	have	VERB
fnp-2639	12	4	αinx	αinx	NOUN
fnp-2639	12	5	-	-	PUNCT
fnp-2639	12	6	positive	positive	ADJ
fnp-2639	12	7	neuronal	neuronal	ADJ
fnp-2639	12	8	inclusions	inclusion	NOUN
fnp-2639	12	9	consistent	consistent	ADJ
fnp-2639	12	10	with	with	ADP
fnp-2639	12	11	nifid	nifid	ADJ
fnp-2639	12	12	,	,	PUNCT
fnp-2639	12	13	but	but	CCONJ
fnp-2639	12	14	both	both	PRON
fnp-2639	12	15	lacked	lack	VERB
fnp-2639	12	16	striatal	striatal	ADJ
fnp-2639	12	17	atrophy	atrophy	NOUN
fnp-2639	12	18	and	and	CCONJ
fnp-2639	12	19	fus	fus	ADJ
fnp-2639	12	20	immunoreactivity	immunoreactivity	NOUN
fnp-2639	12	21	.	.	PUNCT
fnp-2639	13	1	surprisingly	surprisingly	ADV
fnp-2639	13	2	,	,	PUNCT
fnp-2639	13	3	one	one	NUM
fnp-2639	13	4	of	of	ADP
fnp-2639	13	5	these	these	DET
fnp-2639	13	6	two	two	NUM
fnp-2639	13	7	nifid	nifid	ADJ
fnp-2639	13	8	cases	case	NOUN
fnp-2639	13	9	had	have	VERB
fnp-2639	13	10	lesions	lesion	NOUN
fnp-2639	13	11	immunoreactive	immunoreactive	ADJ
fnp-2639	13	12	for	for	ADP
fnp-2639	13	13	tdp-43	tdp-43	PROPN
fnp-2639	13	14	.	.	PUNCT
fnp-2639	14	1	discussion	discussion	NOUN
fnp-2639	14	2	:	:	PUNCT
fnp-2639	14	3	while	while	SCONJ
fnp-2639	14	4	fus	fus	PROPN
fnp-2639	14	5	pathology	pathology	NOUN
fnp-2639	14	6	remains	remain	VERB
fnp-2639	14	7	a	a	DET
fnp-2639	14	8	prominent	prominent	ADJ
fnp-2639	14	9	feature	feature	NOUN
fnp-2639	14	10	of	of	ADP
fnp-2639	14	11	aftld	aftld	NOUN
fnp-2639	14	12	-	-	PUNCT
fnp-2639	14	13	u	u	NOUN
fnp-2639	14	14	,	,	PUNCT
fnp-2639	14	15	there	there	PRON
fnp-2639	14	16	is	be	VERB
fnp-2639	14	17	pathologic	pathologic	ADJ
fnp-2639	14	18	heterogeneity	heterogeneity	NOUN
fnp-2639	14	19	,	,	PUNCT
fnp-2639	14	20	including	include	VERB
fnp-2639	14	21	rare	rare	ADJ
fnp-2639	14	22	cases	case	NOUN
fnp-2639	14	23	of	of	ADP
fnp-2639	14	24	nifid	nifid	ADJ
fnp-2639	14	25	with	with	ADP
fnp-2639	14	26	tdp-43rather	tdp-43rather	ADP
fnp-2639	14	27	than	than	ADP
fnp-2639	14	28	fus	fus	ADJ
fnp-2639	14	29	-	-	PUNCT
fnp-2639	14	30	positive	positive	ADJ
fnp-2639	14	31	inclusions	inclusion	NOUN
fnp-2639	14	32	.	.	PUNCT
fnp-2639	15	1	introduction	introduction	NOUN
fnp-2639	15	2	the	the	DET
fnp-2639	15	3	pathological	pathological	ADJ
fnp-2639	15	4	term	term	NOUN
fnp-2639	15	5	frontotemporal	frontotemporal	ADJ
fnp-2639	15	6	lobar	lobar	ADJ
fnp-2639	15	7	degeneration	degeneration	NOUN
fnp-2639	15	8	(	(	PUNCT
fnp-2639	15	9	ftld	ftld	ADJ
fnp-2639	15	10	)	)	PUNCT
fnp-2639	15	11	assumes	assume	VERB
fnp-2639	15	12	the	the	DET
fnp-2639	15	13	presence	presence	NOUN
fnp-2639	15	14	of	of	ADP
fnp-2639	15	15	focal	focal	ADJ
fnp-2639	15	16	frontal	frontal	ADJ
fnp-2639	15	17	and	and	CCONJ
fnp-2639	15	18	anterior	anterior	ADJ
fnp-2639	16	1	temporal	temporal	ADJ
fnp-2639	16	2	lobar	lobar	ADJ
fnp-2639	16	3	atrophy(1	atrophy(1	PROPN
fnp-2639	16	4	)	)	PUNCT
fnp-2639	16	5	.	.	PUNCT
fnp-2639	17	1	histologically	histologically	PROPN
fnp-2639	17	2	,	,	PUNCT
fnp-2639	17	3	the	the	DET
fnp-2639	17	4	majority	majority	NOUN
fnp-2639	17	5	of	of	ADP
fnp-2639	17	6	ftlds	ftld	NOUN
fnp-2639	17	7	are	be	AUX
fnp-2639	17	8	pathologically	pathologically	ADV
fnp-2639	17	9	classified	classify	VERB
fnp-2639	17	10	into	into	ADP
fnp-2639	17	11	two	two	NUM
fnp-2639	17	12	broad	broad	ADJ
fnp-2639	17	13	categories	category	NOUN
fnp-2639	17	14	of	of	ADP
fnp-2639	17	15	tau	tau	NOUN
fnp-2639	17	16	-	-	PUNCT
fnp-2639	17	17	positive	positive	ADJ
fnp-2639	17	18	ftld	ftld	NOUN
fnp-2639	17	19	(	(	PUNCT
fnp-2639	17	20	ftld	ftld	PROPN
fnp-2639	17	21	-	-	PUNCT
fnp-2639	17	22	tau	tau	PROPN
fnp-2639	17	23	)	)	PUNCT
fnp-2639	17	24	and	and	CCONJ
fnp-2639	17	25	tdp-43	tdp-43	NOUN
fnp-2639	17	26	-	-	PUNCT
fnp-2639	17	27	positive	positive	ADJ
fnp-2639	17	28	ftld	ftld	NOUN
fnp-2639	17	29	(	(	PUNCT
fnp-2639	17	30	ftld	ftld	ADJ
fnp-2639	17	31	-	-	PUNCT
fnp-2639	17	32	tdp	tdp	NOUN
fnp-2639	17	33	)	)	PUNCT
fnp-2639	17	34	based	base	VERB
fnp-2639	17	35	on	on	ADP
fnp-2639	17	36	the	the	DET
fnp-2639	17	37	presence	presence	NOUN
fnp-2639	17	38	of	of	ADP
fnp-2639	17	39	tau	tau	PROPN
fnp-2639	17	40	and	and	CCONJ
fnp-2639	17	41	tdp-43	tdp-43	VERB
fnp-2639	17	42	immunoreactive	immunoreactive	ADJ
fnp-2639	17	43	inclusions	inclusion	NOUN
fnp-2639	17	44	,	,	PUNCT
fnp-2639	17	45	respectively(2	respectively(2	PROPN
fnp-2639	17	46	,	,	PUNCT
fnp-2639	17	47	3	3	NUM
fnp-2639	17	48	)	)	PUNCT
fnp-2639	17	49	.	.	PUNCT
fnp-2639	18	1	a	a	DET
fnp-2639	18	2	subset	subset	NOUN
fnp-2639	18	3	of	of	ADP
fnp-2639	18	4	ftld	ftld	ADJ
fnp-2639	18	5	cases	case	NOUN
fnp-2639	18	6	however	however	ADV
fnp-2639	18	7	,	,	PUNCT
fnp-2639	18	8	lack	lack	VERB
fnp-2639	18	9	tau	tau	PROPN
fnp-2639	18	10	and	and	CCONJ
fnp-2639	18	11	tdp-43	tdp-43	PROPN
fnp-2639	18	12	immunoreactivity	immunoreactivity	PROPN
fnp-2639	18	13	,	,	PUNCT
fnp-2639	18	14	and	and	CCONJ
fnp-2639	18	15	instead	instead	ADV
fnp-2639	18	16	have	have	VERB
fnp-2639	18	17	neuronal	neuronal	ADJ
fnp-2639	18	18	inclusions	inclusion	NOUN
fnp-2639	18	19	that	that	PRON
fnp-2639	18	20	are	be	AUX
fnp-2639	18	21	immunoreactive	immunoreactive	ADJ
fnp-2639	18	22	to	to	ADP
fnp-2639	18	23	ubiquitin(4	ubiquitin(4	PROPN
fnp-2639	18	24	)	)	PUNCT
fnp-2639	18	25	.	.	PUNCT
fnp-2639	19	1	such	such	ADJ
fnp-2639	19	2	cases	case	NOUN
fnp-2639	19	3	have	have	AUX
fnp-2639	19	4	been	be	AUX
fnp-2639	19	5	referred	refer	VERB
fnp-2639	19	6	to	to	ADP
fnp-2639	19	7	in	in	ADP
fnp-2639	19	8	the	the	DET
fnp-2639	19	9	literature	literature	NOUN
fnp-2639	19	10	as	as	ADP
fnp-2639	19	11	atypical	atypical	ADJ
fnp-2639	19	12	ftld	ftld	NOUN
fnp-2639	19	13	with	with	ADP
fnp-2639	19	14	ubiquitin	ubiquitin	ADJ
fnp-2639	19	15	inclusion	inclusion	NOUN
fnp-2639	19	16	(	(	PUNCT
fnp-2639	19	17	aftld	aftld	NOUN
fnp-2639	19	18	-	-	PUNCT
fnp-2639	19	19	u)(5	u)(5	NUM
fnp-2639	19	20	)	)	PUNCT
fnp-2639	19	21	.	.	PUNCT
fnp-2639	20	1	in	in	ADP
fnp-2639	20	2	the	the	DET
fnp-2639	20	3	past	past	ADJ
fnp-2639	20	4	decade	decade	NOUN
fnp-2639	20	5	,	,	PUNCT
fnp-2639	20	6	immunohistochemical	immunohistochemical	ADJ
fnp-2639	20	7	studies	study	NOUN
fnp-2639	20	8	have	have	AUX
fnp-2639	20	9	revealed	reveal	VERB
fnp-2639	20	10	that	that	SCONJ
fnp-2639	20	11	the	the	DET
fnp-2639	20	12	ubiquitinated	ubiquitinated	ADJ
fnp-2639	20	13	protein	protein	NOUN
fnp-2639	20	14	in	in	ADP
fnp-2639	20	15	cases	case	NOUN
fnp-2639	20	16	of	of	ADP
fnp-2639	20	17	aftld	aftld	NOUN
fnp-2639	20	18	-	-	PUNCT
fnp-2639	20	19	u	u	NOUN
fnp-2639	20	20	is	be	AUX
fnp-2639	20	21	the	the	DET
fnp-2639	20	22	fused	fuse	VERB
fnp-2639	20	23	in	in	ADP
fnp-2639	20	24	sarcoma	sarcoma	NOUN
fnp-2639	20	25	(	(	PUNCT
fnp-2639	20	26	fus	fus	NOUN
fnp-2639	20	27	)	)	PUNCT
fnp-2639	20	28	protein(6	protein(6	NUM
fnp-2639	20	29	)	)	PUNCT
fnp-2639	20	30	.	.	PUNCT
fnp-2639	21	1	interestingly	interestingly	ADV
fnp-2639	21	2	,	,	PUNCT
fnp-2639	21	3	there	there	PRON
fnp-2639	21	4	are	be	VERB
fnp-2639	21	5	two	two	NUM
fnp-2639	21	6	other	other	ADJ
fnp-2639	21	7	relatively	relatively	ADV
fnp-2639	21	8	rare	rare	ADJ
fnp-2639	21	9	ftld	ftld	ADJ
fnp-2639	21	10	pathological	pathological	ADJ
fnp-2639	21	11	variants	variant	NOUN
fnp-2639	21	12	that	that	PRON
fnp-2639	21	13	also	also	ADV
fnp-2639	21	14	have	have	VERB
fnp-2639	21	15	neuronal	neuronal	ADJ
fnp-2639	21	16	inclusions	inclusion	NOUN
fnp-2639	21	17	that	that	PRON
fnp-2639	21	18	are	be	AUX
fnp-2639	21	19	immunoreactive	immunoreactive	ADJ
fnp-2639	21	20	to	to	ADP
fnp-2639	21	21	fus(7	fus(7	ADJ
fnp-2639	21	22	,	,	PUNCT
fnp-2639	21	23	8)	8)	NUM
fnp-2639	21	24	.	.	PUNCT
fnp-2639	22	1	these	these	PRON
fnp-2639	22	2	include	include	VERB
fnp-2639	22	3	the	the	DET
fnp-2639	22	4	entity	entity	NOUN
fnp-2639	22	5	neuronal	neuronal	ADJ
fnp-2639	22	6	intermediate	intermediate	ADJ
fnp-2639	22	7	filament	filament	NOUN
fnp-2639	22	8	inclusion	inclusion	NOUN
fnp-2639	22	9	disease	disease	NOUN
fnp-2639	22	10	(	(	PUNCT
fnp-2639	22	11	nifid)(9	nifid)(9	PROPN
fnp-2639	22	12	)	)	PUNCT
fnp-2639	22	13	,	,	PUNCT
fnp-2639	22	14	previously	previously	ADV
fnp-2639	22	15	known	know	VERB
fnp-2639	22	16	as	as	ADP
fnp-2639	22	17	neurofilament	neurofilament	NOUN
fnp-2639	22	18	inclusion	inclusion	NOUN
fnp-2639	22	19	body	body	NOUN
fnp-2639	22	20	disease(10	disease(10	NOUN
fnp-2639	22	21	)	)	PUNCT
fnp-2639	22	22	,	,	PUNCT
fnp-2639	22	23	and	and	CCONJ
fnp-2639	22	24	basophilic	basophilic	ADJ
fnp-2639	22	25	inclusion	inclusion	NOUN
fnp-2639	22	26	body	body	NOUN
fnp-2639	22	27	disease(11	disease(11	NOUN
fnp-2639	22	28	)	)	PUNCT
fnp-2639	22	29	that	that	PRON
fnp-2639	22	30	have	have	AUX
fnp-2639	22	31	also	also	ADV
fnp-2639	22	32	been	be	AUX
fnp-2639	22	33	referred	refer	VERB
fnp-2639	22	34	to	to	ADP
fnp-2639	22	35	as	as	ADP
fnp-2639	22	36	the	the	DET
fnp-2639	22	37	generalized	generalized	ADJ
fnp-2639	22	38	variant	variant	NOUN
fnp-2639	22	39	of	of	ADP
fnp-2639	22	40	pick	pick	NOUN
fnp-2639	22	41	’s	’s	PART
fnp-2639	22	42	disease(12	disease(12	NOUN
fnp-2639	22	43	)	)	PUNCT
fnp-2639	22	44	.	.	PUNCT
fnp-2639	23	1	as	as	ADP
fnp-2639	23	2	a	a	DET
fnp-2639	23	3	result	result	NOUN
fnp-2639	23	4	,	,	PUNCT
fnp-2639	23	5	aftld	aftld	ADJ
fnp-2639	23	6	-	-	PUNCT
fnp-2639	23	7	u	u	NOUN
fnp-2639	23	8	,	,	PUNCT
fnp-2639	23	9	nifid	nifid	ADJ
fnp-2639	23	10	and	and	CCONJ
fnp-2639	23	11	basophilic	basophilic	ADJ
fnp-2639	23	12	inclusion	inclusion	NOUN
fnp-2639	23	13	body	body	NOUN
fnp-2639	23	14	disease	disease	NOUN
fnp-2639	23	15	are	be	AUX
fnp-2639	23	16	all	all	PRON
fnp-2639	23	17	currently	currently	ADV
fnp-2639	23	18	classified	classify	VERB
fnp-2639	23	19	as	as	ADP
fnp-2639	23	20	subtypes	subtype	NOUN
fnp-2639	23	21	of	of	ADP
fnp-2639	23	22	ftld	ftld	ADJ
fnp-2639	23	23	-	-	PUNCT
fnp-2639	23	24	fus(3	fus(3	NOUN
fnp-2639	23	25	,	,	PUNCT
fnp-2639	23	26	13	13	NUM
fnp-2639	23	27	)	)	PUNCT
fnp-2639	23	28	.	.	PUNCT
fnp-2639	24	1	in	in	ADP
fnp-2639	24	2	keeping	keep	VERB
fnp-2639	24	3	with	with	ADP
fnp-2639	24	4	pathologically	pathologically	ADV
fnp-2639	24	5	lumping	lump	VERB
fnp-2639	24	6	these	these	DET
fnp-2639	24	7	three	three	NUM
fnp-2639	24	8	entities	entity	NOUN
fnp-2639	24	9	as	as	ADP
fnp-2639	24	10	ftld	ftld	ADJ
fnp-2639	24	11	-	-	PUNCT
fnp-2639	24	12	fus	fus	NOUN
fnp-2639	24	13	,	,	PUNCT
fnp-2639	24	14	is	be	AUX
fnp-2639	24	15	the	the	DET
fnp-2639	24	16	fact	fact	NOUN
fnp-2639	24	17	that	that	SCONJ
fnp-2639	24	18	all	all	DET
fnp-2639	24	19	three	three	NUM
fnp-2639	24	20	subtypes	subtype	NOUN
fnp-2639	24	21	of	of	ADP
fnp-2639	24	22	ftld	ftld	ADJ
fnp-2639	24	23	-	-	PUNCT
fnp-2639	24	24	fus	fus	ADJ
fnp-2639	24	25	,	,	PUNCT
fnp-2639	24	26	particularly	particularly	ADV
fnp-2639	24	27	aftld	aftld	ADJ
fnp-2639	24	28	-	-	PUNCT
fnp-2639	24	29	u	u	NOUN
fnp-2639	24	30	and	and	CCONJ
fnp-2639	24	31	nifid	nifid	ADJ
fnp-2639	24	32	,	,	PUNCT
fnp-2639	24	33	are	be	AUX
fnp-2639	24	34	strongly	strongly	ADV
fnp-2639	24	35	associated	associate	VERB
fnp-2639	24	36	with	with	ADP
fnp-2639	24	37	a	a	DET
fnp-2639	24	38	clinical	clinical	ADJ
fnp-2639	24	39	presentation	presentation	NOUN
fnp-2639	24	40	of	of	ADP
fnp-2639	24	41	the	the	DET
fnp-2639	24	42	behavioral	behavioral	ADJ
fnp-2639	24	43	variant	variant	NOUN
fnp-2639	24	44	of	of	ADP
fnp-2639	24	45	frontotemporal	frontotemporal	ADJ
fnp-2639	24	46	dementia	dementia	NOUN
fnp-2639	24	47	(	(	PUNCT
fnp-2639	24	48	bvftd)(13	bvftd)(13	NOUN
fnp-2639	24	49	-	-	PUNCT
fnp-2639	24	50	15	15	NUM
fnp-2639	24	51	)	)	PUNCT
fnp-2639	24	52	.	.	PUNCT
fnp-2639	25	1	basophilic	basophilic	ADJ
fnp-2639	25	2	inclusion	inclusion	NOUN
fnp-2639	25	3	body	body	NOUN
fnp-2639	25	4	disease	disease	NOUN
fnp-2639	25	5	is	be	AUX
fnp-2639	25	6	more	more	ADV
fnp-2639	25	7	strongly	strongly	ADV
fnp-2639	25	8	associated	associate	VERB
fnp-2639	25	9	with	with	ADP
fnp-2639	25	10	the	the	DET
fnp-2639	25	11	juvenile	juvenile	ADJ
fnp-2639	25	12	form	form	NOUN
fnp-2639	25	13	of	of	ADP
fnp-2639	25	14	amyotrophic	amyotrophic	ADJ
fnp-2639	25	15	lateral	lateral	ADJ
fnp-2639	25	16	sclerosis(16	sclerosis(16	NOUN
fnp-2639	25	17	)	)	PUNCT
fnp-2639	25	18	.	.	PUNCT
fnp-2639	26	1	in	in	ADP
fnp-2639	26	2	addition	addition	NOUN
fnp-2639	26	3	,	,	PUNCT
fnp-2639	26	4	aftld	aftld	ADJ
fnp-2639	26	5	-	-	PUNCT
fnp-2639	26	6	u	u	NOUN
fnp-2639	26	7	and	and	CCONJ
fnp-2639	26	8	nifid	nifid	ADJ
fnp-2639	26	9	have	have	AUX
fnp-2639	26	10	both	both	PRON
fnp-2639	26	11	been	be	AUX
fnp-2639	26	12	found	find	VERB
fnp-2639	26	13	to	to	PART
fnp-2639	26	14	be	be	AUX
fnp-2639	26	15	associated	associate	VERB
fnp-2639	26	16	with	with	ADP
fnp-2639	26	17	striatal	striatal	ADJ
fnp-2639	26	18	atrophy	atrophy	NOUN
fnp-2639	26	19	on	on	ADP
fnp-2639	26	20	mri(17	mri(17	PROPN
fnp-2639	26	21	,	,	PUNCT
fnp-2639	26	22	18	18	NUM
fnp-2639	26	23	)	)	PUNCT
fnp-2639	26	24	.	.	PUNCT
fnp-2639	27	1	hence	hence	ADV
fnp-2639	27	2	,	,	PUNCT
fnp-2639	27	3	aftld	aftld	ADJ
fnp-2639	27	4	-	-	PUNCT
fnp-2639	27	5	u	u	NOUN
fnp-2639	27	6	and	and	CCONJ
fnp-2639	27	7	nifid	nifid	ADJ
fnp-2639	27	8	have	have	VERB
fnp-2639	27	9	a	a	DET
fnp-2639	27	10	lot	lot	NOUN
fnp-2639	27	11	of	of	ADP
fnp-2639	27	12	features	feature	NOUN
fnp-2639	27	13	in	in	ADP
fnp-2639	27	14	common	common	ADJ
fnp-2639	27	15	.	.	PUNCT
fnp-2639	28	1	one	one	NUM
fnp-2639	28	2	study	study	NOUN
fnp-2639	28	3	has	have	AUX
fnp-2639	28	4	directly	directly	ADV
fnp-2639	28	5	compared	compare	VERB
fnp-2639	28	6	aftld	aftld	ADJ
fnp-2639	28	7	-	-	PUNCT
fnp-2639	28	8	u	u	NOUN
fnp-2639	28	9	and	and	CCONJ
fnp-2639	28	10	nifid(19	nifid(19	NOUN
fnp-2639	28	11	)	)	PUNCT
fnp-2639	28	12	.	.	PUNCT
fnp-2639	29	1	hence	hence	ADV
fnp-2639	29	2	,	,	PUNCT
fnp-2639	29	3	little	little	ADJ
fnp-2639	29	4	is	be	AUX
fnp-2639	29	5	known	know	VERB
fnp-2639	29	6	about	about	ADP
fnp-2639	29	7	which	which	PRON
fnp-2639	29	8	clinical	clinical	ADJ
fnp-2639	29	9	and	and	CCONJ
fnp-2639	29	10	pathologically	pathologically	ADV
fnp-2639	29	11	differences	difference	NOUN
fnp-2639	29	12	between	between	ADP
fnp-2639	29	13	the	the	DET
fnp-2639	29	14	two	two	NUM
fnp-2639	29	15	variants	variant	NOUN
fnp-2639	29	16	may	may	AUX
fnp-2639	29	17	further	far	ADV
fnp-2639	29	18	help	help	VERB
fnp-2639	29	19	to	to	PART
fnp-2639	29	20	distinguish	distinguish	VERB
fnp-2639	29	21	them	they	PRON
fnp-2639	29	22	,	,	PUNCT
fnp-2639	29	23	and	and	CCONJ
fnp-2639	29	24	whether	whether	SCONJ
fnp-2639	29	25	all	all	DET
fnp-2639	29	26	cases	case	NOUN
fnp-2639	29	27	of	of	ADP
fnp-2639	29	28	aftld	aftld	ADJ
fnp-2639	29	29	-	-	PUNCT
fnp-2639	29	30	u	u	NOUN
fnp-2639	29	31	and	and	CCONJ
fnp-2639	29	32	nifid	nifid	ADJ
fnp-2639	29	33	do	do	AUX
fnp-2639	29	34	indeed	indeed	ADV
fnp-2639	29	35	show	show	VERB
fnp-2639	29	36	fus	fus	ADP
fnp-2639	29	37	immunoreactivity	immunoreactivity	NOUN
fnp-2639	29	38	.	.	PUNCT
fnp-2639	30	1	in	in	ADP
fnp-2639	30	2	this	this	DET
fnp-2639	30	3	study	study	NOUN
fnp-2639	30	4	,	,	PUNCT
fnp-2639	30	5	we	we	PRON
fnp-2639	30	6	set	set	VERB
fnp-2639	30	7	out	out	ADP
fnp-2639	30	8	to	to	PART
fnp-2639	30	9	address	address	VERB
fnp-2639	30	10	these	these	DET
fnp-2639	30	11	two	two	NUM
fnp-2639	30	12	unknowns	unknown	NOUN
fnp-2639	30	13	in	in	ADP
fnp-2639	30	14	a	a	DET
fnp-2639	30	15	cohort	cohort	NOUN
fnp-2639	30	16	of	of	ADP
fnp-2639	30	17	15	15	NUM
fnp-2639	30	18	ftld	ftld	ADJ
fnp-2639	30	19	cases	case	NOUN
fnp-2639	30	20	that	that	SCONJ
fnp-2639	30	21	including	include	VERB
fnp-2639	30	22	aftld	aftld	PROPN
fnp-2639	30	23	(	(	PUNCT
fnp-2639	30	24	n=8	n=8	NUM
fnp-2639	30	25	)	)	PUNCT
fnp-2639	30	26	and	and	CCONJ
fnp-2639	30	27	nifid	nifid	ADJ
fnp-2639	30	28	(	(	PUNCT
fnp-2639	30	29	n=7	n=7	PROPN
fnp-2639	30	30	)	)	PUNCT
fnp-2639	30	31	.	.	PUNCT
fnp-2639	31	1	materials	material	NOUN
fnp-2639	31	2	and	and	CCONJ
fnp-2639	31	3	methods	method	NOUN
fnp-2639	31	4	subject	subject	ADJ
fnp-2639	31	5	selection	selection	NOUN
fnp-2639	31	6	the	the	DET
fnp-2639	31	7	neuropathological	neuropathological	ADJ
fnp-2639	31	8	databases	database	NOUN
fnp-2639	31	9	at	at	ADP
fnp-2639	31	10	the	the	DET
fnp-2639	31	11	mayo	mayo	NOUN
fnp-2639	31	12	clinic	clinic	PROPN
fnp-2639	31	13	,	,	PUNCT
fnp-2639	31	14	jacksonville	jacksonville	PROPN
fnp-2639	31	15	,	,	PUNCT
fnp-2639	31	16	florida	florida	PROPN
fnp-2639	31	17	were	be	AUX
fnp-2639	31	18	queried	query	VERB
fnp-2639	31	19	to	to	PART
fnp-2639	31	20	identify	identify	VERB
fnp-2639	31	21	all	all	DET
fnp-2639	31	22	cases	case	NOUN
fnp-2639	31	23	of	of	ADP
fnp-2639	31	24	ftld	ftld	NOUN
fnp-2639	31	25	that	that	PRON
fnp-2639	31	26	had	have	AUX
fnp-2639	31	27	been	be	AUX
fnp-2639	31	28	given	give	VERB
fnp-2639	31	29	a	a	DET
fnp-2639	31	30	pathological	pathological	ADJ
fnp-2639	31	31	diagnosis	diagnosis	NOUN
fnp-2639	31	32	of	of	ADP
fnp-2639	31	33	nifid	nifid	ADJ
fnp-2639	31	34	or	or	CCONJ
fnp-2639	31	35	aftld	aftld	ADJ
fnp-2639	31	36	-	-	PUNCT
fnp-2639	31	37	u.	u.	VERB
fnp-2639	31	38	a	a	DET
fnp-2639	31	39	total	total	NOUN
fnp-2639	31	40	of	of	ADP
fnp-2639	31	41	15	15	NUM
fnp-2639	31	42	cases	case	NOUN
fnp-2639	31	43	were	be	AUX
fnp-2639	31	44	identified	identify	VERB
fnp-2639	31	45	.	.	PUNCT
fnp-2639	32	1	all	all	DET
fnp-2639	32	2	15	15	NUM
fnp-2639	32	3	cases	case	NOUN
fnp-2639	32	4	were	be	AUX
fnp-2639	32	5	evaluated	evaluate	VERB
fnp-2639	32	6	by	by	ADP
fnp-2639	32	7	a	a	DET
fnp-2639	32	8	single	single	ADJ
fnp-2639	32	9	expert	expert	ADJ
fnp-2639	32	10	neuropathologist	neuropathologist	NOUN
fnp-2639	32	11	(	(	PUNCT
fnp-2639	32	12	dwd	dwd	PROPN
fnp-2639	32	13	)	)	PUNCT
fnp-2639	32	14	.	.	PUNCT
fnp-2639	33	1	clinical	clinical	ADJ
fnp-2639	33	2	data	datum	NOUN
fnp-2639	33	3	the	the	DET
fnp-2639	33	4	medical	medical	ADJ
fnp-2639	33	5	records	record	NOUN
fnp-2639	33	6	of	of	ADP
fnp-2639	33	7	all	all	DET
fnp-2639	33	8	15	15	NUM
fnp-2639	33	9	cases	case	NOUN
fnp-2639	33	10	were	be	AUX
fnp-2639	33	11	reviewed	review	VERB
fnp-2639	33	12	by	by	ADP
fnp-2639	33	13	one	one	NUM
fnp-2639	33	14	clinician	clinician	NOUN
fnp-2639	33	15	with	with	ADP
fnp-2639	33	16	expertise	expertise	NOUN
fnp-2639	33	17	in	in	ADP
fnp-2639	33	18	neurodegenerative	neurodegenerative	ADJ
fnp-2639	33	19	diseases	disease	NOUN
fnp-2639	33	20	(	(	PUNCT
fnp-2639	33	21	kaj	kaj	NOUN
fnp-2639	33	22	)	)	PUNCT
fnp-2639	33	23	to	to	PART
fnp-2639	33	24	abstract	abstract	ADJ
fnp-2639	33	25	demographic	demographic	ADJ
fnp-2639	33	26	and	and	CCONJ
fnp-2639	33	27	clinical	clinical	ADJ
fnp-2639	33	28	information	information	NOUN
fnp-2639	33	29	.	.	PUNCT
fnp-2639	34	1	data	datum	NOUN
fnp-2639	34	2	abstracted	abstract	VERB
fnp-2639	34	3	included	include	VERB
fnp-2639	34	4	sex	sex	NOUN
fnp-2639	34	5	,	,	PUNCT
fnp-2639	34	6	age	age	NOUN
fnp-2639	34	7	at	at	ADP
fnp-2639	34	8	onset	onset	NOUN
fnp-2639	34	9	,	,	PUNCT
fnp-2639	34	10	prominent	prominent	ADJ
fnp-2639	34	11	symptoms	symptom	NOUN
fnp-2639	34	12	during	during	ADP
fnp-2639	34	13	the	the	DET
fnp-2639	34	14	disease	disease	NOUN
fnp-2639	34	15	course	course	NOUN
fnp-2639	34	16	,	,	PUNCT
fnp-2639	34	17	family	family	NOUN
fnp-2639	34	18	history	history	NOUN
fnp-2639	34	19	of	of	ADP
fnp-2639	34	20	any	any	DET
fnp-2639	34	21	neurodegenerative	neurodegenerative	ADJ
fnp-2639	34	22	diseases	disease	NOUN
fnp-2639	34	23	and	and	CCONJ
fnp-2639	34	24	final	final	ADJ
fnp-2639	34	25	clinical	clinical	ADJ
fnp-2639	34	26	diagnosis	diagnosis	NOUN
fnp-2639	34	27	prior	prior	ADV
fnp-2639	34	28	to	to	ADP
fnp-2639	34	29	death	death	NOUN
fnp-2639	34	30	.	.	PUNCT
fnp-2639	35	1	pathological	pathological	ADJ
fnp-2639	35	2	methods	method	NOUN
fnp-2639	35	3	all	all	DET
fnp-2639	35	4	15	15	NUM
fnp-2639	35	5	cases	case	NOUN
fnp-2639	35	6	underwent	undergo	VERB
fnp-2639	35	7	histologic	histologic	ADJ
fnp-2639	35	8	and	and	CCONJ
fnp-2639	35	9	ultrastructural	ultrastructural	ADJ
fnp-2639	35	10	evaluation	evaluation	NOUN
fnp-2639	35	11	.	.	PUNCT
fnp-2639	36	1	tissue	tissue	NOUN
fnp-2639	36	2	sections	section	NOUN
fnp-2639	36	3	were	be	AUX
fnp-2639	36	4	stained	stain	VERB
fnp-2639	36	5	with	with	ADP
fnp-2639	36	6	hematoxylin	hematoxylin	NOUN
fnp-2639	36	7	and	and	CCONJ
fnp-2639	36	8	eosin	eosin	NOUN
fnp-2639	36	9	,	,	PUNCT
fnp-2639	36	10	luxol	luxol	NOUN
fnp-2639	36	11	fast	fast	ADJ
fnp-2639	36	12	blue	blue	ADJ
fnp-2639	36	13	-	-	PUNCT
fnp-2639	36	14	periodic	periodic	ADJ
fnp-2639	36	15	acid	acid	NOUN
fnp-2639	36	16	schiff	schiff	NOUN
fnp-2639	36	17	(	(	PUNCT
fnp-2639	36	18	lfb	lfb	PROPN
fnp-2639	36	19	-	-	PUNCT
fnp-2639	36	20	pas	pas	NOUN
fnp-2639	36	21	)	)	PUNCT
fnp-2639	36	22	and	and	CCONJ
fnp-2639	36	23	bielschowsky	bielschowsky	NOUN
fnp-2639	36	24	silver	silver	ADJ
fnp-2639	36	25	stains	stain	NOUN
fnp-2639	36	26	.	.	PUNCT
fnp-2639	37	1	immunohistochemical	immunohistochemical	ADJ
fnp-2639	37	2	staining	stain	VERB
fnp-2639	37	3	was	be	AUX
fnp-2639	37	4	performed	perform	VERB
fnp-2639	37	5	using	use	VERB
fnp-2639	37	6	standard	standard	ADJ
fnp-2639	37	7	methods	method	NOUN
fnp-2639	37	8	.	.	PUNCT
fnp-2639	38	1	the	the	DET
fnp-2639	38	2	deparaffinized	deparaffinize	VERB
fnp-2639	38	3	and	and	CCONJ
fnp-2639	38	4	rehydrated	rehydrated	ADJ
fnp-2639	38	5	sections	section	NOUN
fnp-2639	38	6	were	be	AUX
fnp-2639	38	7	steamed	steam	VERB
fnp-2639	38	8	in	in	ADP
fnp-2639	38	9	distilled	distil	VERB
fnp-2639	38	10	water	water	NOUN
fnp-2639	38	11	for	for	ADP
fnp-2639	38	12	30	30	NUM
fnp-2639	38	13	min	min	NOUN
fnp-2639	38	14	and	and	CCONJ
fnp-2639	38	15	immunostained	immunostaine	VERB
fnp-2639	38	16	in	in	ADP
fnp-2639	38	17	batches	batch	NOUN
fnp-2639	38	18	to	to	PART
fnp-2639	38	19	assure	assure	VERB
fnp-2639	38	20	consistency	consistency	NOUN
fnp-2639	38	21	with	with	ADP
fnp-2639	38	22	a	a	DET
fnp-2639	38	23	dako	dako	PROPN
fnp-2639	38	24	autostainer	autostainer	NOUN
fnp-2639	38	25	(	(	PUNCT
fnp-2639	38	26	dako	dako	PROPN
fnp-2639	38	27	,	,	PUNCT
fnp-2639	38	28	carpinteria	carpinteria	PROPN
fnp-2639	38	29	,	,	PUNCT
fnp-2639	38	30	ca	ca	NOUN
fnp-2639	38	31	)	)	PUNCT
fnp-2639	38	32	using	use	VERB
fnp-2639	38	33	3	3	NUM
fnp-2639	38	34	,	,	PUNCT
fnp-2639	38	35	3’diaminobenzidine	3’diaminobenzidine	NUM
fnp-2639	38	36	as	as	ADP
fnp-2639	38	37	the	the	DET
fnp-2639	38	38	chromogen	chromogen	NOUN
fnp-2639	38	39	.	.	PUNCT
fnp-2639	39	1	after	after	ADP
fnp-2639	39	2	immunostaining	immunostaine	VERB
fnp-2639	39	3	,	,	PUNCT
fnp-2639	39	4	the	the	DET
fnp-2639	39	5	sections	section	NOUN
fnp-2639	39	6	were	be	AUX
fnp-2639	39	7	lightly	lightly	ADV
fnp-2639	39	8	counterstained	counterstaine	VERB
fnp-2639	39	9	with	with	ADP
fnp-2639	39	10	hematoxylin	hematoxylin	NOUN
fnp-2639	39	11	.	.	PUNCT
fnp-2639	40	1	the	the	DET
fnp-2639	40	2	following	follow	VERB
fnp-2639	40	3	antibodies	antibody	NOUN
fnp-2639	40	4	were	be	AUX
fnp-2639	40	5	used	use	VERB
fnp-2639	40	6	:	:	PUNCT
fnp-2639	40	7	phosphorylated	phosphorylated	ADJ
fnp-2639	40	8	neurofilament	neurofilament	NOUN
fnp-2639	40	9	(	(	PUNCT
fnp-2639	40	10	smi-31	smi-31	PROPN
fnp-2639	40	11	,	,	PUNCT
fnp-2639	40	12	1:20,000	1:20,000	NUM
fnp-2639	40	13	;	;	PUNCT
fnp-2639	40	14	covance	covance	NOUN
fnp-2639	40	15	,	,	PUNCT
fnp-2639	40	16	berkeley	berkeley	PROPN
fnp-2639	40	17	,	,	PUNCT
fnp-2639	40	18	ca	ca	NOUN
fnp-2639	40	19	)	)	PUNCT
fnp-2639	40	20	;	;	PUNCT
fnp-2639	40	21	ubiquitin	ubiquitin	X
fnp-2639	40	22	(	(	PUNCT
fnp-2639	40	23	mouse	mouse	NOUN
fnp-2639	40	24	monoclonal	monoclonal	NOUN
fnp-2639	40	25	ubi-1	ubi-1	PRON
fnp-2639	40	26	,	,	PUNCT
fnp-2639	40	27	1:40,000	1:40,000	NUM
fnp-2639	40	28	;	;	PUNCT
fnp-2639	40	29	encor	encor	PROPN
fnp-2639	40	30	biotechnology	biotechnology	PROPN
fnp-2639	40	31	,	,	PUNCT
fnp-2639	40	32	alachua	alachua	PROPN
fnp-2639	40	33	,	,	PUNCT
fnp-2639	40	34	fl	fl	PROPN
fnp-2639	40	35	;	;	PUNCT
fnp-2639	40	36	rabbit	rabbit	NOUN
fnp-2639	40	37	polyclonal	polyclonal	ADJ
fnp-2639	40	38	ubq(20	ubq(20	PROPN
fnp-2639	40	39	)	)	PUNCT
fnp-2639	40	40	,	,	PUNCT
fnp-2639	40	41	1:500	1:500	NUM
fnp-2639	40	42	and	and	CCONJ
fnp-2639	40	43	rabbit	rabbit	NOUN
fnp-2639	40	44	polyclonal	polyclonal	ADJ
fnp-2639	40	45	uh-19(21	uh-19(21	PROPN
fnp-2639	40	46	)	)	PUNCT
fnp-2639	40	47	,	,	PUNCT
fnp-2639	40	48	1:2,500	1:2,500	NUM
fnp-2639	40	49	)	)	PUNCT
fnp-2639	40	50	;	;	PUNCT
fnp-2639	40	51	phospho	phospho	NOUN
fnp-2639	40	52	-	-	PUNCT
fnp-2639	40	53	tau	tau	NOUN
fnp-2639	40	54	(	(	PUNCT
fnp-2639	40	55	cp13	cp13	PROPN
fnp-2639	40	56	,	,	PUNCT
fnp-2639	40	57	1:100	1:100	NUM
fnp-2639	40	58	;	;	PUNCT
fnp-2639	40	59	peter	peter	PROPN
fnp-2639	40	60	davies	davies	PROPN
fnp-2639	40	61	,	,	PUNCT
fnp-2639	40	62	albert	albert	PROPN
fnp-2639	40	63	einstein	einstein	PROPN
fnp-2639	40	64	college	college	PROPN
fnp-2639	40	65	of	of	ADP
fnp-2639	40	66	medicine	medicine	NOUN
fnp-2639	40	67	,	,	PUNCT
fnp-2639	40	68	bronx	bronx	NOUN
fnp-2639	40	69	,	,	PUNCT
fnp-2639	40	70	ny	ny	PROPN
fnp-2639	40	71	)	)	PUNCT
fnp-2639	40	72	;	;	PUNCT
fnp-2639	40	73	alpha	alpha	NOUN
fnp-2639	40	74	-	-	PUNCT
fnp-2639	40	75	synuclein	synuclein	PROPN
fnp-2639	40	76	(	(	PUNCT
fnp-2639	40	77	nacp(22	nacp(22	PROPN
fnp-2639	40	78	)	)	PUNCT
fnp-2639	40	79	,	,	PUNCT
fnp-2639	40	80	1:3,000	1:3,000	NUM
fnp-2639	40	81	)	)	PUNCT
fnp-2639	40	82	,	,	PUNCT
fnp-2639	40	83	alpha	alpha	NOUN
fnp-2639	40	84	-	-	PUNCT
fnp-2639	40	85	internexin	internexin	PROPN
fnp-2639	40	86	(	(	PUNCT
fnp-2639	40	87	1:100	1:100	NUM
fnp-2639	40	88	;	;	PUNCT
fnp-2639	40	89	encor	encor	PROPN
fnp-2639	40	90	biotechnology	biotechnology	PROPN
fnp-2639	40	91	,	,	PUNCT
fnp-2639	40	92	alachua	alachua	PROPN
fnp-2639	40	93	,	,	PUNCT
fnp-2639	40	94	fl	fl	PROPN
fnp-2639	40	95	)	)	PUNCT
fnp-2639	40	96	;	;	PUNCT
fnp-2639	40	97	tdp-43	tdp-43	X
fnp-2639	40	98	(	(	PUNCT
fnp-2639	40	99	mc2085	mc2085	PROPN
fnp-2639	40	100	,	,	PUNCT
fnp-2639	40	101	dr	dr	PROPN
fnp-2639	40	102	.	.	PROPN
fnp-2639	40	103	petrucelli	petrucelli	PROPN
fnp-2639	40	104	,	,	PUNCT
fnp-2639	40	105	1:1500	1:1500	NUM
fnp-2639	40	106	)	)	PUNCT
fnp-2639	40	107	,	,	PUNCT
fnp-2639	40	108	ptdp-43	ptdp-43	PROPN
fnp-2639	40	109	(	(	PUNCT
fnp-2639	40	110	s409/410	s409/410	PROPN
fnp-2639	40	111	,	,	PUNCT
fnp-2639	40	112	cosmo	cosmo	PROPN
fnp-2639	40	113	bio	bio	PROPN
fnp-2639	40	114	co.	co.	PROPN
fnp-2639	40	115	,	,	PUNCT
fnp-2639	40	116	1:5000	1:5000	NUM
fnp-2639	40	117	)	)	PUNCT
fnp-2639	40	118	and	and	CCONJ
fnp-2639	40	119	rabbit	rabbit	NOUN
fnp-2639	40	120	polyclonal	polyclonal	ADJ
fnp-2639	40	121	anti	anti	ADJ
fnp-2639	40	122	-	-	ADJ
fnp-2639	40	123	fus	fus	ADJ
fnp-2639	40	124	(	(	PUNCT
fnp-2639	40	125	1:500	1:500	NUM
fnp-2639	40	126	;	;	PUNCT
fnp-2639	40	127	hpa008784	hpa008784	NOUN
fnp-2639	40	128	;	;	PUNCT
fnp-2639	40	129	sigma	sigma	PROPN
fnp-2639	40	130	,	,	PUNCT
fnp-2639	40	131	st	st	PROPN
fnp-2639	40	132	.	.	PROPN
fnp-2639	40	133	louis	louis	PROPN
fnp-2639	40	134	.	.	PROPN
fnp-2639	40	135	mo	mo	PROPN
fnp-2639	40	136	and	and	CCONJ
fnp-2639	40	137	bethyl	bethyl	PROPN
fnp-2639	40	138	lab	lab	PROPN
fnp-2639	40	139	;	;	PUNCT
fnp-2639	40	140	a300	a300	PROPN
fnp-2639	40	141	-	-	PUNCT
fnp-2639	40	142	302a	302a	PROPN
fnp-2639	40	143	;	;	PUNCT
fnp-2639	40	144	montgomery	montgomery	PROPN
fnp-2639	40	145	,	,	PUNCT
fnp-2639	40	146	tx	tx	PROPN
fnp-2639	40	147	)	)	PUNCT
fnp-2639	40	148	.	.	PUNCT
fnp-2639	41	1	the	the	DET
fnp-2639	41	2	sigma	sigma	PROPN
fnp-2639	41	3	antibody	antibody	NOUN
fnp-2639	41	4	gave	give	VERB
fnp-2639	41	5	consistent	consistent	ADJ
fnp-2639	41	6	and	and	CCONJ
fnp-2639	41	7	better	well	ADV
fnp-2639	41	8	staining	stain	VERB
fnp-2639	41	9	and	and	CCONJ
fnp-2639	41	10	was	be	AUX
fnp-2639	41	11	used	use	VERB
fnp-2639	41	12	throughout	throughout	ADP
fnp-2639	41	13	the	the	DET
fnp-2639	41	14	study	study	NOUN
fnp-2639	41	15	.	.	PUNCT
fnp-2639	42	1	the	the	DET
fnp-2639	42	2	presence	presence	NOUN
fnp-2639	42	3	or	or	CCONJ
fnp-2639	42	4	absence	absence	NOUN
fnp-2639	42	5	of	of	ADP
fnp-2639	42	6	motor	motor	NOUN
fnp-2639	42	7	neuron	neuron	PROPN
fnp-2639	42	8	disease	disease	NOUN
fnp-2639	42	9	was	be	AUX
fnp-2639	42	10	assessed	assess	VERB
fnp-2639	42	11	and	and	CCONJ
fnp-2639	42	12	defined	define	VERB
fnp-2639	42	13	as	as	ADP
fnp-2639	42	14	previously	previously	ADV
fnp-2639	42	15	described	describe	VERB
fnp-2639	42	16	,	,	PUNCT
fnp-2639	42	17	including	include	VERB
fnp-2639	42	18	stains	stain	NOUN
fnp-2639	42	19	for	for	ADP
fnp-2639	42	20	activated	activate	VERB
fnp-2639	42	21	microglia(23	microglia(23	NOUN
fnp-2639	42	22	)	)	PUNCT
fnp-2639	42	23	.	.	PUNCT
fnp-2639	43	1	electron	electron	PROPN
fnp-2639	43	2	microscopy	microscopy	VERB
fnp-2639	43	3	small	small	ADJ
fnp-2639	43	4	pieces	piece	NOUN
fnp-2639	43	5	of	of	ADP
fnp-2639	43	6	formalin	formalin	NOUN
fnp-2639	43	7	-	-	PUNCT
fnp-2639	43	8	fixed	fix	VERB
fnp-2639	43	9	brains	brain	NOUN
fnp-2639	43	10	were	be	AUX
fnp-2639	43	11	immersed	immerse	VERB
fnp-2639	43	12	in	in	ADP
fnp-2639	43	13	2.5	2.5	NUM
fnp-2639	43	14	%	%	NOUN
fnp-2639	43	15	glutaraldehyde-0.1	glutaraldehyde-0.1	NOUN
fnp-2639	43	16	m	m	NOUN
fnp-2639	43	17	cacodylate	cacodylate	ADJ
fnp-2639	43	18	buffer	buffer	NOUN
fnp-2639	43	19	overnight	overnight	ADV
fnp-2639	43	20	at	at	ADP
fnp-2639	43	21	4	4	NUM
fnp-2639	43	22	°	°	NOUN
fnp-2639	43	23	c	c	NOUN
fnp-2639	43	24	.	.	PUNCT
fnp-2639	44	1	after	after	ADP
fnp-2639	44	2	washing	wash	VERB
fnp-2639	44	3	in	in	ADP
fnp-2639	44	4	buffer	buffer	NOUN
fnp-2639	44	5	,	,	PUNCT
fnp-2639	44	6	they	they	PRON
fnp-2639	44	7	were	be	AUX
fnp-2639	44	8	post	post	ADJ
fnp-2639	44	9	-	-	ADJ
fnp-2639	44	10	fixed	fix	VERB
fnp-2639	44	11	in	in	ADP
fnp-2639	44	12	aqueous	aqueous	ADJ
fnp-2639	44	13	2	2	NUM
fnp-2639	44	14	%	%	NOUN
fnp-2639	44	15	osmium	osmium	NOUN
fnp-2639	44	16	tetroxide	tetroxide	NOUN
fnp-2639	44	17	for	for	ADP
fnp-2639	44	18	1	1	NUM
fnp-2639	44	19	hr	hr	NOUN
fnp-2639	44	20	,	,	PUNCT
fnp-2639	44	21	washed	wash	VERB
fnp-2639	44	22	and	and	CCONJ
fnp-2639	44	23	fixed	fix	VERB
fnp-2639	44	24	in	in	ADP
fnp-2639	44	25	1	1	NUM
fnp-2639	44	26	%	%	NOUN
fnp-2639	44	27	uranyl	uranyl	NOUN
fnp-2639	44	28	acetate-50	acetate-50	ADJ
fnp-2639	44	29	%	%	NOUN
fnp-2639	44	30	ethanol	ethanol	NOUN
fnp-2639	44	31	for	for	ADP
fnp-2639	44	32	30	30	NUM
fnp-2639	44	33	min	min	NOUN
fnp-2639	44	34	,	,	PUNCT
fnp-2639	44	35	followed	follow	VERB
fnp-2639	44	36	by	by	ADP
fnp-2639	44	37	dehydration	dehydration	NOUN
fnp-2639	44	38	in	in	ADP
fnp-2639	44	39	70	70	NUM
fnp-2639	44	40	%	%	NOUN
fnp-2639	44	41	,	,	PUNCT
fnp-2639	44	42	80	80	NUM
fnp-2639	44	43	%	%	NOUN
fnp-2639	44	44	,	,	PUNCT
fnp-2639	44	45	95	95	NUM
fnp-2639	44	46	%	%	NOUN
fnp-2639	44	47	,	,	PUNCT
fnp-2639	44	48	100	100	NUM
fnp-2639	44	49	%	%	NOUN
fnp-2639	44	50	ethanols	ethanol	NOUN
fnp-2639	44	51	and	and	CCONJ
fnp-2639	44	52	propylene	propylene	NOUN
fnp-2639	44	53	oxide	oxide	NOUN
fnp-2639	44	54	.	.	PUNCT
fnp-2639	45	1	they	they	PRON
fnp-2639	45	2	were	be	AUX
fnp-2639	45	3	infiltrated	infiltrate	VERB
fnp-2639	45	4	and	and	CCONJ
fnp-2639	45	5	embedded	embed	VERB
fnp-2639	45	6	in	in	ADP
fnp-2639	45	7	epon	epon	ADP
fnp-2639	45	8	812	812	NUM
fnp-2639	45	9	.	.	PUNCT
fnp-2639	46	1	thin	thin	ADJ
fnp-2639	46	2	sections	section	NOUN
fnp-2639	46	3	were	be	AUX
fnp-2639	46	4	stained	stain	VERB
fnp-2639	46	5	with	with	ADP
fnp-2639	46	6	uranyl	uranyl	ADJ
fnp-2639	46	7	acetate	acetate	NOUN
fnp-2639	46	8	and	and	CCONJ
fnp-2639	46	9	lead	lead	ADJ
fnp-2639	46	10	citrate	citrate	NOUN
fnp-2639	46	11	and	and	CCONJ
fnp-2639	46	12	examined	examine	VERB
fnp-2639	46	13	in	in	ADP
fnp-2639	46	14	a	a	DET
fnp-2639	46	15	philips	philips	PROPN
fnp-2639	46	16	208s	208s	PROPN
fnp-2639	46	17	electron	electron	NOUN
fnp-2639	46	18	microscope	microscope	NOUN
fnp-2639	46	19	fitted	fit	VERB
fnp-2639	46	20	with	with	ADP
fnp-2639	46	21	a	a	DET
fnp-2639	46	22	bottom	bottom	ADJ
fnp-2639	46	23	-	-	PUNCT
fnp-2639	46	24	mount	mount	NOUN
fnp-2639	46	25	ccd	ccd	PROPN
fnp-2639	46	26	camera	camera	NOUN
fnp-2639	46	27	(	(	PUNCT
fnp-2639	46	28	orius	orius	NOUN
fnp-2639	46	29	831	831	NUM
fnp-2639	46	30	,	,	PUNCT
fnp-2639	46	31	gatan	gatan	PROPN
fnp-2639	46	32	,	,	PUNCT
fnp-2639	46	33	pleasanton	pleasanton	PROPN
fnp-2639	46	34	,	,	PUNCT
fnp-2639	46	35	ca	ca	NOUN
fnp-2639	46	36	)	)	PUNCT
fnp-2639	46	37	.	.	PUNCT
fnp-2639	47	1	immunoelectron	immunoelectron	ADJ
fnp-2639	47	2	microscopy	microscopy	VERB
fnp-2639	47	3	small	small	ADJ
fnp-2639	47	4	pieces	piece	NOUN
fnp-2639	47	5	of	of	ADP
fnp-2639	47	6	formalin	formalin	NOUN
fnp-2639	47	7	-	-	PUNCT
fnp-2639	47	8	fixed	fix	VERB
fnp-2639	47	9	brains	brain	NOUN
fnp-2639	47	10	were	be	AUX
fnp-2639	47	11	dehydrated	dehydrate	VERB
fnp-2639	47	12	in	in	ADP
fnp-2639	47	13	serial	serial	ADJ
fnp-2639	47	14	washes	wash	NOUN
fnp-2639	47	15	of	of	ADP
fnp-2639	47	16	30	30	NUM
fnp-2639	47	17	%	%	NOUN
fnp-2639	47	18	,	,	PUNCT
fnp-2639	47	19	50	50	NUM
fnp-2639	47	20	%	%	NOUN
fnp-2639	47	21	,	,	PUNCT
fnp-2639	47	22	70	70	NUM
fnp-2639	47	23	%	%	NOUN
fnp-2639	47	24	,	,	PUNCT
fnp-2639	47	25	90	90	NUM
fnp-2639	47	26	%	%	NOUN
fnp-2639	47	27	ethanol	ethanol	NOUN
fnp-2639	47	28	for	for	ADP
fnp-2639	47	29	10	10	NUM
fnp-2639	47	30	min	min	NOUN
fnp-2639	47	31	each	each	PRON
fnp-2639	47	32	,	,	PUNCT
fnp-2639	47	33	infiltrated	infiltrate	VERB
fnp-2639	47	34	and	and	CCONJ
fnp-2639	47	35	embedded	embed	VERB
fnp-2639	47	36	in	in	ADP
fnp-2639	47	37	lr	lr	X
fnp-2639	47	38	white	white	ADJ
fnp-2639	47	39	resin	resin	NOUN
fnp-2639	47	40	.	.	PUNCT
fnp-2639	48	1	they	they	PRON
fnp-2639	48	2	were	be	AUX
fnp-2639	48	3	polymerized	polymerize	VERB
fnp-2639	48	4	in	in	ADP
fnp-2639	48	5	a	a	DET
fnp-2639	48	6	vacuum	vacuum	NOUN
fnp-2639	48	7	oven	oven	NOUN
fnp-2639	48	8	at	at	ADP
fnp-2639	48	9	50	50	NUM
fnp-2639	48	10	°	°	ADP
fnp-2639	48	11	c	c	NOUN
fnp-2639	48	12	for	for	ADP
fnp-2639	48	13	2	2	NUM
fnp-2639	48	14	days	day	NOUN
fnp-2639	48	15	.	.	PUNCT
fnp-2639	49	1	thin	thin	ADJ
fnp-2639	49	2	sections	section	NOUN
fnp-2639	49	3	were	be	AUX
fnp-2639	49	4	collected	collect	VERB
fnp-2639	49	5	on	on	ADP
fnp-2639	49	6	formvar	formvar	ADJ
fnp-2639	49	7	-	-	PUNCT
fnp-2639	49	8	coated	coat	VERB
fnp-2639	49	9	nickel	nickel	NOUN
fnp-2639	49	10	grids	grid	NOUN
fnp-2639	49	11	.	.	PUNCT
fnp-2639	50	1	grids	grid	NOUN
fnp-2639	50	2	were	be	AUX
fnp-2639	50	3	floated	float	VERB
fnp-2639	50	4	with	with	ADP
fnp-2639	50	5	section	section	NOUN
fnp-2639	50	6	-	-	PUNCT
fnp-2639	50	7	sides	side	NOUN
fnp-2639	50	8	down	down	ADP
fnp-2639	50	9	on	on	ADP
fnp-2639	50	10	citrate	citrate	NOUN
fnp-2639	50	11	buffer	buffer	NOUN
fnp-2639	50	12	,	,	PUNCT
fnp-2639	50	13	ph	ph	NOUN
fnp-2639	50	14	6.0	6.0	NUM
fnp-2639	50	15	,	,	PUNCT
fnp-2639	50	16	in	in	ADP
fnp-2639	50	17	a	a	DET
fnp-2639	50	18	100	100	NUM
fnp-2639	50	19	°	°	NOUN
fnp-2639	50	20	c	c	NOUN
fnp-2639	50	21	oven	oven	NOUN
fnp-2639	50	22	for	for	ADP
fnp-2639	50	23	10	10	NUM
fnp-2639	50	24	min	min	NOUN
fnp-2639	50	25	,	,	PUNCT
fnp-2639	50	26	cooled	cool	VERB
fnp-2639	50	27	to	to	ADP
fnp-2639	50	28	room	room	NOUN
fnp-2639	50	29	temperature	temperature	NOUN
fnp-2639	50	30	for	for	ADP
fnp-2639	50	31	15	15	NUM
fnp-2639	50	32	min	min	NOUN
fnp-2639	50	33	followed	follow	VERB
fnp-2639	50	34	by	by	ADP
fnp-2639	50	35	immunogold	immunogold	ADJ
fnp-2639	50	36	labeling	labeling	NOUN
fnp-2639	50	37	.	.	PUNCT
fnp-2639	51	1	the	the	DET
fnp-2639	51	2	sigma	sigma	ADJ
fnp-2639	51	3	anti	anti	ADJ
fnp-2639	51	4	-	-	ADJ
fnp-2639	51	5	fus	fus	ADJ
fnp-2639	51	6	was	be	AUX
fnp-2639	51	7	used	use	VERB
fnp-2639	51	8	at	at	ADP
fnp-2639	51	9	1:20	1:20	NUM
fnp-2639	51	10	in	in	ADP
fnp-2639	51	11	pbs	pbs	PROPN
fnp-2639	51	12	.	.	PUNCT
fnp-2639	52	1	results	result	VERB
fnp-2639	52	2	demographics	demographic	NOUN
fnp-2639	52	3	and	and	CCONJ
fnp-2639	52	4	clinical	clinical	ADJ
fnp-2639	52	5	data	datum	NOUN
fnp-2639	52	6	for	for	ADP
fnp-2639	52	7	all	all	DET
fnp-2639	52	8	15	15	NUM
fnp-2639	52	9	cases	case	NOUN
fnp-2639	52	10	are	be	AUX
fnp-2639	52	11	shown	show	VERB
fnp-2639	52	12	in	in	ADP
fnp-2639	52	13	table	table	NOUN
fnp-2639	52	14	1	1	NUM
fnp-2639	52	15	.	.	PUNCT
fnp-2639	53	1	there	there	PRON
fnp-2639	53	2	were	be	VERB
fnp-2639	53	3	10	10	NUM
fnp-2639	53	4	males	male	NOUN
fnp-2639	53	5	and	and	CCONJ
fnp-2639	53	6	5	5	NUM
fnp-2639	53	7	females	female	NOUN
fnp-2639	53	8	with	with	ADP
fnp-2639	53	9	median	median	ADJ
fnp-2639	53	10	age	age	NOUN
fnp-2639	53	11	at	at	ADP
fnp-2639	53	12	death	death	NOUN
fnp-2639	53	13	of	of	ADP
fnp-2639	53	14	54	54	NUM
fnp-2639	53	15	years	year	NOUN
fnp-2639	53	16	(	(	PUNCT
fnp-2639	53	17	range	range	NOUN
fnp-2639	53	18	41	41	NUM
fnp-2639	53	19	-	-	SYM
fnp-2639	53	20	69	69	NUM
fnp-2639	53	21	years	year	NOUN
fnp-2639	53	22	)	)	PUNCT
fnp-2639	53	23	.	.	PUNCT
fnp-2639	54	1	the	the	DET
fnp-2639	54	2	median	median	ADJ
fnp-2639	54	3	disease	disease	NOUN
fnp-2639	54	4	duration	duration	NOUN
fnp-2639	54	5	was	be	AUX
fnp-2639	54	6	5	5	NUM
fnp-2639	54	7	years	year	NOUN
fnp-2639	54	8	(	(	PUNCT
fnp-2639	54	9	range	range	NOUN
fnp-2639	54	10	3	3	NUM
fnp-2639	54	11	-	-	SYM
fnp-2639	54	12	13	13	NUM
fnp-2639	54	13	years	year	NOUN
fnp-2639	54	14	)	)	PUNCT
fnp-2639	54	15	.	.	PUNCT
fnp-2639	55	1	the	the	DET
fnp-2639	55	2	most	most	ADV
fnp-2639	55	3	common	common	ADJ
fnp-2639	55	4	final	final	ADJ
fnp-2639	55	5	clinical	clinical	ADJ
fnp-2639	55	6	diagnosis	diagnosis	NOUN
fnp-2639	55	7	in	in	ADP
fnp-2639	55	8	this	this	DET
fnp-2639	55	9	series	series	NOUN
fnp-2639	55	10	was	be	AUX
fnp-2639	55	11	behavioral	behavioral	ADJ
fnp-2639	55	12	variant	variant	NOUN
fnp-2639	55	13	of	of	ADP
fnp-2639	55	14	frontotemporal	frontotemporal	ADJ
fnp-2639	55	15	dementia	dementia	NOUN
fnp-2639	55	16	(	(	PUNCT
fnp-2639	55	17	bvftd)(4	bvftd)(4	PROPN
fnp-2639	55	18	,	,	PUNCT
fnp-2639	55	19	24	24	NUM
fnp-2639	55	20	)	)	PUNCT
fnp-2639	55	21	,	,	PUNCT
fnp-2639	55	22	rendered	render	VERB
fnp-2639	55	23	in	in	ADP
fnp-2639	55	24	10	10	NUM
fnp-2639	55	25	(	(	PUNCT
fnp-2639	55	26	67	67	NUM
fnp-2639	55	27	%	%	NOUN
fnp-2639	55	28	)	)	PUNCT
fnp-2639	55	29	cases	case	NOUN
fnp-2639	55	30	.	.	PUNCT
fnp-2639	56	1	for	for	ADP
fnp-2639	56	2	the	the	DET
fnp-2639	56	3	other	other	ADJ
fnp-2639	56	4	5	5	NUM
fnp-2639	56	5	cases	case	NOUN
fnp-2639	56	6	,	,	PUNCT
fnp-2639	56	7	the	the	DET
fnp-2639	56	8	final	final	ADJ
fnp-2639	56	9	clinical	clinical	ADJ
fnp-2639	56	10	diagnoses	diagnosis	NOUN
fnp-2639	56	11	were	be	AUX
fnp-2639	56	12	corticobasal	corticobasal	NOUN
fnp-2639	56	13	syndrome	syndrome	NOUN
fnp-2639	56	14	in	in	ADP
fnp-2639	56	15	two	two	NUM
fnp-2639	56	16	cases(25	cases(25	NOUN
fnp-2639	56	17	)	)	PUNCT
fnp-2639	56	18	,	,	PUNCT
fnp-2639	56	19	and	and	CCONJ
fnp-2639	56	20	one	one	NUM
fnp-2639	56	21	each	each	PRON
fnp-2639	56	22	diagnosed	diagnose	VERB
fnp-2639	56	23	with	with	ADP
fnp-2639	56	24	progressive	progressive	ADJ
fnp-2639	56	25	supranuclear	supranuclear	ADJ
fnp-2639	56	26	palsy(26	palsy(26	PROPN
fnp-2639	56	27	)	)	PUNCT
fnp-2639	56	28	,	,	PUNCT
fnp-2639	56	29	primary	primary	ADJ
fnp-2639	56	30	lateral	lateral	ADJ
fnp-2639	56	31	sclerosis(27	sclerosis(27	NOUN
fnp-2639	56	32	)	)	PUNCT
fnp-2639	56	33	and	and	CCONJ
fnp-2639	56	34	multiple	multiple	ADJ
fnp-2639	56	35	system	system	NOUN
fnp-2639	56	36	atrophy	atrophy	NOUN
fnp-2639	56	37	-	-	PUNCT
fnp-2639	56	38	parkinsonian	parkinsonian	ADJ
fnp-2639	56	39	type	type	NOUN
fnp-2639	56	40	(	(	PUNCT
fnp-2639	56	41	msa	msa	PROPN
fnp-2639	56	42	-	-	PUNCT
fnp-2639	56	43	p)(28	p)(28	PROPN
fnp-2639	56	44	)	)	PUNCT
fnp-2639	56	45	.	.	PUNCT
fnp-2639	57	1	table	table	NOUN
fnp-2639	57	2	1	1	NUM
fnp-2639	57	3	:	:	PUNCT
fnp-2639	57	4	demographic	demographic	ADJ
fnp-2639	57	5	and	and	CCONJ
fnp-2639	57	6	clinical	clinical	ADJ
fnp-2639	57	7	features	feature	NOUN
fnp-2639	57	8	of	of	ADP
fnp-2639	57	9	all	all	DET
fnp-2639	57	10	15	15	NUM
fnp-2639	57	11	cases	case	NOUN
fnp-2639	57	12	als	als	VERB
fnp-2639	57	13	=	=	SYM
fnp-2639	57	14	amyotrophic	amyotrophic	ADJ
fnp-2639	57	15	lateral	lateral	ADJ
fnp-2639	57	16	sclerosis	sclerosis	NOUN
fnp-2639	57	17	;	;	PUNCT
fnp-2639	57	18	bvftd	bvftd	PROPN
fnp-2639	57	19	=	=	PUNCT
fnp-2639	57	20	behavioral	behavioral	ADJ
fnp-2639	57	21	variant	variant	ADJ
fnp-2639	57	22	frontotemporal	frontotemporal	ADJ
fnp-2639	57	23	dementia	dementia	NOUN
fnp-2639	57	24	;	;	PUNCT
fnp-2639	57	25	cbs	cbs	PROPN
fnp-2639	57	26	=	=	SYM
fnp-2639	57	27	corticobasal	corticobasal	PROPN
fnp-2639	57	28	syndrome	syndrome	NOUN
fnp-2639	57	29	ocb	ocb	PROPN
fnp-2639	57	30	=	=	PUNCT
fnp-2639	57	31	obsessive	obsessive	ADJ
fnp-2639	57	32	compulsive	compulsive	ADJ
fnp-2639	57	33	behavior	behavior	NOUN
fnp-2639	57	34	;	;	PUNCT
fnp-2639	57	35	psp	psp	NOUN
fnp-2639	57	36	=	=	SYM
fnp-2639	57	37	progressive	progressive	ADJ
fnp-2639	57	38	supranuclear	supranuclear	ADJ
fnp-2639	57	39	palsy	palsy	ADJ
fnp-2639	57	40	,	,	PUNCT
fnp-2639	57	41	snd	snd	NOUN
fnp-2639	57	42	=	=	SYM
fnp-2639	57	43	striatonigral	striatonigral	ADJ
fnp-2639	57	44	degeneration	degeneration	NOUN
fnp-2639	57	45	†	†	PROPN
fnp-2639	57	46	previously	previously	ADV
fnp-2639	57	47	published	publish	VERB
fnp-2639	57	48	(	(	PUNCT
fnp-2639	58	1	josephs	josephs	PROPN
fnp-2639	58	2	et	et	PROPN
fnp-2639	58	3	al	al	PROPN
fnp-2639	58	4	.	.	PROPN
fnp-2639	58	5	acta	acta	PROPN
fnp-2639	58	6	neuropathol	neuropathol	PROPN
fnp-2639	58	7	2008	2008	NUM
fnp-2639	58	8	;	;	PUNCT
fnp-2639	58	9	116	116	NUM
fnp-2639	58	10	:	:	PUNCT
fnp-2639	58	11	159	159	NUM
fnp-2639	58	12	-	-	SYM
fnp-2639	58	13	167	167	NUM
fnp-2639	58	14	)	)	PUNCT
fnp-2639	58	15	‡	‡	VERB
fnp-2639	58	16	previously	previously	ADV
fnp-2639	58	17	published	publish	VERB
fnp-2639	58	18	(	(	PUNCT
fnp-2639	58	19	josephs	josephs	PROPN
fnp-2639	58	20	et	et	PROPN
fnp-2639	58	21	al	al	PROPN
fnp-2639	58	22	.	.	PROPN
fnp-2639	58	23	brain	brain	PROPN
fnp-2639	58	24	2003	2003	NUM
fnp-2639	58	25	;	;	PUNCT
fnp-2639	58	26	126	126	NUM
fnp-2639	58	27	:	:	PUNCT
fnp-2639	58	28	2291	2291	NUM
fnp-2639	58	29	-	-	SYM
fnp-2639	58	30	2303	2303	NUM
fnp-2639	58	31	*	*	PUNCT
fnp-2639	58	32	previously	previously	ADV
fnp-2639	58	33	published	publish	VERB
fnp-2639	58	34	(	(	PUNCT
fnp-2639	58	35	josephs	josephs	PROPN
fnp-2639	58	36	et	et	PROPN
fnp-2639	58	37	al	al	PROPN
fnp-2639	58	38	.	.	PROPN
fnp-2639	59	1	acta	acta	PROPN
fnp-2639	59	2	neuropathol	neuropathol	PROPN
fnp-2639	59	3	2005	2005	NUM
fnp-2639	59	4	;	;	PUNCT
fnp-2639	59	5	109	109	NUM
fnp-2639	59	6	:	:	SYM
fnp-2639	59	7	427	427	NUM
fnp-2639	59	8	-	-	SYM
fnp-2639	59	9	32	32	NUM
fnp-2639	59	10	)	)	PUNCT
fnp-2639	59	11	the	the	DET
fnp-2639	59	12	median	median	ADJ
fnp-2639	59	13	age	age	NOUN
fnp-2639	59	14	of	of	ADP
fnp-2639	59	15	onset	onset	NOUN
fnp-2639	59	16	of	of	ADP
fnp-2639	59	17	the	the	DET
fnp-2639	59	18	nifid	nifid	ADJ
fnp-2639	59	19	cases	case	NOUN
fnp-2639	59	20	was	be	AUX
fnp-2639	59	21	52	52	NUM
fnp-2639	59	22	years	year	NOUN
fnp-2639	59	23	old	old	ADJ
fnp-2639	59	24	(	(	PUNCT
fnp-2639	59	25	range	range	NOUN
fnp-2639	59	26	:	:	PUNCT
fnp-2639	59	27	41	41	NUM
fnp-2639	59	28	-	-	SYM
fnp-2639	59	29	61	61	NUM
fnp-2639	59	30	years	year	NOUN
fnp-2639	59	31	)	)	PUNCT
fnp-2639	59	32	while	while	SCONJ
fnp-2639	59	33	for	for	ADP
fnp-2639	59	34	aftld	aftld	NOUN
fnp-2639	59	35	-	-	PUNCT
fnp-2639	59	36	u	u	NOUN
fnp-2639	59	37	it	it	PRON
fnp-2639	59	38	was	be	AUX
fnp-2639	59	39	54	54	NUM
fnp-2639	59	40	years	year	NOUN
fnp-2639	59	41	old	old	ADJ
fnp-2639	59	42	(	(	PUNCT
fnp-2639	59	43	range	range	NOUN
fnp-2639	59	44	:	:	PUNCT
fnp-2639	59	45	42	42	NUM
fnp-2639	59	46	-	-	SYM
fnp-2639	59	47	69	69	NUM
fnp-2639	59	48	years	year	NOUN
fnp-2639	59	49	)	)	PUNCT
fnp-2639	59	50	.	.	PUNCT
fnp-2639	60	1	disease	disease	NOUN
fnp-2639	60	2	duration	duration	NOUN
fnp-2639	60	3	in	in	ADP
fnp-2639	60	4	nifid	nifid	ADJ
fnp-2639	60	5	was	be	AUX
fnp-2639	60	6	only	only	ADV
fnp-2639	60	7	3.5	3.5	NUM
fnp-2639	60	8	years	year	NOUN
fnp-2639	60	9	(	(	PUNCT
fnp-2639	60	10	range	range	NOUN
fnp-2639	60	11	:	:	PUNCT
fnp-2639	60	12	2.0	2.0	NUM
fnp-2639	60	13	-	-	SYM
fnp-2639	60	14	5.0	5.0	NUM
fnp-2639	60	15	years	year	NOUN
fnp-2639	60	16	)	)	PUNCT
fnp-2639	60	17	and	and	CCONJ
fnp-2639	60	18	was	be	AUX
fnp-2639	60	19	much	much	ADV
fnp-2639	60	20	shorter	short	ADJ
fnp-2639	60	21	than	than	ADP
fnp-2639	60	22	the	the	DET
fnp-2639	60	23	median	median	ADJ
fnp-2639	60	24	disease	disease	NOUN
fnp-2639	60	25	duration	duration	NOUN
fnp-2639	60	26	of	of	ADP
fnp-2639	60	27	the	the	DET
fnp-2639	60	28	aftld	aftld	ADJ
fnp-2639	60	29	-	-	PUNCT
fnp-2639	60	30	u	u	NOUN
fnp-2639	60	31	group	group	NOUN
fnp-2639	60	32	which	which	PRON
fnp-2639	60	33	was	be	AUX
fnp-2639	60	34	10	10	NUM
fnp-2639	60	35	years	year	NOUN
fnp-2639	60	36	(	(	PUNCT
fnp-2639	60	37	range	range	NOUN
fnp-2639	60	38	:	:	PUNCT
fnp-2639	60	39	4	4	NUM
fnp-2639	60	40	-	-	SYM
fnp-2639	60	41	13	13	NUM
fnp-2639	60	42	years	year	NOUN
fnp-2639	60	43	)	)	PUNCT
fnp-2639	60	44	(	(	PUNCT
fnp-2639	60	45	p<0.05	p<0.05	NOUN
fnp-2639	60	46	)	)	PUNCT
fnp-2639	60	47	.	.	PUNCT
fnp-2639	61	1	the	the	DET
fnp-2639	61	2	clinical	clinical	ADJ
fnp-2639	61	3	diagnoses	diagnosis	NOUN
fnp-2639	61	4	were	be	AUX
fnp-2639	61	5	heterogeneous	heterogeneous	ADJ
fnp-2639	61	6	in	in	ADP
fnp-2639	61	7	the	the	DET
fnp-2639	61	8	nifid	nifid	ADJ
fnp-2639	61	9	cases	case	NOUN
fnp-2639	61	10	,	,	PUNCT
fnp-2639	61	11	with	with	ADP
fnp-2639	61	12	three	three	NUM
fnp-2639	61	13	cases	case	NOUN
fnp-2639	61	14	(	(	PUNCT
fnp-2639	61	15	43	43	NUM
fnp-2639	61	16	%	%	NOUN
fnp-2639	61	17	)	)	PUNCT
fnp-2639	61	18	diagnosed	diagnose	VERB
fnp-2639	61	19	as	as	ADP
fnp-2639	61	20	bvftd	bvftd	PROPN
fnp-2639	61	21	.	.	PUNCT
fnp-2639	62	1	on	on	ADP
fnp-2639	62	2	the	the	DET
fnp-2639	62	3	other	other	ADJ
fnp-2639	62	4	hand	hand	NOUN
fnp-2639	62	5	,	,	PUNCT
fnp-2639	62	6	of	of	ADP
fnp-2639	62	7	the	the	DET
fnp-2639	62	8	aftld	aftld	ADJ
fnp-2639	62	9	-	-	PUNCT
fnp-2639	62	10	u	u	NOUN
fnp-2639	62	11	cases	case	NOUN
fnp-2639	62	12	all	all	PRON
fnp-2639	62	13	but	but	SCONJ
fnp-2639	62	14	one	one	NUM
fnp-2639	62	15	(	(	PUNCT
fnp-2639	62	16	88	88	NUM
fnp-2639	62	17	%	%	NOUN
fnp-2639	62	18	)	)	PUNCT
fnp-2639	62	19	had	have	AUX
fnp-2639	62	20	been	be	AUX
fnp-2639	62	21	diagnosed	diagnose	VERB
fnp-2639	62	22	with	with	ADP
fnp-2639	62	23	bvftd	bvftd	PROPN
fnp-2639	62	24	.	.	PUNCT
fnp-2639	63	1	the	the	DET
fnp-2639	63	2	nifid	nifid	ADJ
fnp-2639	63	3	cases	case	NOUN
fnp-2639	63	4	were	be	AUX
fnp-2639	63	5	more	more	ADV
fnp-2639	63	6	likely	likely	ADJ
fnp-2639	63	7	to	to	PART
fnp-2639	63	8	have	have	AUX
fnp-2639	63	9	had	have	VERB
fnp-2639	63	10	pyramidal	pyramidal	ADJ
fnp-2639	63	11	tract	tract	NOUN
fnp-2639	63	12	signs	sign	NOUN
fnp-2639	63	13	and	and	CCONJ
fnp-2639	63	14	motor	motor	NOUN
fnp-2639	63	15	dysfunction	dysfunction	NOUN
fnp-2639	63	16	compared	compare	VERB
fnp-2639	63	17	to	to	ADP
fnp-2639	63	18	the	the	DET
fnp-2639	63	19	aftld	aftld	ADJ
fnp-2639	63	20	-	-	PUNCT
fnp-2639	63	21	u	u	NOUN
fnp-2639	63	22	cases	case	NOUN
fnp-2639	63	23	;	;	PUNCT
fnp-2639	63	24	myoclonic	myoclonic	ADJ
fnp-2639	63	25	jerks	jerk	NOUN
fnp-2639	63	26	and	and	CCONJ
fnp-2639	63	27	excessive	excessive	ADJ
fnp-2639	63	28	startle	startle	NOUN
fnp-2639	63	29	were	be	AUX
fnp-2639	63	30	also	also	ADV
fnp-2639	63	31	observed	observe	VERB
fnp-2639	63	32	in	in	ADP
fnp-2639	63	33	nifid	nifid	ADJ
fnp-2639	63	34	but	but	CCONJ
fnp-2639	63	35	not	not	PART
fnp-2639	63	36	aftld	aftld	PROPN
fnp-2639	63	37	-	-	PUNCT
fnp-2639	63	38	u.	u.	NOUN
fnp-2639	63	39	pathological	pathological	ADJ
fnp-2639	63	40	findings	finding	NOUN
fnp-2639	63	41	gross	gross	ADJ
fnp-2639	63	42	examination	examination	NOUN
fnp-2639	63	43	all	all	DET
fnp-2639	63	44	15	15	NUM
fnp-2639	63	45	cases	case	NOUN
fnp-2639	63	46	had	have	VERB
fnp-2639	63	47	evidence	evidence	NOUN
fnp-2639	63	48	of	of	ADP
fnp-2639	63	49	frontal	frontal	ADJ
fnp-2639	63	50	and	and	CCONJ
fnp-2639	63	51	temporal	temporal	ADJ
fnp-2639	63	52	lobe	lobe	ADJ
fnp-2639	63	53	atrophy	atrophy	NOUN
fnp-2639	63	54	,	,	PUNCT
fnp-2639	63	55	and	and	CCONJ
fnp-2639	63	56	hence	hence	ADV
fnp-2639	63	57	all	all	PRON
fnp-2639	63	58	met	meet	VERB
fnp-2639	63	59	criteria	criterion	NOUN
fnp-2639	63	60	for	for	ADP
fnp-2639	63	61	ftld	ftld	ADJ
fnp-2639	63	62	.	.	PUNCT
fnp-2639	64	1	striatal	striatal	ADJ
fnp-2639	64	2	atrophy	atrophy	NOUN
fnp-2639	64	3	was	be	AUX
fnp-2639	64	4	observed	observe	VERB
fnp-2639	64	5	in	in	ADP
fnp-2639	64	6	nine	nine	NUM
fnp-2639	64	7	of	of	ADP
fnp-2639	64	8	the	the	DET
fnp-2639	64	9	15	15	NUM
fnp-2639	64	10	cases	case	NOUN
fnp-2639	64	11	(	(	PUNCT
fnp-2639	64	12	table	table	NOUN
fnp-2639	64	13	2	2	NUM
fnp-2639	64	14	,	,	PUNCT
fnp-2639	64	15	figure	figure	NOUN
fnp-2639	64	16	1	1	NUM
fnp-2639	64	17	)	)	PUNCT
fnp-2639	64	18	.	.	PUNCT
fnp-2639	65	1	table	table	NOUN
fnp-2639	65	2	2	2	NUM
fnp-2639	65	3	:	:	PUNCT
fnp-2639	65	4	nci	nci	PROPN
fnp-2639	65	5	immunohistochemical	immunohistochemical	ADJ
fnp-2639	65	6	profile	profile	NOUN
fnp-2639	65	7	in	in	ADP
fnp-2639	65	8	15	15	NUM
fnp-2639	65	9	aftld	aftld	ADJ
fnp-2639	65	10	-	-	PUNCT
fnp-2639	65	11	u	u	NOUN
fnp-2639	65	12	and	and	CCONJ
fnp-2639	65	13	nifid	nifid	ADJ
fnp-2639	65	14	cases	case	NOUN
fnp-2639	65	15	β	β	X
fnp-2639	65	16	diffuse	diffuse	VERB
fnp-2639	65	17	cytoplasmic	cytoplasmic	ADJ
fnp-2639	65	18	fus	fu	NOUN
fnp-2639	65	19	staining	stain	VERB
fnp-2639	65	20	with	with	ADP
fnp-2639	65	21	mini	mini	ADJ
fnp-2639	65	22	-	-	NOUN
fnp-2639	65	23	pick	pick	ADJ
fnp-2639	65	24	body	body	NOUN
fnp-2639	65	25	-	-	PUNCT
fnp-2639	65	26	like	like	ADJ
fnp-2639	65	27	nci	nci	NOUN
fnp-2639	65	28	na	na	NOUN
fnp-2639	65	29	=	=	PUNCT
fnp-2639	65	30	not	not	PART
fnp-2639	65	31	able	able	ADJ
fnp-2639	65	32	to	to	PART
fnp-2639	65	33	find	find	VERB
fnp-2639	65	34	any	any	DET
fnp-2639	65	35	neuronal	neuronal	ADJ
fnp-2639	65	36	intranuclear	intranuclear	NOUN
fnp-2639	65	37	inclusions	inclusion	NOUN
fnp-2639	65	38	(	(	PUNCT
fnp-2639	65	39	nii	nii	NOUN
fnp-2639	65	40	)	)	PUNCT
fnp-2639	65	41	figure	figure	NOUN
fnp-2639	65	42	1	1	NUM
fnp-2639	65	43	:	:	PUNCT
fnp-2639	65	44	striatal	striatal	ADJ
fnp-2639	65	45	atrophy	atrophy	NOUN
fnp-2639	65	46	on	on	ADP
fnp-2639	65	47	gross	gross	ADJ
fnp-2639	65	48	examination	examination	NOUN
fnp-2639	65	49	striatal	striatal	ADJ
fnp-2639	65	50	atrophy	atrophy	NOUN
fnp-2639	65	51	was	be	AUX
fnp-2639	65	52	not	not	PART
fnp-2639	65	53	seen	see	VERB
fnp-2639	65	54	in	in	ADP
fnp-2639	65	55	many	many	ADJ
fnp-2639	65	56	nifid	nifid	ADJ
fnp-2639	65	57	cases	case	NOUN
fnp-2639	65	58	(	(	PUNCT
fnp-2639	65	59	a	a	PRON
fnp-2639	65	60	;	;	PUNCT
fnp-2639	65	61	case	case	NOUN
fnp-2639	65	62	5	5	NUM
fnp-2639	65	63	)	)	PUNCT
fnp-2639	65	64	and	and	CCONJ
fnp-2639	65	65	was	be	AUX
fnp-2639	65	66	only	only	ADV
fnp-2639	65	67	observed	observe	VERB
fnp-2639	65	68	in	in	ADP
fnp-2639	65	69	two	two	NUM
fnp-2639	65	70	cases	case	NOUN
fnp-2639	65	71	(	(	PUNCT
fnp-2639	65	72	b	b	NOUN
fnp-2639	65	73	;	;	PUNCT
fnp-2639	65	74	case	case	NOUN
fnp-2639	65	75	6	6	NUM
fnp-2639	65	76	)	)	PUNCT
fnp-2639	65	77	.	.	PUNCT
fnp-2639	66	1	conversely	conversely	ADV
fnp-2639	66	2	,	,	PUNCT
fnp-2639	66	3	only	only	ADV
fnp-2639	66	4	one	one	NUM
fnp-2639	66	5	aftld	aftld	ADJ
fnp-2639	66	6	-	-	PUNCT
fnp-2639	66	7	u	u	NOUN
fnp-2639	66	8	case	case	NOUN
fnp-2639	66	9	lacked	lacked	AUX
fnp-2639	66	10	marked	mark	VERB
fnp-2639	66	11	striatal	striatal	ADJ
fnp-2639	66	12	atrophy	atrophy	NOUN
fnp-2639	66	13	(	(	PUNCT
fnp-2639	66	14	c	c	NOUN
fnp-2639	66	15	;	;	PUNCT
fnp-2639	66	16	case	case	NOUN
fnp-2639	66	17	14	14	NUM
fnp-2639	66	18	)	)	PUNCT
fnp-2639	66	19	while	while	SCONJ
fnp-2639	66	20	the	the	DET
fnp-2639	66	21	rest	rest	NOUN
fnp-2639	66	22	of	of	ADP
fnp-2639	66	23	the	the	DET
fnp-2639	66	24	aftld	aftld	ADJ
fnp-2639	66	25	-	-	PUNCT
fnp-2639	66	26	u	u	NOUN
fnp-2639	66	27	cases	case	NOUN
fnp-2639	66	28	demonstrated	demonstrate	VERB
fnp-2639	66	29	severe	severe	ADJ
fnp-2639	66	30	atrophy	atrophy	NOUN
fnp-2639	66	31	(	(	PUNCT
fnp-2639	66	32	d	d	NOUN
fnp-2639	66	33	;	;	PUNCT
fnp-2639	66	34	case	case	NOUN
fnp-2639	66	35	13	13	NUM
fnp-2639	66	36	)	)	PUNCT
fnp-2639	67	1	[	[	X
fnp-2639	67	2	bar	bar	NOUN
fnp-2639	67	3	:	:	PUNCT
fnp-2639	67	4	1	1	NUM
fnp-2639	67	5	cm	cm	NOUN
fnp-2639	67	6	]	]	PUNCT
fnp-2639	67	7	.	.	PUNCT
fnp-2639	68	1	light	light	ADJ
fnp-2639	68	2	microscopy	microscopy	NOUN
fnp-2639	68	3	results	result	NOUN
fnp-2639	68	4	of	of	ADP
fnp-2639	68	5	the	the	DET
fnp-2639	68	6	light	light	ADJ
fnp-2639	68	7	microscopic	microscopic	ADJ
fnp-2639	68	8	examination	examination	NOUN
fnp-2639	68	9	are	be	AUX
fnp-2639	68	10	shown	show	VERB
fnp-2639	68	11	in	in	ADP
fnp-2639	68	12	table	table	NOUN
fnp-2639	68	13	2	2	NUM
fnp-2639	68	14	and	and	CCONJ
fnp-2639	68	15	figure	figure	NOUN
fnp-2639	68	16	2	2	NUM
fnp-2639	68	17	.	.	PUNCT
fnp-2639	69	1	none	none	NOUN
fnp-2639	69	2	of	of	ADP
fnp-2639	69	3	the	the	DET
fnp-2639	69	4	15	15	NUM
fnp-2639	69	5	cases	case	NOUN
fnp-2639	69	6	had	have	VERB
fnp-2639	69	7	evidence	evidence	NOUN
fnp-2639	69	8	of	of	ADP
fnp-2639	69	9	tau	tau	PROPN
fnp-2639	69	10	deposition	deposition	NOUN
fnp-2639	69	11	,	,	PUNCT
fnp-2639	69	12	and	and	CCONJ
fnp-2639	69	13	none	none	NOUN
fnp-2639	69	14	met	meet	VERB
fnp-2639	69	15	criteria	criterion	NOUN
fnp-2639	69	16	for	for	ADP
fnp-2639	69	17	alzheimer	alzheimer	PROPN
fnp-2639	69	18	’s	’s	PART
fnp-2639	69	19	or	or	CCONJ
fnp-2639	69	20	lewy	lewy	ADJ
fnp-2639	69	21	body	body	NOUN
fnp-2639	69	22	disease	disease	NOUN
fnp-2639	69	23	.	.	PUNCT
fnp-2639	70	1	all	all	DET
fnp-2639	70	2	15	15	NUM
fnp-2639	70	3	cases	case	NOUN
fnp-2639	70	4	were	be	AUX
fnp-2639	70	5	immune	immune	NOUN
fnp-2639	70	6	-	-	PUNCT
fnp-2639	70	7	reactive	reactive	ADJ
fnp-2639	70	8	to	to	ADP
fnp-2639	70	9	ubiquitin	ubiquitin	NOUN
fnp-2639	70	10	.	.	PUNCT
fnp-2639	71	1	thirteen	thirteen	NUM
fnp-2639	71	2	of	of	ADP
fnp-2639	71	3	the	the	DET
fnp-2639	71	4	15	15	NUM
fnp-2639	71	5	cases	case	NOUN
fnp-2639	71	6	had	have	VERB
fnp-2639	71	7	neuronal	neuronal	ADJ
fnp-2639	71	8	inclusions	inclusion	NOUN
fnp-2639	71	9	that	that	PRON
fnp-2639	71	10	were	be	AUX
fnp-2639	71	11	immune	immune	NOUN
fnp-2639	71	12	-	-	PUNCT
fnp-2639	71	13	reactive	reactive	ADJ
fnp-2639	71	14	to	to	ADP
fnp-2639	71	15	fus	fus	PROPN
fnp-2639	71	16	.	.	PUNCT
fnp-2639	72	1	seven	seven	NUM
fnp-2639	72	2	of	of	ADP
fnp-2639	72	3	the	the	DET
fnp-2639	72	4	15	15	NUM
fnp-2639	72	5	cases	case	NOUN
fnp-2639	72	6	had	have	VERB
fnp-2639	72	7	eosinophilic	eosinophilic	ADJ
fnp-2639	72	8	inclusions	inclusion	NOUN
fnp-2639	72	9	that	that	PRON
fnp-2639	72	10	were	be	AUX
fnp-2639	72	11	seen	see	VERB
fnp-2639	72	12	on	on	ADP
fnp-2639	72	13	hematoxylin	hematoxylin	NOUN
fnp-2639	72	14	and	and	CCONJ
fnp-2639	72	15	eosin	eosin	NOUN
fnp-2639	72	16	and	and	CCONJ
fnp-2639	72	17	were	be	AUX
fnp-2639	72	18	immunostained	immunostaine	VERB
fnp-2639	72	19	for	for	ADP
fnp-2639	72	20	α	α	NOUN
fnp-2639	72	21	-	-	NOUN
fnp-2639	72	22	internexin	internexin	NOUN
fnp-2639	72	23	in	in	ADP
fnp-2639	72	24	keeping	keep	VERB
fnp-2639	72	25	with	with	ADP
fnp-2639	72	26	their	their	PRON
fnp-2639	72	27	pathological	pathological	ADJ
fnp-2639	72	28	diagnosis	diagnosis	NOUN
fnp-2639	72	29	of	of	ADP
fnp-2639	72	30	nifid	nifid	NOUN
fnp-2639	72	31	.	.	PUNCT
fnp-2639	73	1	none	none	NOUN
fnp-2639	73	2	of	of	ADP
fnp-2639	73	3	the	the	DET
fnp-2639	73	4	remaining	remain	VERB
fnp-2639	73	5	eight	eight	NUM
fnp-2639	73	6	cases	case	NOUN
fnp-2639	73	7	that	that	PRON
fnp-2639	73	8	had	have	AUX
fnp-2639	73	9	been	be	AUX
fnp-2639	73	10	diagnosed	diagnose	VERB
fnp-2639	73	11	as	as	ADP
fnp-2639	73	12	aftld	aftld	ADJ
fnp-2639	73	13	-	-	PUNCT
fnp-2639	73	14	u	u	NOUN
fnp-2639	73	15	showed	show	VERB
fnp-2639	73	16	α	α	PRON
fnp-2639	73	17	-	-	ADJ
fnp-2639	73	18	internexin	internexin	ADJ
fnp-2639	73	19	immunoreactivity	immunoreactivity	NOUN
fnp-2639	73	20	.	.	PUNCT
fnp-2639	74	1	seven	seven	NUM
fnp-2639	74	2	of	of	ADP
fnp-2639	74	3	the	the	DET
fnp-2639	74	4	eight	eight	NUM
fnp-2639	74	5	aftld	aftld	ADJ
fnp-2639	74	6	-	-	PUNCT
fnp-2639	74	7	u	u	NOUN
fnp-2639	74	8	cases	case	NOUN
fnp-2639	74	9	(	(	PUNCT
fnp-2639	74	10	88	88	NUM
fnp-2639	74	11	%	%	NOUN
fnp-2639	74	12	)	)	PUNCT
fnp-2639	74	13	showed	show	VERB
fnp-2639	74	14	severe	severe	ADJ
fnp-2639	74	15	striatal	striatal	ADJ
fnp-2639	74	16	atrophy	atrophy	NOUN
fnp-2639	74	17	with	with	ADP
fnp-2639	74	18	fus	fus	ADJ
fnp-2639	74	19	-	-	PUNCT
fnp-2639	74	20	positive	positive	ADJ
fnp-2639	74	21	neuronal	neuronal	ADJ
fnp-2639	74	22	cytoplasmic	cytoplasmic	ADJ
fnp-2639	74	23	and	and	CCONJ
fnp-2639	74	24	vermiform	vermiform	ADJ
fnp-2639	74	25	intranuclear	intranuclear	NOUN
fnp-2639	74	26	inclusions	inclusion	NOUN
fnp-2639	74	27	.	.	PUNCT
fnp-2639	75	1	of	of	ADP
fnp-2639	75	2	the	the	DET
fnp-2639	75	3	seven	seven	NUM
fnp-2639	75	4	nifid	nifid	ADJ
fnp-2639	75	5	cases	case	NOUN
fnp-2639	75	6	,	,	PUNCT
fnp-2639	75	7	five	five	NUM
fnp-2639	75	8	cases	case	NOUN
fnp-2639	75	9	had	have	VERB
fnp-2639	75	10	neuronal	neuronal	ADJ
fnp-2639	75	11	inclusions	inclusion	NOUN
fnp-2639	75	12	that	that	PRON
fnp-2639	75	13	were	be	AUX
fnp-2639	75	14	immunoreactive	immunoreactive	ADJ
fnp-2639	75	15	to	to	ADP
fnp-2639	75	16	fus	fus	PROPN
fnp-2639	75	17	.	.	PUNCT
fnp-2639	76	1	unlike	unlike	ADP
fnp-2639	76	2	in	in	ADP
fnp-2639	76	3	aftld	aftld	ADJ
fnp-2639	76	4	-	-	PUNCT
fnp-2639	76	5	u	u	NOUN
fnp-2639	76	6	,	,	PUNCT
fnp-2639	76	7	striatal	striatal	ADJ
fnp-2639	76	8	atrophy	atrophy	NOUN
fnp-2639	76	9	was	be	AUX
fnp-2639	76	10	only	only	ADV
fnp-2639	76	11	present	present	ADJ
fnp-2639	76	12	in	in	ADP
fnp-2639	76	13	only	only	ADV
fnp-2639	76	14	2/7	2/7	NUM
fnp-2639	76	15	(	(	PUNCT
fnp-2639	76	16	29	29	NUM
fnp-2639	76	17	%	%	NOUN
fnp-2639	76	18	)	)	PUNCT
fnp-2639	76	19	of	of	ADP
fnp-2639	76	20	the	the	DET
fnp-2639	76	21	nifid	nifid	ADJ
fnp-2639	76	22	cases	case	NOUN
fnp-2639	76	23	,	,	PUNCT
fnp-2639	76	24	both	both	PRON
fnp-2639	76	25	of	of	ADP
fnp-2639	76	26	which	which	PRON
fnp-2639	76	27	were	be	AUX
fnp-2639	76	28	fus	fus	ADV
fnp-2639	76	29	positive	positive	ADJ
fnp-2639	76	30	.	.	PUNCT
fnp-2639	77	1	hence	hence	ADV
fnp-2639	77	2	,	,	PUNCT
fnp-2639	77	3	neither	neither	PRON
fnp-2639	77	4	of	of	ADP
fnp-2639	77	5	the	the	DET
fnp-2639	77	6	two	two	NUM
fnp-2639	77	7	fus	fus	ADJ
fnp-2639	77	8	negative	negative	ADJ
fnp-2639	77	9	nifid	nifid	ADJ
fnp-2639	77	10	cases	case	NOUN
fnp-2639	77	11	had	have	VERB
fnp-2639	77	12	striatal	striatal	ADJ
fnp-2639	77	13	atrophy	atrophy	NOUN
fnp-2639	77	14	.	.	PUNCT
fnp-2639	78	1	therefore	therefore	ADV
fnp-2639	78	2	,	,	PUNCT
fnp-2639	78	3	9/13	9/13	NUM
fnp-2639	78	4	cases	case	NOUN
fnp-2639	78	5	with	with	ADP
fnp-2639	78	6	fus	fus	X
fnp-2639	78	7	immunoreactive	immunoreactive	ADJ
fnp-2639	78	8	inclusions	inclusion	NOUN
fnp-2639	78	9	showed	show	VERB
fnp-2639	78	10	striatal	striatal	ADJ
fnp-2639	78	11	atrophy	atrophy	NOUN
fnp-2639	78	12	while	while	SCONJ
fnp-2639	78	13	0/2	0/2	NUM
fnp-2639	78	14	without	without	ADP
fnp-2639	78	15	fus	fus	PROPN
fnp-2639	78	16	showed	show	VERB
fnp-2639	78	17	striatal	striatal	ADJ
fnp-2639	78	18	atrophy	atrophy	NOUN
fnp-2639	78	19	.	.	PUNCT
fnp-2639	79	1	surprisingly	surprisingly	ADV
fnp-2639	79	2	,	,	PUNCT
fnp-2639	79	3	one	one	NUM
fnp-2639	79	4	of	of	ADP
fnp-2639	79	5	the	the	DET
fnp-2639	79	6	two	two	NUM
fnp-2639	79	7	nifid	nifid	ADJ
fnp-2639	79	8	cases	case	NOUN
fnp-2639	79	9	without	without	ADP
fnp-2639	79	10	fus	fus	PROPN
fnp-2639	79	11	immunoreactivity	immunoreactivity	NOUN
fnp-2639	79	12	had	have	VERB
fnp-2639	79	13	lesions	lesion	NOUN
fnp-2639	79	14	that	that	PRON
fnp-2639	79	15	were	be	AUX
fnp-2639	79	16	immunoreactive	immunoreactive	ADJ
fnp-2639	79	17	for	for	ADP
fnp-2639	79	18	both	both	DET
fnp-2639	79	19	α	α	NOUN
fnp-2639	79	20	-	-	NOUN
fnp-2639	79	21	internexin	internexin	NOUN
fnp-2639	79	22	and	and	CCONJ
fnp-2639	79	23	tdp-43	tdp-43	PROPN
fnp-2639	79	24	(	(	PUNCT
fnp-2639	79	25	figure	figure	NOUN
fnp-2639	79	26	3	3	NUM
fnp-2639	79	27	)	)	PUNCT
fnp-2639	79	28	.	.	PUNCT
fnp-2639	80	1	figure	figure	VERB
fnp-2639	80	2	2	2	NUM
fnp-2639	80	3	:	:	PUNCT
fnp-2639	80	4	alpha	alpha	NOUN
fnp-2639	80	5	-	-	PUNCT
fnp-2639	80	6	internexin	internexin	PROPN
fnp-2639	80	7	and	and	CCONJ
fnp-2639	80	8	fus	fus	ADJ
fnp-2639	80	9	pathology	pathology	NOUN
fnp-2639	80	10	hematoxylin	hematoxylin	NOUN
fnp-2639	80	11	and	and	CCONJ
fnp-2639	80	12	eosin	eosin	NOUN
fnp-2639	80	13	(	(	PUNCT
fnp-2639	80	14	a	a	DET
fnp-2639	80	15	/	/	SYM
fnp-2639	80	16	e	e	NOUN
fnp-2639	80	17	/	/	SYM
fnp-2639	80	18	i	i	PROPN
fnp-2639	80	19	/	/	SYM
fnp-2639	80	20	m	m	PROPN
fnp-2639	80	21	)	)	PUNCT
fnp-2639	80	22	,	,	PUNCT
fnp-2639	80	23	α	α	X
fnp-2639	80	24	-	-	NOUN
fnp-2639	80	25	internexin	internexin	NOUN
fnp-2639	80	26	(	(	PUNCT
fnp-2639	80	27	b	b	X
fnp-2639	80	28	/	/	SYM
fnp-2639	80	29	f	f	PROPN
fnp-2639	80	30	/	/	SYM
fnp-2639	80	31	j	j	PROPN
fnp-2639	80	32	/	/	SYM
fnp-2639	80	33	n	n	CCONJ
fnp-2639	80	34	)	)	PUNCT
fnp-2639	80	35	and	and	CCONJ
fnp-2639	80	36	fus	fus	INTJ
fnp-2639	80	37	(	(	PUNCT
fnp-2639	80	38	c	c	NOUN
fnp-2639	80	39	/	/	SYM
fnp-2639	80	40	g	g	NOUN
fnp-2639	80	41	/	/	SYM
fnp-2639	80	42	k	k	NOUN
fnp-2639	80	43	/	/	SYM
fnp-2639	80	44	o	o	NOUN
fnp-2639	80	45	)	)	PUNCT
fnp-2639	80	46	in	in	ADP
fnp-2639	80	47	the	the	DET
fnp-2639	80	48	frontal	frontal	ADJ
fnp-2639	80	49	cortex	cortex	NOUN
fnp-2639	80	50	and	and	CCONJ
fnp-2639	80	51	fus	fus	ADJ
fnp-2639	80	52	(	(	PUNCT
fnp-2639	80	53	d	d	NOUN
fnp-2639	80	54	/	/	SYM
fnp-2639	80	55	h	h	NOUN
fnp-2639	80	56	/	/	SYM
fnp-2639	80	57	l	l	NOUN
fnp-2639	80	58	/	/	SYM
fnp-2639	80	59	p	p	NOUN
fnp-2639	80	60	)	)	PUNCT
fnp-2639	80	61	in	in	ADP
fnp-2639	80	62	the	the	DET
fnp-2639	80	63	hippocampus	hippocampus	NOUN
fnp-2639	80	64	of	of	ADP
fnp-2639	80	65	cases	case	NOUN
fnp-2639	80	66	4	4	NUM
fnp-2639	80	67	(	(	PUNCT
fnp-2639	80	68	a	a	NOUN
fnp-2639	80	69	-	-	PUNCT
fnp-2639	80	70	d	d	NOUN
fnp-2639	80	71	)	)	PUNCT
fnp-2639	80	72	,	,	PUNCT
fnp-2639	80	73	5	5	NUM
fnp-2639	80	74	(	(	PUNCT
fnp-2639	80	75	e	e	NOUN
fnp-2639	80	76	-	-	NOUN
fnp-2639	80	77	h	h	NOUN
fnp-2639	80	78	)	)	PUNCT
fnp-2639	80	79	,	,	PUNCT
fnp-2639	80	80	7	7	NUM
fnp-2639	80	81	(	(	PUNCT
fnp-2639	80	82	i	i	NOUN
fnp-2639	80	83	-	-	PUNCT
fnp-2639	80	84	l	l	NOUN
fnp-2639	80	85	)	)	PUNCT
fnp-2639	80	86	,	,	PUNCT
fnp-2639	80	87	and	and	CCONJ
fnp-2639	80	88	15	15	NUM
fnp-2639	80	89	(	(	PUNCT
fnp-2639	80	90	m	m	NOUN
fnp-2639	80	91	-	-	ADJ
fnp-2639	80	92	p	p	X
fnp-2639	80	93	)	)	PUNCT
fnp-2639	81	1	[	[	X
fnp-2639	81	2	bar:100	bar:100	NOUN
fnp-2639	81	3	μm	μm	NUM
fnp-2639	81	4	]	]	PUNCT
fnp-2639	81	5	figure	figure	NOUN
fnp-2639	81	6	3	3	NUM
fnp-2639	81	7	:	:	PUNCT
fnp-2639	81	8	fus	fus	NUM
fnp-2639	81	9	negative	negative	ADJ
fnp-2639	81	10	tdp-43	tdp-43	ADP
fnp-2639	81	11	positive	positive	ADJ
fnp-2639	81	12	nifid	nifid	ADJ
fnp-2639	81	13	case	case	NOUN
fnp-2639	81	14	neuronal	neuronal	ADJ
fnp-2639	81	15	eosinophilic	eosinophilic	NOUN
fnp-2639	81	16	(	(	PUNCT
fnp-2639	81	17	a	a	PROPN
fnp-2639	81	18	/	/	SYM
fnp-2639	81	19	b	b	NOUN
fnp-2639	81	20	)	)	PUNCT
fnp-2639	81	21	inclusions	inclusion	NOUN
fnp-2639	81	22	in	in	ADP
fnp-2639	81	23	the	the	DET
fnp-2639	81	24	hippocampus	hippocampus	NOUN
fnp-2639	81	25	(	(	PUNCT
fnp-2639	81	26	a	a	X
fnp-2639	81	27	/	/	SYM
fnp-2639	81	28	c	c	NOUN
fnp-2639	81	29	/	/	SYM
fnp-2639	81	30	e	e	NOUN
fnp-2639	81	31	/	/	SYM
fnp-2639	81	32	g	g	NOUN
fnp-2639	81	33	)	)	PUNCT
fnp-2639	81	34	and	and	CCONJ
fnp-2639	81	35	frontal	frontal	ADJ
fnp-2639	81	36	cortex	cortex	NOUN
fnp-2639	81	37	(	(	PUNCT
fnp-2639	81	38	b	b	X
fnp-2639	81	39	/	/	SYM
fnp-2639	81	40	d	d	NOUN
fnp-2639	81	41	/	/	SYM
fnp-2639	81	42	f	f	NOUN
fnp-2639	81	43	/	/	SYM
fnp-2639	81	44	h	h	NOUN
fnp-2639	81	45	)	)	PUNCT
fnp-2639	81	46	of	of	ADP
fnp-2639	81	47	case	case	NOUN
fnp-2639	81	48	3	3	NUM
fnp-2639	81	49	are	be	AUX
fnp-2639	81	50	negative	negative	ADJ
fnp-2639	81	51	for	for	ADP
fnp-2639	81	52	fus	fus	PROPN
fnp-2639	81	53	(	(	PUNCT
fnp-2639	81	54	c	c	NOUN
fnp-2639	81	55	/	/	SYM
fnp-2639	81	56	d	d	NOUN
fnp-2639	81	57	)	)	PUNCT
fnp-2639	81	58	but	but	CCONJ
fnp-2639	81	59	positive	positive	ADJ
fnp-2639	81	60	for	for	ADP
fnp-2639	81	61	tdp-43	tdp-43	PROPN
fnp-2639	81	62	(	(	PUNCT
fnp-2639	81	63	e	e	NOUN
fnp-2639	81	64	/	/	SYM
fnp-2639	81	65	f	f	NOUN
fnp-2639	81	66	/	/	SYM
fnp-2639	81	67	h	h	NOUN
fnp-2639	81	68	)	)	PUNCT
fnp-2639	81	69	,	,	PUNCT
fnp-2639	81	70	as	as	ADV
fnp-2639	81	71	well	well	ADV
fnp-2639	81	72	as	as	ADP
fnp-2639	81	73	αinx	αinx	NOUN
fnp-2639	81	74	(	(	PUNCT
fnp-2639	81	75	g	g	NOUN
fnp-2639	81	76	/	/	SYM
fnp-2639	81	77	h	h	NOUN
fnp-2639	81	78	)	)	PUNCT
fnp-2639	81	79	.	.	PUNCT
fnp-2639	82	1	α	α	X
fnp-2639	82	2	-	-	NOUN
fnp-2639	82	3	internexin	internexin	PROPN
fnp-2639	82	4	(	(	PUNCT
fnp-2639	82	5	brown	brown	PROPN
fnp-2639	82	6	)	)	PUNCT
fnp-2639	82	7	and	and	CCONJ
fnp-2639	82	8	tdp-43	tdp-43	PROPN
fnp-2639	82	9	(	(	PUNCT
fnp-2639	82	10	blue	blue	ADJ
fnp-2639	82	11	)	)	PUNCT
fnp-2639	82	12	colocalizes	colocalize	VERB
fnp-2639	82	13	on	on	ADP
fnp-2639	82	14	double	double	ADJ
fnp-2639	82	15	-	-	PUNCT
fnp-2639	82	16	labeling	labeling	NOUN
fnp-2639	82	17	immunohistochemistry	immunohistochemistry	NOUN
fnp-2639	82	18	(	(	PUNCT
fnp-2639	82	19	h)[bar:100	h)[bar:100	NOUN
fnp-2639	82	20	μm	μm	NUM
fnp-2639	82	21	]	]	X
fnp-2639	82	22	electron	electron	NOUN
fnp-2639	82	23	and	and	CCONJ
fnp-2639	82	24	immunoelectron	immunoelectron	ADJ
fnp-2639	82	25	microscopy	microscopy	NOUN
fnp-2639	82	26	results	result	NOUN
fnp-2639	82	27	of	of	ADP
fnp-2639	82	28	the	the	DET
fnp-2639	82	29	electron	electron	NOUN
fnp-2639	82	30	microscopic	microscopic	ADJ
fnp-2639	82	31	examination	examination	NOUN
fnp-2639	82	32	are	be	AUX
fnp-2639	82	33	shown	show	VERB
fnp-2639	82	34	in	in	ADP
fnp-2639	82	35	figure	figure	NOUN
fnp-2639	82	36	4	4	NUM
fnp-2639	82	37	.	.	PUNCT
fnp-2639	83	1	in	in	ADP
fnp-2639	83	2	the	the	DET
fnp-2639	83	3	fus	fus	ADJ
fnp-2639	83	4	-	-	PUNCT
fnp-2639	83	5	positive	positive	ADJ
fnp-2639	83	6	nifid	nifid	ADJ
fnp-2639	83	7	cases	case	NOUN
fnp-2639	83	8	,	,	PUNCT
fnp-2639	83	9	we	we	PRON
fnp-2639	83	10	found	find	VERB
fnp-2639	83	11	that	that	SCONJ
fnp-2639	83	12	fus	fus	PROPN
fnp-2639	83	13	was	be	AUX
fnp-2639	83	14	localized	localize	VERB
fnp-2639	83	15	to	to	ADP
fnp-2639	83	16	loose	loose	ADJ
fnp-2639	83	17	granulofilaments	granulofilament	NOUN
fnp-2639	83	18	that	that	PRON
fnp-2639	83	19	were	be	AUX
fnp-2639	83	20	in	in	ADP
fnp-2639	83	21	close	close	ADJ
fnp-2639	83	22	proximity	proximity	NOUN
fnp-2639	83	23	to	to	ADP
fnp-2639	83	24	intermediate	intermediate	ADJ
fnp-2639	83	25	filament	filament	NOUN
fnp-2639	83	26	inclusions	inclusion	NOUN
fnp-2639	83	27	that	that	PRON
fnp-2639	83	28	contained	contain	VERB
fnp-2639	83	29	tightly	tightly	ADV
fnp-2639	83	30	packed	pack	VERB
fnp-2639	83	31	uncoated	uncoated	ADJ
fnp-2639	83	32	filaments	filament	NOUN
fnp-2639	83	33	unlabeled	unlabele	VERB
fnp-2639	83	34	by	by	ADP
fnp-2639	83	35	fus	fus	ADJ
fnp-2639	83	36	antibody	antibody	NOUN
fnp-2639	83	37	.	.	PUNCT
fnp-2639	84	1	the	the	DET
fnp-2639	84	2	two	two	NUM
fnp-2639	84	3	types	type	NOUN
fnp-2639	84	4	of	of	ADP
fnp-2639	84	5	filaments	filament	NOUN
fnp-2639	84	6	did	do	AUX
fnp-2639	84	7	not	not	PART
fnp-2639	84	8	mix	mix	VERB
fnp-2639	84	9	.	.	PUNCT
fnp-2639	85	1	the	the	DET
fnp-2639	85	2	compact	compact	ADJ
fnp-2639	85	3	intermediate	intermediate	ADJ
fnp-2639	85	4	filament	filament	NOUN
fnp-2639	85	5	inclusions	inclusion	NOUN
fnp-2639	85	6	were	be	AUX
fnp-2639	85	7	similar	similar	ADJ
fnp-2639	85	8	to	to	ADP
fnp-2639	85	9	those	those	PRON
fnp-2639	85	10	we	we	PRON
fnp-2639	85	11	previously	previously	ADV
fnp-2639	85	12	reported(29	reported(29	NOUN
fnp-2639	85	13	)	)	PUNCT
fnp-2639	85	14	.	.	PUNCT
fnp-2639	86	1	in	in	ADP
fnp-2639	86	2	the	the	DET
fnp-2639	86	3	tdp	tdp	NOUN
fnp-2639	86	4	-	-	ADJ
fnp-2639	86	5	positive	positive	ADJ
fnp-2639	86	6	nifid	nifid	ADJ
fnp-2639	86	7	case	case	NOUN
fnp-2639	86	8	(	(	PUNCT
fnp-2639	86	9	#	#	SYM
fnp-2639	86	10	3	3	NUM
fnp-2639	86	11	)	)	PUNCT
fnp-2639	86	12	,	,	PUNCT
fnp-2639	86	13	the	the	DET
fnp-2639	86	14	tdp	tdp	NOUN
fnp-2639	86	15	-	-	PUNCT
fnp-2639	86	16	positive	positive	ADJ
fnp-2639	86	17	ncis	ncis	NOUN
fnp-2639	86	18	were	be	AUX
fnp-2639	86	19	composed	compose	VERB
fnp-2639	86	20	of	of	ADP
fnp-2639	86	21	granulofilaments	granulofilament	NOUN
fnp-2639	86	22	in	in	ADP
fnp-2639	86	23	tightly	tightly	ADV
fnp-2639	86	24	packed	pack	VERB
fnp-2639	86	25	bundles	bundle	NOUN
fnp-2639	86	26	or	or	CCONJ
fnp-2639	86	27	loose	loose	ADJ
fnp-2639	86	28	orientations	orientation	NOUN
fnp-2639	86	29	.	.	PUNCT
fnp-2639	87	1	cytoplasmic	cytoplasmic	ADJ
fnp-2639	87	2	organelles	organelle	NOUN
fnp-2639	87	3	,	,	PUNCT
fnp-2639	87	4	e.g.	e.g.	ADV
fnp-2639	87	5	mitochondria	mitochondria	NOUN
fnp-2639	87	6	,	,	PUNCT
fnp-2639	87	7	were	be	AUX
fnp-2639	87	8	occasionally	occasionally	ADV
fnp-2639	87	9	encompassed	encompass	VERB
fnp-2639	87	10	by	by	ADP
fnp-2639	87	11	these	these	DET
fnp-2639	87	12	inclusions	inclusion	NOUN
fnp-2639	87	13	.	.	PUNCT
fnp-2639	88	1	figure	figure	VERB
fnp-2639	88	2	4	4	NUM
fnp-2639	88	3	:	:	PUNCT
fnp-2639	88	4	electron	electron	NOUN
fnp-2639	88	5	microscopy	microscopy	NOUN
fnp-2639	88	6	variable	variable	NOUN
fnp-2639	88	7	α	α	PROPN
fnp-2639	88	8	-	-	NOUN
fnp-2639	88	9	internexin	internexin	NOUN
fnp-2639	88	10	(	(	PUNCT
fnp-2639	88	11	a	a	NOUN
fnp-2639	88	12	/	/	SYM
fnp-2639	88	13	d	d	NOUN
fnp-2639	88	14	/	/	SYM
fnp-2639	88	15	g	g	NOUN
fnp-2639	88	16	)	)	PUNCT
fnp-2639	88	17	,	,	PUNCT
fnp-2639	88	18	fus	fus	X
fnp-2639	88	19	(	(	PUNCT
fnp-2639	88	20	b	b	NOUN
fnp-2639	88	21	/	/	SYM
fnp-2639	88	22	e	e	NOUN
fnp-2639	88	23	/	/	SYM
fnp-2639	88	24	h	h	NOUN
fnp-2639	88	25	)	)	PUNCT
fnp-2639	88	26	,	,	PUNCT
fnp-2639	88	27	and	and	CCONJ
fnp-2639	88	28	tdp-43	tdp-43	NOUN
fnp-2639	88	29	(	(	PUNCT
fnp-2639	88	30	c	c	X
fnp-2639	88	31	/	/	SYM
fnp-2639	88	32	f	f	NOUN
fnp-2639	88	33	/	/	SYM
fnp-2639	88	34	i	i	NOUN
fnp-2639	88	35	)	)	PUNCT
fnp-2639	88	36	immunoreactivity	immunoreactivity	NOUN
fnp-2639	88	37	on	on	ADP
fnp-2639	88	38	electron	electron	NOUN
fnp-2639	88	39	microscopy	microscopy	NOUN
fnp-2639	88	40	in	in	ADP
fnp-2639	88	41	the	the	DET
fnp-2639	88	42	neuronal	neuronal	ADJ
fnp-2639	88	43	inclusions	inclusion	NOUN
fnp-2639	88	44	of	of	ADP
fnp-2639	88	45	cases	case	NOUN
fnp-2639	88	46	3	3	NUM
fnp-2639	88	47	(	(	PUNCT
fnp-2639	88	48	a	a	NOUN
fnp-2639	88	49	-	-	PUNCT
fnp-2639	88	50	c	c	NOUN
fnp-2639	88	51	)	)	PUNCT
fnp-2639	88	52	,	,	PUNCT
fnp-2639	88	53	2	2	NUM
fnp-2639	88	54	(	(	PUNCT
fnp-2639	88	55	d	d	NOUN
fnp-2639	88	56	-	-	PUNCT
fnp-2639	88	57	f	f	NOUN
fnp-2639	88	58	)	)	PUNCT
fnp-2639	88	59	,	,	PUNCT
fnp-2639	88	60	and	and	CCONJ
fnp-2639	88	61	9	9	NUM
fnp-2639	88	62	(	(	PUNCT
fnp-2639	88	63	g	g	NOUN
fnp-2639	88	64	-	-	PUNCT
fnp-2639	88	65	i)[bar	i)[bar	NOUN
fnp-2639	88	66	:	:	PUNCT
fnp-2639	88	67	2	2	NUM
fnp-2639	88	68	μm	μm	NOUN
fnp-2639	88	69	main	main	ADJ
fnp-2639	88	70	;	;	PUNCT
fnp-2639	88	71	0.3	0.3	NUM
fnp-2639	88	72	μm	μm	NUM
fnp-2639	88	73	inset	inset	NOUN
fnp-2639	88	74	]	]	PUNCT
fnp-2639	88	75	these	these	DET
fnp-2639	88	76	granulofilaments	granulofilament	NOUN
fnp-2639	88	77	were	be	AUX
fnp-2639	88	78	not	not	PART
fnp-2639	88	79	labeled	label	VERB
fnp-2639	88	80	with	with	ADP
fnp-2639	88	81	fus	fus	PROPN
fnp-2639	88	82	.	.	PUNCT
fnp-2639	89	1	the	the	DET
fnp-2639	89	2	characteristic	characteristic	ADJ
fnp-2639	89	3	compact	compact	ADJ
fnp-2639	89	4	intermediate	intermediate	ADJ
fnp-2639	89	5	filament	filament	NOUN
fnp-2639	89	6	inclusions	inclusion	NOUN
fnp-2639	89	7	were	be	AUX
fnp-2639	89	8	not	not	PART
fnp-2639	89	9	as	as	ADV
fnp-2639	89	10	widespread	widespread	ADJ
fnp-2639	89	11	as	as	ADP
fnp-2639	89	12	the	the	DET
fnp-2639	89	13	tdp	tdp	NOUN
fnp-2639	89	14	-	-	PUNCT
fnp-2639	89	15	positive	positive	ADJ
fnp-2639	89	16	inclusions	inclusion	NOUN
fnp-2639	89	17	in	in	ADP
fnp-2639	89	18	this	this	DET
fnp-2639	89	19	case	case	NOUN
fnp-2639	89	20	.	.	PUNCT
fnp-2639	90	1	importantly	importantly	ADV
fnp-2639	90	2	,	,	PUNCT
fnp-2639	90	3	they	they	PRON
fnp-2639	90	4	were	be	AUX
fnp-2639	90	5	located	locate	VERB
fnp-2639	90	6	in	in	ADP
fnp-2639	90	7	separate	separate	ADJ
fnp-2639	90	8	neurons	neuron	NOUN
fnp-2639	90	9	.	.	PUNCT
fnp-2639	91	1	in	in	ADP
fnp-2639	91	2	addition	addition	NOUN
fnp-2639	91	3	to	to	ADP
fnp-2639	91	4	their	their	PRON
fnp-2639	91	5	ultrastructural	ultrastructural	ADJ
fnp-2639	91	6	difference	difference	NOUN
fnp-2639	91	7	from	from	ADP
fnp-2639	91	8	the	the	DET
fnp-2639	91	9	tdp	tdp	NOUN
fnp-2639	91	10	-	-	ADJ
fnp-2639	91	11	positive	positive	ADJ
fnp-2639	91	12	inclusions	inclusion	NOUN
fnp-2639	91	13	,	,	PUNCT
fnp-2639	91	14	these	these	DET
fnp-2639	91	15	intermediate	intermediate	ADJ
fnp-2639	91	16	filament	filament	NOUN
fnp-2639	91	17	inclusions	inclusion	NOUN
fnp-2639	91	18	were	be	AUX
fnp-2639	91	19	not	not	PART
fnp-2639	91	20	labeled	label	VERB
fnp-2639	91	21	by	by	ADP
fnp-2639	91	22	tdp-43	tdp-43	PROPN
fnp-2639	91	23	.	.	PUNCT
fnp-2639	92	1	immunohistochemistry	immunohistochemistry	PROPN
fnp-2639	92	2	showed	show	VERB
fnp-2639	92	3	that	that	SCONJ
fnp-2639	92	4	the	the	DET
fnp-2639	92	5	intermediate	intermediate	ADJ
fnp-2639	92	6	filament	filament	NOUN
fnp-2639	92	7	inclusions	inclusion	NOUN
fnp-2639	92	8	were	be	AUX
fnp-2639	92	9	immuno	immuno	ADJ
fnp-2639	92	10	-	-	ADJ
fnp-2639	92	11	negative	negative	ADJ
fnp-2639	92	12	for	for	ADP
fnp-2639	92	13	fus	fus	PROPN
fnp-2639	92	14	.	.	PUNCT
fnp-2639	93	1	the	the	DET
fnp-2639	93	2	tdp	tdp	NOUN
fnp-2639	93	3	-	-	PUNCT
fnp-2639	93	4	negative	negative	ADJ
fnp-2639	93	5	,	,	PUNCT
fnp-2639	93	6	fus	fus	ADJ
fnp-2639	93	7	-	-	PUNCT
fnp-2639	93	8	negative	negative	ADJ
fnp-2639	93	9	nifid	nifid	ADJ
fnp-2639	93	10	case	case	NOUN
fnp-2639	93	11	(	(	PUNCT
fnp-2639	93	12	#	#	SYM
fnp-2639	93	13	4	4	NUM
fnp-2639	93	14	)	)	PUNCT
fnp-2639	93	15	had	have	VERB
fnp-2639	93	16	compact	compact	ADJ
fnp-2639	93	17	intermediate	intermediate	ADJ
fnp-2639	93	18	filament	filament	NOUN
fnp-2639	93	19	inclusions	inclusion	NOUN
fnp-2639	93	20	similar	similar	ADJ
fnp-2639	93	21	to	to	ADP
fnp-2639	93	22	those	those	PRON
fnp-2639	93	23	described	describe	VERB
fnp-2639	93	24	above	above	ADV
fnp-2639	93	25	.	.	PUNCT
fnp-2639	94	1	these	these	DET
fnp-2639	94	2	compact	compact	ADJ
fnp-2639	94	3	intermediate	intermediate	ADJ
fnp-2639	94	4	filament	filament	NOUN
fnp-2639	94	5	inclusions	inclusion	NOUN
fnp-2639	94	6	were	be	AUX
fnp-2639	94	7	immuno	immuno	ADJ
fnp-2639	94	8	-	-	ADJ
fnp-2639	94	9	negative	negative	ADJ
fnp-2639	94	10	to	to	ADP
fnp-2639	94	11	fus	fus	PROPN
fnp-2639	94	12	and	and	CCONJ
fnp-2639	94	13	tdp-43	tdp-43	NOUN
fnp-2639	94	14	.	.	PUNCT
fnp-2639	95	1	neuronal	neuronal	ADJ
fnp-2639	95	2	cytoplasmic	cytoplasmic	ADJ
fnp-2639	95	3	inclusions	inclusion	NOUN
fnp-2639	95	4	in	in	ADP
fnp-2639	95	5	all	all	DET
fnp-2639	95	6	the	the	DET
fnp-2639	95	7	aftld	aftld	ADJ
fnp-2639	95	8	-	-	PUNCT
fnp-2639	95	9	u	u	NOUN
fnp-2639	95	10	cases	case	NOUN
fnp-2639	95	11	consisted	consist	VERB
fnp-2639	95	12	of	of	ADP
fnp-2639	95	13	granulofilaments	granulofilament	NOUN
fnp-2639	95	14	inclusions	inclusion	NOUN
fnp-2639	95	15	in	in	ADP
fnp-2639	95	16	loose	loose	ADJ
fnp-2639	95	17	arrangement	arrangement	NOUN
fnp-2639	95	18	and	and	CCONJ
fnp-2639	95	19	all	all	PRON
fnp-2639	95	20	were	be	AUX
fnp-2639	95	21	immuno	immuno	ADJ
fnp-2639	95	22	-	-	ADJ
fnp-2639	95	23	positive	positive	ADJ
fnp-2639	95	24	for	for	ADP
fnp-2639	95	25	fus	fus	PROPN
fnp-2639	95	26	.	.	PUNCT
fnp-2639	96	1	discussion	discussion	NOUN
fnp-2639	96	2	in	in	ADP
fnp-2639	96	3	this	this	DET
fnp-2639	96	4	study	study	NOUN
fnp-2639	96	5	we	we	PRON
fnp-2639	96	6	found	find	VERB
fnp-2639	96	7	pathological	pathological	ADJ
fnp-2639	96	8	evidence	evidence	NOUN
fnp-2639	96	9	for	for	SCONJ
fnp-2639	96	10	aftld	aftld	NOUN
fnp-2639	96	11	-	-	PUNCT
fnp-2639	96	12	u	u	NOUN
fnp-2639	96	13	to	to	PART
fnp-2639	96	14	be	be	AUX
fnp-2639	96	15	a	a	DET
fnp-2639	96	16	homogeneous	homogeneous	ADJ
fnp-2639	96	17	entity	entity	NOUN
fnp-2639	96	18	that	that	PRON
fnp-2639	96	19	is	be	AUX
fnp-2639	96	20	strongly	strongly	ADV
fnp-2639	96	21	associated	associate	VERB
fnp-2639	96	22	with	with	ADP
fnp-2639	96	23	a	a	DET
fnp-2639	96	24	clinical	clinical	ADJ
fnp-2639	96	25	diagnosis	diagnosis	NOUN
fnp-2639	96	26	of	of	ADP
fnp-2639	96	27	bvftd	bvftd	PROPN
fnp-2639	96	28	,	,	PUNCT
fnp-2639	96	29	and	and	CCONJ
fnp-2639	96	30	pathologically	pathologically	ADV
fnp-2639	96	31	by	by	ADP
fnp-2639	96	32	fus	fus	PROPN
fnp-2639	96	33	immunoreactivity	immunoreactivity	NOUN
fnp-2639	96	34	and	and	CCONJ
fnp-2639	96	35	striatal	striatal	ADJ
fnp-2639	96	36	atrophy	atrophy	NOUN
fnp-2639	96	37	.	.	PUNCT
fnp-2639	97	1	on	on	ADP
fnp-2639	97	2	the	the	DET
fnp-2639	97	3	other	other	ADJ
fnp-2639	97	4	hand	hand	NOUN
fnp-2639	97	5	,	,	PUNCT
fnp-2639	97	6	we	we	PRON
fnp-2639	97	7	found	find	VERB
fnp-2639	97	8	nifid	nifid	ADJ
fnp-2639	97	9	to	to	PART
fnp-2639	97	10	be	be	AUX
fnp-2639	97	11	more	more	ADV
fnp-2639	97	12	heterogeneous	heterogeneous	ADJ
fnp-2639	97	13	with	with	ADP
fnp-2639	97	14	more	more	ADJ
fnp-2639	97	15	variable	variable	ADJ
fnp-2639	97	16	clinical	clinical	ADJ
fnp-2639	97	17	presentations	presentation	NOUN
fnp-2639	97	18	.	.	PUNCT
fnp-2639	98	1	furthermore	furthermore	ADV
fnp-2639	98	2	,	,	PUNCT
fnp-2639	98	3	nifid	nifid	ADJ
fnp-2639	98	4	does	do	AUX
fnp-2639	98	5	not	not	PART
fnp-2639	98	6	always	always	ADV
fnp-2639	98	7	appear	appear	VERB
fnp-2639	98	8	to	to	PART
fnp-2639	98	9	be	be	AUX
fnp-2639	98	10	associated	associate	VERB
fnp-2639	98	11	with	with	ADP
fnp-2639	98	12	fus	fus	PROPN
fnp-2639	98	13	immunoreactivity	immunoreactivity	NOUN
fnp-2639	98	14	and	and	CCONJ
fnp-2639	98	15	is	be	AUX
fnp-2639	98	16	typically	typically	ADV
fnp-2639	98	17	not	not	PART
fnp-2639	98	18	associated	associate	VERB
fnp-2639	98	19	with	with	ADP
fnp-2639	98	20	striatal	striatal	ADJ
fnp-2639	98	21	atrophy	atrophy	NOUN
fnp-2639	98	22	.	.	PUNCT
fnp-2639	99	1	interestingly	interestingly	ADV
fnp-2639	99	2	,	,	PUNCT
fnp-2639	99	3	we	we	PRON
fnp-2639	99	4	found	find	VERB
fnp-2639	99	5	evidence	evidence	NOUN
fnp-2639	99	6	of	of	ADP
fnp-2639	99	7	overlap	overlap	NOUN
fnp-2639	99	8	between	between	ADP
fnp-2639	99	9	a	a	DET
fnp-2639	99	10	case	case	NOUN
fnp-2639	99	11	that	that	PRON
fnp-2639	99	12	would	would	AUX
fnp-2639	99	13	meet	meet	VERB
fnp-2639	99	14	criteria	criterion	NOUN
fnp-2639	99	15	for	for	ADP
fnp-2639	99	16	ftld	ftld	ADJ
fnp-2639	99	17	-	-	PUNCT
fnp-2639	99	18	tdp	tdp	NOUN
fnp-2639	99	19	as	as	ADV
fnp-2639	99	20	well	well	ADV
fnp-2639	99	21	as	as	ADP
fnp-2639	99	22	nifid	nifid	ADJ
fnp-2639	99	23	.	.	PUNCT
fnp-2639	100	1	in	in	ADP
fnp-2639	100	2	this	this	DET
fnp-2639	100	3	study	study	NOUN
fnp-2639	100	4	,	,	PUNCT
fnp-2639	100	5	aftld	aftld	PROPN
fnp-2639	100	6	-	-	PUNCT
fnp-2639	100	7	u	u	NOUN
fnp-2639	100	8	was	be	AUX
fnp-2639	100	9	a	a	DET
fnp-2639	100	10	very	very	ADV
fnp-2639	100	11	homogeneous	homogeneous	ADJ
fnp-2639	100	12	entity	entity	NOUN
fnp-2639	100	13	and	and	CCONJ
fnp-2639	100	14	the	the	DET
fnp-2639	100	15	evidence	evidence	NOUN
fnp-2639	100	16	supports	support	VERB
fnp-2639	100	17	aftld	aftld	ADJ
fnp-2639	100	18	-	-	PUNCT
fnp-2639	100	19	u	u	NOUN
fnp-2639	100	20	being	be	AUX
fnp-2639	100	21	classified	classify	VERB
fnp-2639	100	22	as	as	ADP
fnp-2639	100	23	ftld	ftld	ADJ
fnp-2639	100	24	-	-	PUNCT
fnp-2639	100	25	fus	fus	NOUN
fnp-2639	100	26	.	.	PUNCT
fnp-2639	101	1	from	from	ADP
fnp-2639	101	2	a	a	DET
fnp-2639	101	3	clinical	clinical	ADJ
fnp-2639	101	4	standpoint	standpoint	NOUN
fnp-2639	101	5	aftld	aftld	NOUN
fnp-2639	101	6	-	-	PUNCT
fnp-2639	101	7	u	u	NOUN
fnp-2639	101	8	is	be	AUX
fnp-2639	101	9	strongly	strongly	ADV
fnp-2639	101	10	associated	associate	VERB
fnp-2639	101	11	with	with	ADP
fnp-2639	101	12	clinical	clinical	ADJ
fnp-2639	101	13	features	feature	NOUN
fnp-2639	101	14	of	of	ADP
fnp-2639	101	15	bvftd	bvftd	PROPN
fnp-2639	101	16	as	as	ADP
fnp-2639	101	17	previously	previously	ADV
fnp-2639	101	18	reported(14	reported(14	NOUN
fnp-2639	101	19	,	,	PUNCT
fnp-2639	101	20	30	30	NUM
fnp-2639	101	21	)	)	PUNCT
fnp-2639	101	22	and	and	CCONJ
fnp-2639	101	23	hence	hence	ADV
fnp-2639	101	24	should	should	AUX
fnp-2639	101	25	be	be	AUX
fnp-2639	101	26	considered	consider	VERB
fnp-2639	101	27	in	in	ADP
fnp-2639	101	28	patients	patient	NOUN
fnp-2639	101	29	presenting	present	VERB
fnp-2639	101	30	with	with	ADP
fnp-2639	101	31	bvftd	bvftd	PROPN
fnp-2639	101	32	especially	especially	ADV
fnp-2639	101	33	in	in	ADP
fnp-2639	101	34	the	the	DET
fnp-2639	101	35	presence	presence	NOUN
fnp-2639	101	36	of	of	ADP
fnp-2639	101	37	striatal	striatal	ADJ
fnp-2639	101	38	atrophy	atrophy	NOUN
fnp-2639	101	39	.	.	PUNCT
fnp-2639	102	1	indeed	indeed	ADV
fnp-2639	102	2	striatal	striatal	ADJ
fnp-2639	102	3	atrophy	atrophy	NOUN
fnp-2639	102	4	has	have	AUX
fnp-2639	102	5	been	be	AUX
fnp-2639	102	6	reported	report	VERB
fnp-2639	102	7	in	in	ADP
fnp-2639	102	8	aftld	aftld	ADJ
fnp-2639	102	9	-	-	PUNCT
fnp-2639	102	10	u	u	NOUN
fnp-2639	102	11	on	on	ADP
fnp-2639	102	12	antemortem	antemortem	PROPN
fnp-2639	102	13	mri	mri	NOUN
fnp-2639	102	14	imaging(17	imaging(17	PROPN
fnp-2639	102	15	)	)	PUNCT
fnp-2639	102	16	.	.	PUNCT
fnp-2639	103	1	nifid	nifid	ADJ
fnp-2639	103	2	,	,	PUNCT
fnp-2639	103	3	on	on	ADP
fnp-2639	103	4	the	the	DET
fnp-2639	103	5	other	other	ADJ
fnp-2639	103	6	hand	hand	NOUN
fnp-2639	103	7	,	,	PUNCT
fnp-2639	103	8	as	as	ADV
fnp-2639	103	9	currently	currently	ADV
fnp-2639	103	10	defined	define	VERB
fnp-2639	103	11	does	do	AUX
fnp-2639	103	12	not	not	PART
fnp-2639	103	13	appear	appear	VERB
fnp-2639	103	14	to	to	PART
fnp-2639	103	15	be	be	AUX
fnp-2639	103	16	as	as	ADV
fnp-2639	103	17	distinct	distinct	ADJ
fnp-2639	103	18	an	an	DET
fnp-2639	103	19	entity	entity	NOUN
fnp-2639	103	20	clinically	clinically	ADV
fnp-2639	103	21	and	and	CCONJ
fnp-2639	103	22	pathologically	pathologically	ADV
fnp-2639	103	23	as	as	ADP
fnp-2639	103	24	aftld	aftld	NOUN
fnp-2639	103	25	-	-	PUNCT
fnp-2639	103	26	u.	u.	NOUN
fnp-2639	103	27	supportive	supportive	ADJ
fnp-2639	103	28	of	of	ADP
fnp-2639	103	29	this	this	DET
fnp-2639	103	30	statement	statement	NOUN
fnp-2639	103	31	is	be	AUX
fnp-2639	103	32	the	the	DET
fnp-2639	103	33	fact	fact	NOUN
fnp-2639	103	34	that	that	SCONJ
fnp-2639	103	35	of	of	ADP
fnp-2639	103	36	the	the	DET
fnp-2639	103	37	seven	seven	NUM
fnp-2639	103	38	nifid	nifid	ADJ
fnp-2639	103	39	cases	case	NOUN
fnp-2639	103	40	in	in	ADP
fnp-2639	103	41	this	this	DET
fnp-2639	103	42	study	study	NOUN
fnp-2639	103	43	,	,	PUNCT
fnp-2639	103	44	patients	patient	NOUN
fnp-2639	103	45	were	be	AUX
fnp-2639	103	46	given	give	VERB
fnp-2639	103	47	five	five	NUM
fnp-2639	103	48	different	different	ADJ
fnp-2639	103	49	clinical	clinical	ADJ
fnp-2639	103	50	diagnoses	diagnosis	NOUN
fnp-2639	103	51	at	at	ADP
fnp-2639	103	52	the	the	DET
fnp-2639	103	53	last	last	ADJ
fnp-2639	103	54	evaluation	evaluation	NOUN
fnp-2639	103	55	prior	prior	ADV
fnp-2639	103	56	to	to	ADP
fnp-2639	103	57	death	death	NOUN
fnp-2639	103	58	.	.	PUNCT
fnp-2639	104	1	secondly	secondly	ADV
fnp-2639	104	2	,	,	PUNCT
fnp-2639	104	3	striatal	striatal	ADJ
fnp-2639	104	4	atrophy	atrophy	NOUN
fnp-2639	104	5	,	,	PUNCT
fnp-2639	104	6	although	although	SCONJ
fnp-2639	104	7	present	present	ADJ
fnp-2639	104	8	in	in	ADP
fnp-2639	104	9	two	two	NUM
fnp-2639	104	10	nifid	nifid	ADJ
fnp-2639	104	11	case	case	NOUN
fnp-2639	104	12	was	be	AUX
fnp-2639	104	13	absent	absent	ADJ
fnp-2639	104	14	in	in	ADP
fnp-2639	104	15	the	the	DET
fnp-2639	104	16	rest	rest	NOUN
fnp-2639	104	17	.	.	PUNCT
fnp-2639	105	1	interestingly	interestingly	ADV
fnp-2639	105	2	,	,	PUNCT
fnp-2639	105	3	both	both	DET
fnp-2639	105	4	nifid	nifid	ADJ
fnp-2639	105	5	cases	case	NOUN
fnp-2639	105	6	with	with	ADP
fnp-2639	105	7	striatal	striatal	ADJ
fnp-2639	105	8	atrophy	atrophy	NOUN
fnp-2639	105	9	showed	show	VERB
fnp-2639	105	10	fus	fus	ADP
fnp-2639	105	11	immunoreactivity	immunoreactivity	NOUN
fnp-2639	105	12	,	,	PUNCT
fnp-2639	105	13	one	one	NUM
fnp-2639	105	14	with	with	ADP
fnp-2639	105	15	a	a	DET
fnp-2639	105	16	clinical	clinical	ADJ
fnp-2639	105	17	diagnosis	diagnosis	NOUN
fnp-2639	105	18	of	of	ADP
fnp-2639	105	19	bvftd	bvftd	PROPN
fnp-2639	105	20	.	.	PUNCT
fnp-2639	106	1	it	it	PRON
fnp-2639	106	2	therefore	therefore	ADV
fnp-2639	106	3	appears	appear	VERB
fnp-2639	106	4	that	that	SCONJ
fnp-2639	106	5	striatal	striatal	ADJ
fnp-2639	106	6	atrophy	atrophy	NOUN
fnp-2639	106	7	is	be	AUX
fnp-2639	106	8	predictive	predictive	ADJ
fnp-2639	106	9	of	of	ADP
fnp-2639	106	10	fus	fus	PROPN
fnp-2639	106	11	,	,	PUNCT
fnp-2639	106	12	but	but	CCONJ
fnp-2639	106	13	fus	fus	PROPN
fnp-2639	106	14	is	be	AUX
fnp-2639	106	15	not	not	PART
fnp-2639	106	16	necessarily	necessarily	ADV
fnp-2639	106	17	predictive	predictive	ADJ
fnp-2639	106	18	of	of	ADP
fnp-2639	106	19	striatal	striatal	ADJ
fnp-2639	106	20	atrophy	atrophy	NOUN
fnp-2639	106	21	.	.	PUNCT
fnp-2639	107	1	regardless	regardless	ADV
fnp-2639	107	2	,	,	PUNCT
fnp-2639	107	3	nifid	nifid	ADJ
fnp-2639	107	4	should	should	AUX
fnp-2639	107	5	also	also	ADV
fnp-2639	107	6	be	be	AUX
fnp-2639	107	7	considered	consider	VERB
fnp-2639	107	8	in	in	ADP
fnp-2639	107	9	the	the	DET
fnp-2639	107	10	differential	differential	ADJ
fnp-2639	107	11	diagnosis	diagnosis	NOUN
fnp-2639	107	12	of	of	ADP
fnp-2639	107	13	bvftd	bvftd	PROPN
fnp-2639	107	14	with	with	ADP
fnp-2639	107	15	striatal	striatal	ADJ
fnp-2639	107	16	atrophy	atrophy	NOUN
fnp-2639	107	17	and	and	CCONJ
fnp-2639	107	18	should	should	AUX
fnp-2639	107	19	suggest	suggest	VERB
fnp-2639	107	20	the	the	DET
fnp-2639	107	21	presence	presence	NOUN
fnp-2639	107	22	of	of	ADP
fnp-2639	107	23	ftld	ftld	NOUN
fnp-2639	107	24	-	-	PUNCT
fnp-2639	107	25	fus	fus	NOUN
fnp-2639	107	26	.	.	PUNCT
fnp-2639	108	1	the	the	DET
fnp-2639	108	2	one	one	NUM
fnp-2639	108	3	feature	feature	NOUN
fnp-2639	108	4	that	that	PRON
fnp-2639	108	5	may	may	AUX
fnp-2639	108	6	be	be	AUX
fnp-2639	108	7	helpful	helpful	ADJ
fnp-2639	108	8	in	in	ADP
fnp-2639	108	9	predicting	predict	VERB
fnp-2639	108	10	ftld	ftld	ADJ
fnp-2639	108	11	-	-	PUNCT
fnp-2639	108	12	fus	fus	NOUN
fnp-2639	108	13	nifid	nifid	NOUN
fnp-2639	108	14	from	from	ADP
fnp-2639	108	15	ftld	ftld	ADJ
fnp-2639	108	16	-	-	PUNCT
fnp-2639	108	17	fus	fus	ADJ
fnp-2639	108	18	aftld	aftld	NOUN
fnp-2639	108	19	-	-	PUNCT
fnp-2639	108	20	u	u	NOUN
fnp-2639	108	21	in	in	ADP
fnp-2639	108	22	patients	patient	NOUN
fnp-2639	108	23	with	with	ADP
fnp-2639	108	24	bvftd	bvftd	PROPN
fnp-2639	108	25	and	and	CCONJ
fnp-2639	108	26	striatal	striatal	ADJ
fnp-2639	108	27	atrophy	atrophy	NOUN
fnp-2639	108	28	may	may	AUX
fnp-2639	108	29	be	be	AUX
fnp-2639	108	30	the	the	DET
fnp-2639	108	31	rapidity	rapidity	NOUN
fnp-2639	108	32	of	of	ADP
fnp-2639	108	33	progression	progression	NOUN
fnp-2639	108	34	,	,	PUNCT
fnp-2639	108	35	with	with	ADP
fnp-2639	108	36	faster	fast	ADJ
fnp-2639	108	37	progression	progression	NOUN
fnp-2639	108	38	being	be	AUX
fnp-2639	108	39	more	more	ADV
fnp-2639	108	40	suggestive	suggestive	ADJ
fnp-2639	108	41	of	of	ADP
fnp-2639	108	42	ftld	ftld	ADJ
fnp-2639	108	43	-	-	PUNCT
fnp-2639	108	44	fus	fus	NOUN
fnp-2639	108	45	nifid	nifid	NOUN
fnp-2639	108	46	.	.	PUNCT
fnp-2639	109	1	to	to	PART
fnp-2639	109	2	understand	understand	VERB
fnp-2639	109	3	what	what	PRON
fnp-2639	109	4	may	may	AUX
fnp-2639	109	5	be	be	AUX
fnp-2639	109	6	happening	happen	VERB
fnp-2639	109	7	with	with	ADP
fnp-2639	109	8	nifid	nifid	ADJ
fnp-2639	109	9	it	it	PRON
fnp-2639	109	10	is	be	AUX
fnp-2639	109	11	worth	worth	ADJ
fnp-2639	109	12	further	further	ADJ
fnp-2639	109	13	discussion	discussion	NOUN
fnp-2639	109	14	.	.	PUNCT
fnp-2639	110	1	neuronal	neuronal	ADJ
fnp-2639	110	2	intermediate	intermediate	ADJ
fnp-2639	110	3	filament	filament	NOUN
fnp-2639	110	4	inclusion	inclusion	NOUN
fnp-2639	110	5	body	body	NOUN
fnp-2639	110	6	disease	disease	NOUN
fnp-2639	110	7	is	be	AUX
fnp-2639	110	8	a	a	DET
fnp-2639	110	9	type	type	NOUN
fnp-2639	110	10	of	of	ADP
fnp-2639	110	11	ftld	ftld	NOUN
fnp-2639	110	12	with	with	ADP
fnp-2639	110	13	previously	previously	ADV
fnp-2639	110	14	reported	report	VERB
fnp-2639	110	15	clinical	clinical	ADJ
fnp-2639	110	16	presenting	presenting	NOUN
fnp-2639	110	17	features	feature	NOUN
fnp-2639	110	18	of	of	ADP
fnp-2639	110	19	bvftd	bvftd	PROPN
fnp-2639	110	20	,	,	PUNCT
fnp-2639	110	21	corticobasal	corticobasal	NOUN
fnp-2639	110	22	syndrome	syndrome	NOUN
fnp-2639	110	23	,	,	PUNCT
fnp-2639	110	24	and	and	CCONJ
fnp-2639	110	25	motor	motor	PROPN
fnp-2639	110	26	neuron	neuron	PROPN
fnp-2639	110	27	disease	disease	PROPN
fnp-2639	110	28	,	,	PUNCT
fnp-2639	110	29	especially	especially	ADV
fnp-2639	110	30	the	the	DET
fnp-2639	110	31	primary	primary	ADJ
fnp-2639	110	32	lateral	lateral	ADJ
fnp-2639	110	33	sclerosis	sclerosis	NOUN
fnp-2639	110	34	variant(10	variant(10	NOUN
fnp-2639	110	35	,	,	PUNCT
fnp-2639	110	36	31	31	NUM
fnp-2639	110	37	,	,	PUNCT
fnp-2639	110	38	32	32	NUM
fnp-2639	110	39	)	)	PUNCT
fnp-2639	110	40	.	.	PUNCT
fnp-2639	111	1	typically	typically	ADV
fnp-2639	111	2	,	,	PUNCT
fnp-2639	111	3	patients	patient	NOUN
fnp-2639	111	4	with	with	ADP
fnp-2639	111	5	nifid	nifid	ADJ
fnp-2639	111	6	have	have	VERB
fnp-2639	111	7	a	a	DET
fnp-2639	111	8	relatively	relatively	ADV
fnp-2639	111	9	rapidly	rapidly	ADV
fnp-2639	111	10	progressive	progressive	ADJ
fnp-2639	111	11	course	course	NOUN
fnp-2639	111	12	,	,	PUNCT
fnp-2639	111	13	becoming	become	VERB
fnp-2639	111	14	mute	mute	ADJ
fnp-2639	111	15	and	and	CCONJ
fnp-2639	111	16	unable	unable	ADJ
fnp-2639	111	17	to	to	PART
fnp-2639	111	18	ambulate	ambulate	VERB
fnp-2639	111	19	,	,	PUNCT
fnp-2639	111	20	dying	die	VERB
fnp-2639	111	21	around	around	ADP
fnp-2639	111	22	3	3	NUM
fnp-2639	111	23	½	½	NOUN
fnp-2639	111	24	years	year	NOUN
fnp-2639	111	25	after	after	ADP
fnp-2639	111	26	onset(10	onset(10	NOUN
fnp-2639	111	27	)	)	PUNCT
fnp-2639	111	28	.	.	PUNCT
fnp-2639	112	1	these	these	DET
fnp-2639	112	2	features	feature	NOUN
fnp-2639	112	3	were	be	AUX
fnp-2639	112	4	observed	observe	VERB
fnp-2639	112	5	in	in	ADP
fnp-2639	112	6	this	this	DET
fnp-2639	112	7	cohort	cohort	NOUN
fnp-2639	112	8	of	of	ADP
fnp-2639	112	9	seven	seven	NUM
fnp-2639	112	10	nifid	nifid	ADJ
fnp-2639	112	11	cases	case	NOUN
fnp-2639	112	12	.	.	PUNCT
fnp-2639	113	1	from	from	ADP
fnp-2639	113	2	a	a	DET
fnp-2639	113	3	pathological	pathological	ADJ
fnp-2639	113	4	standpoint	standpoint	NOUN
fnp-2639	113	5	,	,	PUNCT
fnp-2639	113	6	in	in	ADP
fnp-2639	113	7	nifid	nifid	ADJ
fnp-2639	113	8	,	,	PUNCT
fnp-2639	113	9	neuronal	neuronal	ADJ
fnp-2639	113	10	cytoplasmic	cytoplasmic	ADJ
fnp-2639	113	11	inclusions	inclusion	NOUN
fnp-2639	113	12	(	(	PUNCT
fnp-2639	113	13	ncis	ncis	NOUN
fnp-2639	113	14	)	)	PUNCT
fnp-2639	113	15	are	be	AUX
fnp-2639	113	16	easily	easily	ADV
fnp-2639	113	17	visible	visible	ADJ
fnp-2639	113	18	on	on	ADP
fnp-2639	113	19	hematoxylin	hematoxylin	NOUN
fnp-2639	113	20	and	and	CCONJ
fnp-2639	113	21	eosin	eosin	NOUN
fnp-2639	113	22	,	,	PUNCT
fnp-2639	113	23	show	show	VERB
fnp-2639	113	24	variable	variable	NOUN
fnp-2639	113	25	staining	stain	VERB
fnp-2639	113	26	to	to	ADP
fnp-2639	113	27	ubiquitin	ubiquitin	ADJ
fnp-2639	113	28	and	and	CCONJ
fnp-2639	113	29	silver	silver	ADJ
fnp-2639	113	30	stains	stain	NOUN
fnp-2639	113	31	but	but	CCONJ
fnp-2639	113	32	are	be	AUX
fnp-2639	113	33	strikingly	strikingly	ADV
fnp-2639	113	34	immunoreactive	immunoreactive	ADJ
fnp-2639	113	35	to	to	PART
fnp-2639	113	36	type	type	VERB
fnp-2639	113	37	iv	iv	PRON
fnp-2639	113	38	intermediate	intermediate	ADJ
fnp-2639	113	39	filaments	filament	NOUN
fnp-2639	113	40	,	,	PUNCT
fnp-2639	113	41	including	include	VERB
fnp-2639	113	42	neurofilament	neurofilament	NOUN
fnp-2639	113	43	and	and	CCONJ
fnp-2639	113	44	α	α	NOUN
fnp-2639	113	45	-	-	NOUN
fnp-2639	113	46	internexin(9	internexin(9	NOUN
fnp-2639	113	47	,	,	PUNCT
fnp-2639	113	48	10	10	NUM
fnp-2639	113	49	,	,	PUNCT
fnp-2639	113	50	33	33	NUM
fnp-2639	113	51	,	,	PUNCT
fnp-2639	113	52	34	34	NUM
fnp-2639	113	53	)	)	PUNCT
fnp-2639	113	54	.	.	PUNCT
fnp-2639	114	1	these	these	DET
fnp-2639	114	2	nci	nci	PROPN
fnp-2639	114	3	,	,	PUNCT
fnp-2639	114	4	however	however	ADV
fnp-2639	114	5	,	,	PUNCT
fnp-2639	114	6	are	be	AUX
fnp-2639	114	7	not	not	PART
fnp-2639	114	8	morphologically	morphologically	ADV
fnp-2639	114	9	homogeneous	homogeneous	ADJ
fnp-2639	114	10	and	and	CCONJ
fnp-2639	114	11	it	it	PRON
fnp-2639	114	12	has	have	AUX
fnp-2639	114	13	been	be	AUX
fnp-2639	114	14	known	know	VERB
fnp-2639	114	15	from	from	ADP
fnp-2639	114	16	the	the	DET
fnp-2639	114	17	original	original	ADJ
fnp-2639	114	18	description	description	NOUN
fnp-2639	114	19	of	of	ADP
fnp-2639	114	20	nifid(10	nifid(10	NOUN
fnp-2639	114	21	)	)	PUNCT
fnp-2639	114	22	that	that	PRON
fnp-2639	114	23	nci	nci	PROPN
fnp-2639	114	24	appeared	appear	VERB
fnp-2639	114	25	to	to	PART
fnp-2639	114	26	separate	separate	VERB
fnp-2639	114	27	into	into	ADP
fnp-2639	114	28	two	two	NUM
fnp-2639	114	29	types	type	NOUN
fnp-2639	114	30	:	:	PUNCT
fnp-2639	114	31	rounded	rounded	ADJ
fnp-2639	114	32	inclusions	inclusion	NOUN
fnp-2639	114	33	that	that	PRON
fnp-2639	114	34	are	be	AUX
fnp-2639	114	35	similar	similar	ADJ
fnp-2639	114	36	to	to	PART
fnp-2639	114	37	pick	pick	VERB
fnp-2639	114	38	bodies	body	NOUN
fnp-2639	114	39	,	,	PUNCT
fnp-2639	114	40	hence	hence	ADV
fnp-2639	114	41	called	call	VERB
fnp-2639	114	42	‘	'	PUNCT
fnp-2639	114	43	pick	pick	NOUN
fnp-2639	114	44	-	-	PUNCT
fnp-2639	114	45	body	body	NOUN
fnp-2639	114	46	like	like	ADP
fnp-2639	114	47	(	(	PUNCT
fnp-2639	114	48	pbl	pbl	NOUN
fnp-2639	114	49	)	)	PUNCT
fnp-2639	114	50	inclusions	inclusion	NOUN
fnp-2639	114	51	,	,	PUNCT
fnp-2639	114	52	’	'	PUNCT
fnp-2639	114	53	and	and	CCONJ
fnp-2639	114	54	smaller	small	ADJ
fnp-2639	114	55	more	more	ADV
fnp-2639	114	56	compact	compact	ADJ
fnp-2639	114	57	inclusions	inclusion	NOUN
fnp-2639	114	58	with	with	ADP
fnp-2639	114	59	a	a	DET
fnp-2639	114	60	glass	glass	NOUN
fnp-2639	114	61	like	like	ADP
fnp-2639	114	62	appearance	appearance	NOUN
fnp-2639	114	63	called	call	VERB
fnp-2639	114	64	‘	'	PUNCT
fnp-2639	114	65	compact	compact	ADJ
fnp-2639	114	66	hyaline	hyaline	NOUN
fnp-2639	114	67	inclusions’(7	inclusions’(7	PROPN
fnp-2639	114	68	,	,	PUNCT
fnp-2639	114	69	10	10	NUM
fnp-2639	114	70	,	,	PUNCT
fnp-2639	114	71	19	19	NUM
fnp-2639	114	72	,	,	PUNCT
fnp-2639	114	73	29	29	NUM
fnp-2639	114	74	)	)	PUNCT
fnp-2639	114	75	.	.	PUNCT
fnp-2639	115	1	could	could	AUX
fnp-2639	115	2	this	this	DET
fnp-2639	115	3	nci	nci	PROPN
fnp-2639	115	4	inclusion	inclusion	NOUN
fnp-2639	115	5	type	type	NOUN
fnp-2639	115	6	difference	difference	NOUN
fnp-2639	115	7	be	be	AUX
fnp-2639	115	8	playing	play	VERB
fnp-2639	115	9	any	any	DET
fnp-2639	115	10	role	role	NOUN
fnp-2639	115	11	in	in	ADP
fnp-2639	115	12	the	the	DET
fnp-2639	115	13	heterogeneity	heterogeneity	NOUN
fnp-2639	115	14	we	we	PRON
fnp-2639	115	15	observed	observe	VERB
fnp-2639	115	16	in	in	ADP
fnp-2639	115	17	this	this	DET
fnp-2639	115	18	study	study	NOUN
fnp-2639	115	19	?	?	PUNCT
fnp-2639	116	1	the	the	DET
fnp-2639	116	2	ultrastructual	ultrastructual	ADJ
fnp-2639	116	3	analysis	analysis	NOUN
fnp-2639	116	4	in	in	ADP
fnp-2639	116	5	our	our	PRON
fnp-2639	116	6	seven	seven	NUM
fnp-2639	116	7	nifid	nifid	ADJ
fnp-2639	116	8	cases	case	NOUN
fnp-2639	116	9	shows	show	VERB
fnp-2639	116	10	that	that	SCONJ
fnp-2639	116	11	these	these	DET
fnp-2639	116	12	two	two	NUM
fnp-2639	116	13	different	different	ADJ
fnp-2639	116	14	types	type	NOUN
fnp-2639	116	15	of	of	ADP
fnp-2639	116	16	nci	nci	PROPN
fnp-2639	116	17	also	also	ADV
fnp-2639	116	18	have	have	VERB
fnp-2639	116	19	different	different	ADJ
fnp-2639	116	20	ultrastructual	ultrastructual	ADJ
fnp-2639	116	21	appearances	appearance	NOUN
fnp-2639	116	22	.	.	PUNCT
fnp-2639	117	1	the	the	DET
fnp-2639	117	2	pbl	pbl	NOUN
fnp-2639	117	3	inclusions	inclusion	NOUN
fnp-2639	117	4	were	be	AUX
fnp-2639	117	5	ultrastructually	ultrastructually	ADV
fnp-2639	117	6	granulofilamentous	granulofilamentous	ADJ
fnp-2639	117	7	while	while	SCONJ
fnp-2639	117	8	the	the	DET
fnp-2639	117	9	compact	compact	ADJ
fnp-2639	117	10	hyaline	hyaline	NOUN
fnp-2639	117	11	inclusions	inclusion	NOUN
fnp-2639	117	12	had	have	VERB
fnp-2639	117	13	a	a	DET
fnp-2639	117	14	more	more	ADV
fnp-2639	117	15	tightly	tightly	ADV
fnp-2639	117	16	compact	compact	ADJ
fnp-2639	117	17	appearance	appearance	NOUN
fnp-2639	117	18	.	.	PUNCT
fnp-2639	118	1	with	with	ADP
fnp-2639	118	2	immunoelectron	immunoelectron	ADJ
fnp-2639	118	3	microscopy	microscopy	NOUN
fnp-2639	118	4	we	we	PRON
fnp-2639	118	5	found	find	VERB
fnp-2639	118	6	that	that	SCONJ
fnp-2639	118	7	the	the	DET
fnp-2639	118	8	granulofilamentous	granulofilamentous	ADJ
fnp-2639	118	9	inclusions	inclusion	NOUN
fnp-2639	118	10	were	be	AUX
fnp-2639	118	11	immunoreactive	immunoreactive	ADJ
fnp-2639	118	12	to	to	ADP
fnp-2639	118	13	fus	fus	PROPN
fnp-2639	118	14	while	while	SCONJ
fnp-2639	118	15	the	the	DET
fnp-2639	118	16	compact	compact	ADJ
fnp-2639	118	17	hyaline	hyaline	NOUN
fnp-2639	118	18	inclusions	inclusion	NOUN
fnp-2639	118	19	were	be	AUX
fnp-2639	118	20	immunoreactive	immunoreactive	ADJ
fnp-2639	118	21	to	to	ADP
fnp-2639	118	22	intermediate	intermediate	ADJ
fnp-2639	118	23	filament	filament	NOUN
fnp-2639	118	24	.	.	PUNCT
fnp-2639	119	1	interestingly	interestingly	ADV
fnp-2639	119	2	all	all	DET
fnp-2639	119	3	seven	seven	NUM
fnp-2639	119	4	nifid	nifid	ADJ
fnp-2639	119	5	cases	case	NOUN
fnp-2639	119	6	had	have	VERB
fnp-2639	119	7	compact	compact	ADJ
fnp-2639	119	8	hyaline	hyaline	NOUN
fnp-2639	119	9	inclusions	inclusion	NOUN
fnp-2639	119	10	,	,	PUNCT
fnp-2639	119	11	and	and	CCONJ
fnp-2639	119	12	all	all	DET
fnp-2639	119	13	seven	seven	NUM
fnp-2639	119	14	showed	show	VERB
fnp-2639	119	15	α	α	PRON
fnp-2639	119	16	-	-	ADJ
fnp-2639	119	17	internexin	internexin	ADJ
fnp-2639	119	18	immunoreactivity	immunoreactivity	NOUN
fnp-2639	119	19	.	.	PUNCT
fnp-2639	120	1	however	however	ADV
fnp-2639	120	2	,	,	PUNCT
fnp-2639	120	3	unlike	unlike	ADP
fnp-2639	120	4	in	in	ADP
fnp-2639	120	5	previous	previous	ADJ
fnp-2639	120	6	reports(35	reports(35	NOUN
fnp-2639	120	7	,	,	PUNCT
fnp-2639	120	8	36	36	NUM
fnp-2639	120	9	)	)	PUNCT
fnp-2639	120	10	,	,	PUNCT
fnp-2639	120	11	two	two	NUM
fnp-2639	120	12	of	of	ADP
fnp-2639	120	13	our	our	PRON
fnp-2639	120	14	seven	seven	NUM
fnp-2639	120	15	nifid	nifid	ADJ
fnp-2639	120	16	cases	case	NOUN
fnp-2639	120	17	did	do	AUX
fnp-2639	120	18	not	not	PART
fnp-2639	120	19	show	show	VERB
fnp-2639	120	20	fus	fus	ADP
fnp-2639	120	21	immunoreactivity	immunoreactivity	NOUN
fnp-2639	120	22	and	and	CCONJ
fnp-2639	120	23	one	one	NUM
fnp-2639	120	24	of	of	ADP
fnp-2639	120	25	these	these	DET
fnp-2639	120	26	two	two	NUM
fnp-2639	120	27	nifid	nifid	ADJ
fnp-2639	120	28	cases	case	NOUN
fnp-2639	120	29	showed	show	VERB
fnp-2639	120	30	predominantly	predominantly	ADV
fnp-2639	120	31	,	,	PUNCT
fnp-2639	120	32	almost	almost	ADV
fnp-2639	120	33	exclusively	exclusively	ADV
fnp-2639	120	34	,	,	PUNCT
fnp-2639	120	35	compact	compact	ADJ
fnp-2639	120	36	hyaline	hyaline	NOUN
fnp-2639	120	37	inclusions	inclusion	NOUN
fnp-2639	120	38	(	(	PUNCT
fnp-2639	120	39	case	case	NOUN
fnp-2639	120	40	#	#	SYM
fnp-2639	120	41	4	4	NUM
fnp-2639	120	42	)	)	PUNCT
fnp-2639	120	43	.	.	PUNCT
fnp-2639	121	1	this	this	DET
fnp-2639	121	2	nifid	nifid	ADJ
fnp-2639	121	3	case	case	NOUN
fnp-2639	121	4	was	be	AUX
fnp-2639	121	5	immuno	immuno	ADJ
fnp-2639	121	6	-	-	ADJ
fnp-2639	121	7	negative	negative	ADJ
fnp-2639	121	8	to	to	ADP
fnp-2639	121	9	fus	fus	PROPN
fnp-2639	121	10	,	,	PUNCT
fnp-2639	121	11	suggesting	suggest	VERB
fnp-2639	121	12	that	that	SCONJ
fnp-2639	121	13	the	the	DET
fnp-2639	121	14	absence	absence	NOUN
fnp-2639	121	15	of	of	ADP
fnp-2639	121	16	the	the	DET
fnp-2639	121	17	granulofilamentous	granulofilamentous	ADJ
fnp-2639	121	18	inclusions	inclusion	NOUN
fnp-2639	121	19	may	may	AUX
fnp-2639	121	20	be	be	AUX
fnp-2639	121	21	the	the	DET
fnp-2639	121	22	explanation	explanation	NOUN
fnp-2639	121	23	for	for	ADP
fnp-2639	121	24	the	the	DET
fnp-2639	121	25	absence	absence	NOUN
fnp-2639	121	26	of	of	ADP
fnp-2639	121	27	fus	fus	PROPN
fnp-2639	121	28	immunoreactivity	immunoreactivity	NOUN
fnp-2639	121	29	.	.	PUNCT
fnp-2639	122	1	the	the	DET
fnp-2639	122	2	other	other	ADJ
fnp-2639	122	3	fus	fus	ADP
fnp-2639	122	4	negative	negative	ADJ
fnp-2639	122	5	case	case	NOUN
fnp-2639	122	6	(	(	PUNCT
fnp-2639	122	7	case	case	NOUN
fnp-2639	122	8	#	#	SYM
fnp-2639	122	9	3	3	NUM
fnp-2639	122	10	)	)	PUNCT
fnp-2639	122	11	is	be	AUX
fnp-2639	122	12	also	also	ADV
fnp-2639	122	13	unique	unique	ADJ
fnp-2639	122	14	.	.	PUNCT
fnp-2639	123	1	in	in	ADP
fnp-2639	123	2	this	this	DET
fnp-2639	123	3	case	case	NOUN
fnp-2639	123	4	,	,	PUNCT
fnp-2639	123	5	both	both	DET
fnp-2639	123	6	granulofilamentous	granulofilamentous	ADJ
fnp-2639	123	7	inclusions	inclusion	NOUN
fnp-2639	123	8	and	and	CCONJ
fnp-2639	123	9	compact	compact	ADJ
fnp-2639	123	10	hyaline	hyaline	NOUN
fnp-2639	123	11	inclusions	inclusion	NOUN
fnp-2639	123	12	were	be	AUX
fnp-2639	123	13	present	present	ADJ
fnp-2639	123	14	.	.	PUNCT
fnp-2639	124	1	as	as	SCONJ
fnp-2639	124	2	expected	expect	VERB
fnp-2639	124	3	,	,	PUNCT
fnp-2639	124	4	the	the	DET
fnp-2639	124	5	presence	presence	NOUN
fnp-2639	124	6	of	of	ADP
fnp-2639	124	7	the	the	DET
fnp-2639	124	8	compact	compact	ADJ
fnp-2639	124	9	hyaline	hyaline	NOUN
fnp-2639	124	10	inclusions	inclusion	NOUN
fnp-2639	124	11	was	be	AUX
fnp-2639	124	12	associated	associate	VERB
fnp-2639	124	13	with	with	ADP
fnp-2639	124	14	α	α	NOUN
fnp-2639	124	15	-	-	PUNCT
fnp-2639	124	16	internexin	internexin	ADJ
fnp-2639	124	17	immunoreactivity	immunoreactivity	NOUN
fnp-2639	124	18	.	.	PUNCT
fnp-2639	125	1	surprisingly	surprisingly	ADV
fnp-2639	125	2	though	though	ADV
fnp-2639	125	3	,	,	PUNCT
fnp-2639	125	4	the	the	DET
fnp-2639	125	5	granulofilamentous	granulofilamentous	ADJ
fnp-2639	125	6	inclusions	inclusion	NOUN
fnp-2639	125	7	in	in	ADP
fnp-2639	125	8	this	this	DET
fnp-2639	125	9	case	case	NOUN
fnp-2639	125	10	(	(	PUNCT
fnp-2639	125	11	case	case	NOUN
fnp-2639	125	12	#	#	SYM
fnp-2639	125	13	3	3	NUM
fnp-2639	125	14	)	)	PUNCT
fnp-2639	125	15	showed	show	VERB
fnp-2639	125	16	immunoreactivity	immunoreactivity	NOUN
fnp-2639	125	17	to	to	ADP
fnp-2639	125	18	tdp-43	tdp-43	PROPN
fnp-2639	125	19	but	but	CCONJ
fnp-2639	125	20	not	not	PART
fnp-2639	125	21	fus	fus	PROPN
fnp-2639	125	22	.	.	PUNCT
fnp-2639	126	1	it	it	PRON
fnp-2639	126	2	is	be	AUX
fnp-2639	126	3	therefore	therefore	ADV
fnp-2639	126	4	possible	possible	ADJ
fnp-2639	126	5	that	that	SCONJ
fnp-2639	126	6	this	this	PRON
fnp-2639	126	7	is	be	AUX
fnp-2639	126	8	a	a	DET
fnp-2639	126	9	case	case	NOUN
fnp-2639	126	10	of	of	ADP
fnp-2639	126	11	ftld	ftld	ADJ
fnp-2639	126	12	-	-	PUNCT
fnp-2639	126	13	tdp	tdp	NOUN
fnp-2639	126	14	in	in	ADP
fnp-2639	126	15	which	which	PRON
fnp-2639	126	16	compact	compact	ADJ
fnp-2639	126	17	hyaline	hyaline	NOUN
fnp-2639	126	18	inclusions	inclusion	NOUN
fnp-2639	126	19	happen	happen	VERB
fnp-2639	126	20	to	to	PART
fnp-2639	126	21	also	also	ADV
fnp-2639	126	22	be	be	AUX
fnp-2639	126	23	present	present	ADJ
fnp-2639	126	24	and	and	CCONJ
fnp-2639	126	25	hence	hence	ADV
fnp-2639	126	26	accounts	account	VERB
fnp-2639	126	27	for	for	SCONJ
fnp-2639	126	28	the	the	DET
fnp-2639	126	29	α	α	NOUN
fnp-2639	126	30	-	-	NOUN
fnp-2639	126	31	internexin	internexin	ADJ
fnp-2639	126	32	immunoreactivity	immunoreactivity	NOUN
fnp-2639	126	33	observed	observe	VERB
fnp-2639	126	34	.	.	PUNCT
fnp-2639	127	1	this	this	PRON
fnp-2639	127	2	would	would	AUX
fnp-2639	127	3	not	not	PART
fnp-2639	127	4	be	be	AUX
fnp-2639	127	5	counterintuitive	counterintuitive	ADJ
fnp-2639	127	6	since	since	SCONJ
fnp-2639	127	7	granulofilamentous	granulofilamentous	ADJ
fnp-2639	127	8	morphology	morphology	NOUN
fnp-2639	127	9	is	be	AUX
fnp-2639	127	10	the	the	DET
fnp-2639	127	11	typical	typical	ADJ
fnp-2639	127	12	appearance	appearance	NOUN
fnp-2639	127	13	of	of	ADP
fnp-2639	127	14	the	the	DET
fnp-2639	127	15	ncis	ncis	NOUN
fnp-2639	127	16	in	in	ADP
fnp-2639	127	17	ftld	ftld	NOUN
fnp-2639	127	18	-	-	PUNCT
fnp-2639	127	19	tdp(37	tdp(37	NUM
fnp-2639	127	20	)	)	PUNCT
fnp-2639	127	21	.	.	PUNCT
fnp-2639	128	1	on	on	ADP
fnp-2639	128	2	the	the	DET
fnp-2639	128	3	other	other	ADJ
fnp-2639	128	4	hand	hand	NOUN
fnp-2639	128	5	,	,	PUNCT
fnp-2639	128	6	we	we	PRON
fnp-2639	128	7	can	can	AUX
fnp-2639	128	8	not	not	PART
fnp-2639	128	9	exclude	exclude	VERB
fnp-2639	128	10	the	the	DET
fnp-2639	128	11	possibility	possibility	NOUN
fnp-2639	128	12	that	that	SCONJ
fnp-2639	128	13	this	this	PRON
fnp-2639	128	14	is	be	AUX
fnp-2639	128	15	a	a	DET
fnp-2639	128	16	case	case	NOUN
fnp-2639	128	17	of	of	ADP
fnp-2639	128	18	nifid	nifid	ADJ
fnp-2639	128	19	with	with	ADP
fnp-2639	128	20	tdp-43	tdp-43	NOUN
fnp-2639	128	21	immunoreactivity	immunoreactivity	NOUN
fnp-2639	128	22	given	give	VERB
fnp-2639	128	23	that	that	PRON
fnp-2639	128	24	tdp-43	tdp-43	PROPN
fnp-2639	128	25	immunoreactivity	immunoreactivity	PROPN
fnp-2639	128	26	has	have	AUX
fnp-2639	128	27	been	be	AUX
fnp-2639	128	28	described	describe	VERB
fnp-2639	128	29	in	in	ADP
fnp-2639	128	30	many	many	ADJ
fnp-2639	128	31	different	different	ADJ
fnp-2639	128	32	diseases(38	diseases(38	NOUN
fnp-2639	128	33	)	)	PUNCT
fnp-2639	128	34	.	.	PUNCT
fnp-2639	129	1	compared	compare	VERB
fnp-2639	129	2	to	to	ADP
fnp-2639	129	3	our	our	PRON
fnp-2639	129	4	nifid	nifid	ADJ
fnp-2639	129	5	cases	case	NOUN
fnp-2639	129	6	,	,	PUNCT
fnp-2639	129	7	all	all	DET
fnp-2639	129	8	eight	eight	NUM
fnp-2639	129	9	aftld	aftld	ADJ
fnp-2639	129	10	-	-	PUNCT
fnp-2639	129	11	u	u	NOUN
fnp-2639	129	12	cases	case	NOUN
fnp-2639	129	13	showed	show	VERB
fnp-2639	129	14	a	a	DET
fnp-2639	129	15	homogeneous	homogeneous	ADJ
fnp-2639	129	16	pattern	pattern	NOUN
fnp-2639	129	17	of	of	ADP
fnp-2639	129	18	fus	fus	PROPN
fnp-2639	129	19	immunoreactivity	immunoreactivity	NOUN
fnp-2639	129	20	similar	similar	ADJ
fnp-2639	129	21	to	to	ADP
fnp-2639	129	22	what	what	PRON
fnp-2639	129	23	has	have	AUX
fnp-2639	129	24	been	be	AUX
fnp-2639	129	25	previously	previously	ADV
fnp-2639	129	26	reported(6	reported(6	NOUN
fnp-2639	129	27	,	,	PUNCT
fnp-2639	129	28	8	8	NUM
fnp-2639	129	29	,	,	PUNCT
fnp-2639	129	30	19	19	NUM
fnp-2639	129	31	,	,	PUNCT
fnp-2639	129	32	36	36	NUM
fnp-2639	129	33	)	)	PUNCT
fnp-2639	129	34	.	.	PUNCT
fnp-2639	130	1	in	in	ADP
fnp-2639	130	2	our	our	PRON
fnp-2639	130	3	eight	eight	NUM
fnp-2639	130	4	aftld	aftld	ADJ
fnp-2639	130	5	-	-	PUNCT
fnp-2639	130	6	u	u	NOUN
fnp-2639	130	7	cases	case	NOUN
fnp-2639	130	8	,	,	PUNCT
fnp-2639	130	9	ultrastructural	ultrastructural	ADJ
fnp-2639	130	10	analysis	analysis	NOUN
fnp-2639	130	11	demonstrated	demonstrate	VERB
fnp-2639	130	12	granulofilamentous	granulofilamentous	ADJ
fnp-2639	130	13	inclusions	inclusion	NOUN
fnp-2639	130	14	as	as	ADP
fnp-2639	130	15	we	we	PRON
fnp-2639	130	16	previously	previously	ADV
fnp-2639	130	17	reported(4	reported(4	PROPN
fnp-2639	130	18	)	)	PUNCT
fnp-2639	130	19	,	,	PUNCT
fnp-2639	130	20	and	and	CCONJ
fnp-2639	130	21	immunoelectron	immunoelectron	ADJ
fnp-2639	130	22	microscopy	microscopy	NOUN
fnp-2639	130	23	revealed	reveal	VERB
fnp-2639	130	24	fus	fus	PROPN
fnp-2639	130	25	immunoreactivity	immunoreactivity	NOUN
fnp-2639	130	26	.	.	PUNCT
fnp-2639	131	1	of	of	ADP
fnp-2639	131	2	note	note	NOUN
fnp-2639	131	3	is	be	AUX
fnp-2639	131	4	the	the	DET
fnp-2639	131	5	fact	fact	NOUN
fnp-2639	131	6	that	that	SCONJ
fnp-2639	131	7	compact	compact	ADJ
fnp-2639	131	8	hyaline	hyaline	NOUN
fnp-2639	131	9	inclusions	inclusion	NOUN
fnp-2639	131	10	were	be	AUX
fnp-2639	131	11	absent	absent	ADJ
fnp-2639	131	12	in	in	ADP
fnp-2639	131	13	all	all	DET
fnp-2639	131	14	eight	eight	NUM
fnp-2639	131	15	aftld	aftld	ADJ
fnp-2639	131	16	-	-	PUNCT
fnp-2639	131	17	u	u	NOUN
fnp-2639	131	18	cases	case	NOUN
fnp-2639	131	19	.	.	PUNCT
fnp-2639	132	1	this	this	DET
fnp-2639	132	2	finding	finding	NOUN
fnp-2639	132	3	would	would	AUX
fnp-2639	132	4	also	also	ADV
fnp-2639	132	5	support	support	VERB
fnp-2639	132	6	our	our	PRON
fnp-2639	132	7	hypothesis	hypothesis	NOUN
fnp-2639	132	8	that	that	PRON
fnp-2639	132	9	fus	fus	PROPN
fnp-2639	132	10	immunoreactivity	immunoreactivity	NOUN
fnp-2639	132	11	in	in	ADP
fnp-2639	132	12	nifid	nifid	ADJ
fnp-2639	132	13	and	and	CCONJ
fnp-2639	132	14	aftld	aftld	ADJ
fnp-2639	132	15	-	-	PUNCT
fnp-2639	132	16	u	u	NOUN
fnp-2639	132	17	is	be	AUX
fnp-2639	132	18	associated	associate	VERB
fnp-2639	132	19	with	with	ADP
fnp-2639	132	20	the	the	DET
fnp-2639	132	21	presence	presence	NOUN
fnp-2639	132	22	of	of	ADP
fnp-2639	132	23	the	the	DET
fnp-2639	132	24	granulofilamentous	granulofilamentous	ADJ
fnp-2639	132	25	inclusions	inclusion	NOUN
fnp-2639	132	26	while	while	SCONJ
fnp-2639	132	27	α	α	NOUN
fnp-2639	132	28	-	-	PUNCT
fnp-2639	132	29	internexin	internexin	ADJ
fnp-2639	132	30	immunoreactivity	immunoreactivity	NOUN
fnp-2639	132	31	is	be	AUX
fnp-2639	132	32	associated	associate	VERB
fnp-2639	132	33	with	with	ADP
fnp-2639	132	34	the	the	DET
fnp-2639	132	35	presence	presence	NOUN
fnp-2639	132	36	of	of	ADP
fnp-2639	132	37	the	the	DET
fnp-2639	132	38	compact	compact	ADJ
fnp-2639	132	39	hyaline	hyaline	NOUN
fnp-2639	132	40	inclusions	inclusion	NOUN
fnp-2639	132	41	.	.	PUNCT
fnp-2639	133	1	it	it	PRON
fnp-2639	133	2	remains	remain	VERB
fnp-2639	133	3	unclear	unclear	ADJ
fnp-2639	133	4	however	however	ADV
fnp-2639	133	5	;	;	PUNCT
fnp-2639	133	6	why	why	SCONJ
fnp-2639	133	7	some	some	DET
fnp-2639	133	8	granulofilamentous	granulofilamentous	ADJ
fnp-2639	133	9	inclusions	inclusion	NOUN
fnp-2639	133	10	show	show	VERB
fnp-2639	133	11	exclusive	exclusive	ADJ
fnp-2639	133	12	fus	fus	PROPN
fnp-2639	133	13	immunoreactivity	immunoreactivity	NOUN
fnp-2639	133	14	(	(	PUNCT
fnp-2639	133	15	e.g.	e.g.	ADV
fnp-2639	133	16	aftld	aftld	ADJ
fnp-2639	133	17	-	-	PUNCT
fnp-2639	133	18	u	u	NOUN
fnp-2639	133	19	)	)	PUNCT
fnp-2639	133	20	and	and	CCONJ
fnp-2639	133	21	others	other	NOUN
fnp-2639	133	22	show	show	VERB
fnp-2639	133	23	exclusive	exclusive	ADJ
fnp-2639	133	24	tdp-43	tdp-43	PROPN
fnp-2639	133	25	immunoreactivity	immunoreactivity	PROPN
fnp-2639	133	26	(	(	PUNCT
fnp-2639	133	27	e.g.	e.g.	ADV
fnp-2639	133	28	ftld	ftld	ADJ
fnp-2639	133	29	-	-	PUNCT
fnp-2639	133	30	tdp	tdp	NOUN
fnp-2639	133	31	)	)	PUNCT
fnp-2639	133	32	.	.	PUNCT
fnp-2639	134	1	only	only	ADV
fnp-2639	134	2	one	one	NUM
fnp-2639	134	3	study	study	NOUN
fnp-2639	134	4	to	to	ADP
fnp-2639	134	5	date	date	NOUN
fnp-2639	134	6	has	have	AUX
fnp-2639	134	7	reported	report	VERB
fnp-2639	134	8	both	both	DET
fnp-2639	134	9	fus	fus	PROPN
fnp-2639	134	10	and	and	CCONJ
fnp-2639	134	11	tdp-43	tdp-43	X
fnp-2639	134	12	immunoreactivity	immunoreactivity	NOUN
fnp-2639	134	13	in	in	ADP
fnp-2639	134	14	the	the	DET
fnp-2639	134	15	same	same	ADJ
fnp-2639	134	16	ncis(39	ncis(39	PROPN
fnp-2639	134	17	)	)	PUNCT
fnp-2639	134	18	.	.	PUNCT
fnp-2639	135	1	overall	overall	ADV
fnp-2639	135	2	,	,	PUNCT
fnp-2639	135	3	the	the	DET
fnp-2639	135	4	data	datum	NOUN
fnp-2639	135	5	from	from	ADP
fnp-2639	135	6	this	this	DET
fnp-2639	135	7	study	study	NOUN
fnp-2639	135	8	support	support	VERB
fnp-2639	135	9	the	the	DET
fnp-2639	135	10	importance	importance	NOUN
fnp-2639	135	11	of	of	ADP
fnp-2639	135	12	fus	fus	PROPN
fnp-2639	135	13	in	in	ADP
fnp-2639	135	14	the	the	DET
fnp-2639	135	15	pathogenesis	pathogenesis	NOUN
fnp-2639	135	16	of	of	ADP
fnp-2639	135	17	aftld	aftld	ADJ
fnp-2639	135	18	-	-	PUNCT
fnp-2639	135	19	u	u	NOUN
fnp-2639	135	20	and	and	CCONJ
fnp-2639	135	21	the	the	DET
fnp-2639	135	22	classification	classification	NOUN
fnp-2639	135	23	of	of	ADP
fnp-2639	135	24	aftld	aftld	ADJ
fnp-2639	135	25	-	-	PUNCT
fnp-2639	135	26	u	u	NOUN
fnp-2639	135	27	as	as	ADP
fnp-2639	135	28	an	an	DET
fnp-2639	135	29	ftld	ftld	ADJ
fnp-2639	135	30	-	-	PUNCT
fnp-2639	135	31	fus	fus	NOUN
fnp-2639	135	32	.	.	PUNCT
fnp-2639	136	1	however	however	ADV
fnp-2639	136	2	,	,	PUNCT
fnp-2639	136	3	the	the	DET
fnp-2639	136	4	role	role	NOUN
fnp-2639	136	5	of	of	ADP
fnp-2639	136	6	fus	fus	PROPN
fnp-2639	136	7	in	in	ADP
fnp-2639	136	8	nifid	nifid	ADJ
fnp-2639	136	9	is	be	AUX
fnp-2639	136	10	less	less	ADV
fnp-2639	136	11	clear	clear	ADJ
fnp-2639	136	12	,	,	PUNCT
fnp-2639	136	13	with	with	ADP
fnp-2639	136	14	evidence	evidence	NOUN
fnp-2639	136	15	supporting	support	VERB
fnp-2639	136	16	nifid	nifid	ADJ
fnp-2639	136	17	being	be	AUX
fnp-2639	136	18	somewhat	somewhat	ADV
fnp-2639	136	19	different	different	ADJ
fnp-2639	136	20	from	from	ADP
fnp-2639	136	21	aftld	aftld	ADJ
fnp-2639	136	22	-	-	PUNCT
fnp-2639	136	23	u	u	NOUN
fnp-2639	136	24	with	with	ADP
fnp-2639	136	25	a	a	DET
fnp-2639	136	26	concern	concern	NOUN
fnp-2639	136	27	that	that	SCONJ
fnp-2639	136	28	nifid	nifid	ADJ
fnp-2639	136	29	,	,	PUNCT
fnp-2639	136	30	at	at	ADP
fnp-2639	136	31	least	least	ADJ
fnp-2639	136	32	not	not	PART
fnp-2639	136	33	all	all	DET
fnp-2639	136	34	cases	case	NOUN
fnp-2639	136	35	,	,	PUNCT
fnp-2639	136	36	may	may	AUX
fnp-2639	136	37	be	be	AUX
fnp-2639	136	38	incorrectly	incorrectly	ADV
fnp-2639	136	39	classified	classify	VERB
fnp-2639	136	40	as	as	ADP
fnp-2639	136	41	a	a	DET
fnp-2639	136	42	subtype	subtype	NOUN
fnp-2639	136	43	of	of	ADP
fnp-2639	136	44	ftld	ftld	ADJ
fnp-2639	136	45	-	-	PUNCT
fnp-2639	136	46	fus	fus	NOUN
fnp-2639	136	47	.	.	PUNCT
fnp-2639	137	1	supporting	support	VERB
fnp-2639	137	2	this	this	DET
fnp-2639	137	3	statement	statement	NOUN
fnp-2639	137	4	is	be	AUX
fnp-2639	137	5	the	the	DET
fnp-2639	137	6	fact	fact	NOUN
fnp-2639	137	7	that	that	SCONJ
fnp-2639	137	8	another	another	DET
fnp-2639	137	9	fus	fus	ADP
fnp-2639	137	10	negative	negative	ADJ
fnp-2639	137	11	case	case	NOUN
fnp-2639	137	12	with	with	ADP
fnp-2639	137	13	α	α	NOUN
fnp-2639	137	14	-	-	ADJ
fnp-2639	137	15	internexin	internexin	ADJ
fnp-2639	137	16	positive	positive	ADJ
fnp-2639	137	17	inclusions	inclusion	NOUN
fnp-2639	137	18	has	have	AUX
fnp-2639	137	19	been	be	AUX
fnp-2639	137	20	described(40	described(40	ADJ
fnp-2639	137	21	)	)	PUNCT
fnp-2639	137	22	.	.	PUNCT
fnp-2639	138	1	in	in	ADP
fnp-2639	138	2	this	this	DET
fnp-2639	138	3	other	other	ADJ
fnp-2639	138	4	case	case	NOUN
fnp-2639	138	5	,	,	PUNCT
fnp-2639	138	6	however	however	ADV
fnp-2639	138	7	,	,	PUNCT
fnp-2639	138	8	a	a	DET
fnp-2639	138	9	sod1	sod1	ADJ
fnp-2639	138	10	mutation	mutation	NOUN
fnp-2639	138	11	was	be	AUX
fnp-2639	138	12	identified	identify	VERB
fnp-2639	138	13	and	and	CCONJ
fnp-2639	138	14	some	some	DET
fnp-2639	138	15	inclusions	inclusion	NOUN
fnp-2639	138	16	were	be	AUX
fnp-2639	138	17	immunoreactive	immunoreactive	ADJ
fnp-2639	138	18	to	to	ADP
fnp-2639	138	19	sod1	sod1	NOUN
fnp-2639	138	20	.	.	PUNCT
fnp-2639	139	1	on	on	ADP
fnp-2639	139	2	a	a	DET
fnp-2639	139	3	different	different	ADJ
fnp-2639	139	4	note	note	NOUN
fnp-2639	139	5	,	,	PUNCT
fnp-2639	139	6	the	the	DET
fnp-2639	139	7	presence	presence	NOUN
fnp-2639	139	8	of	of	ADP
fnp-2639	139	9	intermediate	intermediate	ADJ
fnp-2639	139	10	filament	filament	NOUN
fnp-2639	139	11	inclusions	inclusion	NOUN
fnp-2639	139	12	and	and	CCONJ
fnp-2639	139	13	tdp-43	tdp-43	VERB
fnp-2639	139	14	immunoreactive	immunoreactive	ADJ
fnp-2639	139	15	inclusions	inclusion	NOUN
fnp-2639	139	16	in	in	ADP
fnp-2639	139	17	the	the	DET
fnp-2639	139	18	same	same	ADJ
fnp-2639	139	19	case	case	NOUN
fnp-2639	139	20	makes	make	VERB
fnp-2639	139	21	one	one	NUM
fnp-2639	139	22	contemplate	contemplate	VERB
fnp-2639	139	23	the	the	DET
fnp-2639	139	24	current	current	ADJ
fnp-2639	139	25	sub	sub	NOUN
fnp-2639	139	26	-	-	NOUN
fnp-2639	139	27	classification	classification	NOUN
fnp-2639	139	28	of	of	ADP
fnp-2639	139	29	ftld	ftld	NOUN
fnp-2639	139	30	into	into	ADP
fnp-2639	139	31	strict	strict	ADJ
fnp-2639	139	32	categories	category	NOUN
fnp-2639	139	33	.	.	PUNCT
fnp-2639	140	1	the	the	DET
fnp-2639	140	2	relationship	relationship	NOUN
fnp-2639	140	3	between	between	ADP
fnp-2639	140	4	fus	fus	PROPN
fnp-2639	140	5	and	and	CCONJ
fnp-2639	140	6	intermediate	intermediate	ADJ
fnp-2639	140	7	filament	filament	NOUN
fnp-2639	140	8	is	be	AUX
fnp-2639	140	9	reminiscent	reminiscent	ADJ
fnp-2639	140	10	of	of	ADP
fnp-2639	140	11	the	the	DET
fnp-2639	140	12	relationship	relationship	NOUN
fnp-2639	140	13	between	between	ADP
fnp-2639	140	14	alzheimer	alzheimer	PROPN
fnp-2639	140	15	’s	’s	PART
fnp-2639	140	16	disease	disease	NOUN
fnp-2639	140	17	pathology	pathology	PROPN
fnp-2639	140	18	and	and	CCONJ
fnp-2639	140	19	lewy	lewy	PROPN
fnp-2639	140	20	body	body	NOUN
fnp-2639	140	21	disease	disease	NOUN
fnp-2639	140	22	.	.	PUNCT
fnp-2639	141	1	alzheimer	alzheimer	PROPN
fnp-2639	141	2	’s	’s	PART
fnp-2639	141	3	disease	disease	NOUN
fnp-2639	141	4	pathology	pathology	NOUN
fnp-2639	141	5	can	can	AUX
fnp-2639	141	6	occur	occur	VERB
fnp-2639	141	7	in	in	ADP
fnp-2639	141	8	isolation	isolation	NOUN
fnp-2639	141	9	,	,	PUNCT
fnp-2639	141	10	as	as	SCONJ
fnp-2639	141	11	can	can	AUX
fnp-2639	141	12	lewy	lewy	PROPN
fnp-2639	141	13	body	body	NOUN
fnp-2639	141	14	disease	disease	NOUN
fnp-2639	141	15	,	,	PUNCT
fnp-2639	141	16	but	but	CCONJ
fnp-2639	141	17	there	there	PRON
fnp-2639	141	18	are	be	VERB
fnp-2639	141	19	instances	instance	NOUN
fnp-2639	141	20	in	in	ADP
fnp-2639	141	21	which	which	PRON
fnp-2639	141	22	both	both	CCONJ
fnp-2639	141	23	alzheimer	alzheimer	PROPN
fnp-2639	141	24	’s	’s	PART
fnp-2639	141	25	disease	disease	NOUN
fnp-2639	141	26	and	and	CCONJ
fnp-2639	141	27	lewy	lewy	ADJ
fnp-2639	141	28	body	body	NOUN
fnp-2639	141	29	disease	disease	NOUN
fnp-2639	141	30	co	co	VERB
fnp-2639	141	31	-	-	VERB
fnp-2639	141	32	occur	occur	VERB
fnp-2639	141	33	.	.	PUNCT
fnp-2639	142	1	it	it	PRON
fnp-2639	142	2	would	would	AUX
fnp-2639	142	3	be	be	AUX
fnp-2639	142	4	naïve	naïve	ADJ
fnp-2639	142	5	to	to	PART
fnp-2639	142	6	argue	argue	VERB
fnp-2639	142	7	that	that	SCONJ
fnp-2639	142	8	when	when	SCONJ
fnp-2639	142	9	two	two	NUM
fnp-2639	142	10	pathologies	pathology	NOUN
fnp-2639	142	11	co	co	VERB
fnp-2639	142	12	-	-	VERB
fnp-2639	142	13	occur	occur	ADJ
fnp-2639	142	14	,	,	PUNCT
fnp-2639	142	15	that	that	SCONJ
fnp-2639	142	16	one	one	NUM
fnp-2639	142	17	pathology	pathology	NOUN
fnp-2639	142	18	is	be	AUX
fnp-2639	142	19	more	more	ADV
fnp-2639	142	20	important	important	ADJ
fnp-2639	142	21	or	or	CCONJ
fnp-2639	142	22	more	more	ADV
fnp-2639	142	23	relevant	relevant	ADJ
fnp-2639	142	24	than	than	ADP
fnp-2639	142	25	the	the	DET
fnp-2639	142	26	other	other	ADJ
fnp-2639	142	27	.	.	PUNCT
fnp-2639	143	1	in	in	ADP
fnp-2639	143	2	summary	summary	NOUN
fnp-2639	143	3	,	,	PUNCT
fnp-2639	143	4	aftld	aftld	PROPN
fnp-2639	143	5	-	-	PUNCT
fnp-2639	143	6	u	u	NOUN
fnp-2639	143	7	and	and	CCONJ
fnp-2639	143	8	nifid	nifid	ADJ
fnp-2639	143	9	share	share	NOUN
fnp-2639	143	10	some	some	PRON
fnp-2639	143	11	but	but	CCONJ
fnp-2639	143	12	not	not	PART
fnp-2639	143	13	all	all	PRON
fnp-2639	143	14	features	feature	NOUN
fnp-2639	143	15	.	.	PUNCT
fnp-2639	144	1	striatal	striatal	ADJ
fnp-2639	144	2	atrophy	atrophy	NOUN
fnp-2639	144	3	,	,	PUNCT
fnp-2639	144	4	while	while	SCONJ
fnp-2639	144	5	appearing	appear	VERB
fnp-2639	144	6	to	to	PART
fnp-2639	144	7	be	be	AUX
fnp-2639	144	8	a	a	DET
fnp-2639	144	9	characteristic	characteristic	ADJ
fnp-2639	144	10	feature	feature	NOUN
fnp-2639	144	11	of	of	ADP
fnp-2639	144	12	aftld	aftld	NOUN
fnp-2639	144	13	-	-	PUNCT
fnp-2639	144	14	u	u	NOUN
fnp-2639	144	15	,	,	PUNCT
fnp-2639	144	16	does	do	AUX
fnp-2639	144	17	not	not	PART
fnp-2639	144	18	appear	appear	VERB
fnp-2639	144	19	to	to	PART
fnp-2639	144	20	be	be	AUX
fnp-2639	144	21	a	a	DET
fnp-2639	144	22	feature	feature	NOUN
fnp-2639	144	23	of	of	ADP
fnp-2639	144	24	nifid	nifid	ADJ
fnp-2639	144	25	although	although	SCONJ
fnp-2639	144	26	it	it	PRON
fnp-2639	144	27	can	can	AUX
fnp-2639	144	28	occur	occur	VERB
fnp-2639	144	29	in	in	ADP
fnp-2639	144	30	some	some	DET
fnp-2639	144	31	cases	case	NOUN
fnp-2639	144	32	.	.	PUNCT
fnp-2639	145	1	further	further	ADJ
fnp-2639	145	2	analyses	analysis	NOUN
fnp-2639	145	3	are	be	AUX
fnp-2639	145	4	needed	need	VERB
fnp-2639	145	5	to	to	PART
fnp-2639	145	6	better	well	ADV
fnp-2639	145	7	understand	understand	VERB
fnp-2639	145	8	the	the	DET
fnp-2639	145	9	relationship	relationship	NOUN
fnp-2639	145	10	of	of	ADP
fnp-2639	145	11	aftld	aftld	NOUN
fnp-2639	145	12	-	-	PUNCT
fnp-2639	145	13	u	u	NOUN
fnp-2639	145	14	to	to	PART
fnp-2639	145	15	nifid	nifid	ADJ
fnp-2639	145	16	and	and	CCONJ
fnp-2639	145	17	of	of	ADP
fnp-2639	145	18	nifid	nifid	ADJ
fnp-2639	145	19	to	to	ADP
fnp-2639	145	20	fus	fus	PROPN
fnp-2639	145	21	.	.	PUNCT
fnp-2639	146	1	such	such	ADJ
fnp-2639	146	2	analysis	analysis	NOUN
fnp-2639	146	3	should	should	AUX
fnp-2639	146	4	include	include	VERB
fnp-2639	146	5	the	the	DET
fnp-2639	146	6	assessment	assessment	NOUN
fnp-2639	146	7	of	of	ADP
fnp-2639	146	8	other	other	ADJ
fnp-2639	146	9	proteins	protein	NOUN
fnp-2639	146	10	that	that	PRON
fnp-2639	146	11	have	have	AUX
fnp-2639	146	12	been	be	AUX
fnp-2639	146	13	reported	report	VERB
fnp-2639	146	14	to	to	PART
fnp-2639	146	15	be	be	AUX
fnp-2639	146	16	associated	associate	VERB
fnp-2639	146	17	with	with	ADP
fnp-2639	146	18	aftld	aftld	ADJ
fnp-2639	146	19	-	-	PUNCT
fnp-2639	146	20	u	u	NOUN
fnp-2639	146	21	and	and	CCONJ
fnp-2639	146	22	nifid	nifid	ADJ
fnp-2639	146	23	including	include	VERB
fnp-2639	146	24	taf15	taf15	PROPN
fnp-2639	146	25	and	and	CCONJ
fnp-2639	146	26	ews(41	ews(41	PROPN
fnp-2639	146	27	)	)	PUNCT
fnp-2639	146	28	,	,	PUNCT
fnp-2639	146	29	as	as	ADV
fnp-2639	146	30	well	well	ADV
fnp-2639	146	31	as	as	ADP
fnp-2639	146	32	transportin1(42	transportin1(42	NUM
fnp-2639	146	33	)	)	PUNCT
fnp-2639	146	34	.	.	PUNCT
fnp-2639	147	1	references	reference	NOUN
fnp-2639	147	2	1	1	NUM
fnp-2639	147	3	.	.	PUNCT
fnp-2639	147	4	cairns	cairns	PROPN
fnp-2639	147	5	nj	nj	PROPN
fnp-2639	147	6	,	,	PUNCT
fnp-2639	147	7	bigio	bigio	NOUN
fnp-2639	147	8	eh	eh	INTJ
fnp-2639	147	9	,	,	PUNCT
fnp-2639	147	10	mackenzie	mackenzie	PROPN
fnp-2639	147	11	ir	ir	PROPN
fnp-2639	147	12	,	,	PUNCT
fnp-2639	147	13	neumann	neumann	PROPN
fnp-2639	147	14	m	m	PROPN
fnp-2639	147	15	,	,	PUNCT
fnp-2639	147	16	lee	lee	PROPN
fnp-2639	147	17	vm	vm	PROPN
fnp-2639	147	18	,	,	PUNCT
fnp-2639	147	19	hatanpaa	hatanpaa	PROPN
fnp-2639	147	20	kj	kj	PROPN
fnp-2639	147	21	,	,	PUNCT
fnp-2639	147	22	et	et	PROPN
fnp-2639	147	23	al	al	PROPN
fnp-2639	147	24	.	.	PROPN
fnp-2639	147	25	neuropathologic	neuropathologic	PROPN
fnp-2639	147	26	diagnostic	diagnostic	ADJ
fnp-2639	147	27	and	and	CCONJ
fnp-2639	147	28	nosologic	nosologic	ADJ
fnp-2639	147	29	criteria	criterion	NOUN
fnp-2639	147	30	for	for	ADP
fnp-2639	147	31	frontotemporal	frontotemporal	ADJ
fnp-2639	147	32	lobar	lobar	ADJ
fnp-2639	147	33	degeneration	degeneration	NOUN
fnp-2639	147	34	:	:	PUNCT
fnp-2639	147	35	consensus	consensus	NOUN
fnp-2639	147	36	of	of	ADP
fnp-2639	147	37	the	the	DET
fnp-2639	147	38	consortium	consortium	NOUN
fnp-2639	147	39	for	for	ADP
fnp-2639	147	40	frontotemporal	frontotemporal	ADJ
fnp-2639	147	41	lobar	lobar	ADJ
fnp-2639	147	42	degeneration	degeneration	NOUN
fnp-2639	147	43	.	.	PUNCT
fnp-2639	148	1	acta	acta	PROPN
fnp-2639	148	2	neuropathol	neuropathol	PROPN
fnp-2639	148	3	.	.	PUNCT
fnp-2639	149	1	2007;114(1):5	2007;114(1):5	NUM
fnp-2639	149	2	-	-	SYM
fnp-2639	149	3	22	22	NUM
fnp-2639	149	4	.	.	PUNCT
fnp-2639	150	1	2	2	X
fnp-2639	150	2	.	.	X
fnp-2639	150	3	mackenzie	mackenzie	PROPN
fnp-2639	150	4	ir	ir	PROPN
fnp-2639	150	5	,	,	PUNCT
fnp-2639	150	6	neumann	neumann	PROPN
fnp-2639	150	7	m	m	PROPN
fnp-2639	150	8	,	,	PUNCT
fnp-2639	150	9	bigio	bigio	NOUN
fnp-2639	150	10	eh	eh	INTJ
fnp-2639	150	11	,	,	PUNCT
fnp-2639	150	12	cairns	cairns	PROPN
fnp-2639	150	13	nj	nj	PROPN
fnp-2639	150	14	,	,	PUNCT
fnp-2639	150	15	alafuzoff	alafuzoff	NOUN
fnp-2639	151	1	i	i	PRON
fnp-2639	151	2	,	,	PUNCT
fnp-2639	151	3	kril	kril	PROPN
fnp-2639	151	4	j	j	PROPN
fnp-2639	151	5	,	,	PUNCT
fnp-2639	151	6	et	et	PROPN
fnp-2639	151	7	al	al	PROPN
fnp-2639	151	8	.	.	PUNCT
fnp-2639	151	9	nomenclature	nomenclature	NOUN
fnp-2639	151	10	for	for	ADP
fnp-2639	151	11	neuropathologic	neuropathologic	ADJ
fnp-2639	151	12	subtypes	subtype	NOUN
fnp-2639	151	13	of	of	ADP
fnp-2639	151	14	frontotemporal	frontotemporal	ADJ
fnp-2639	151	15	lobar	lobar	ADJ
fnp-2639	151	16	degeneration	degeneration	NOUN
fnp-2639	151	17	:	:	PUNCT
fnp-2639	151	18	consensus	consensus	NOUN
fnp-2639	151	19	recommendations	recommendation	NOUN
fnp-2639	151	20	.	.	PUNCT
fnp-2639	152	1	acta	acta	PROPN
fnp-2639	152	2	neuropathol	neuropathol	PROPN
fnp-2639	152	3	.	.	PUNCT
fnp-2639	153	1	2009;117(1):15	2009;117(1):15	NUM
fnp-2639	153	2	-	-	PUNCT
fnp-2639	153	3	8	8	NUM
fnp-2639	153	4	.	.	NOUN
fnp-2639	154	1	3	3	X
fnp-2639	154	2	.	.	X
fnp-2639	154	3	mackenzie	mackenzie	PROPN
fnp-2639	154	4	ir	ir	PROPN
fnp-2639	154	5	,	,	PUNCT
fnp-2639	154	6	neumann	neumann	PROPN
fnp-2639	154	7	m	m	PROPN
fnp-2639	154	8	,	,	PUNCT
fnp-2639	154	9	bigio	bigio	NOUN
fnp-2639	154	10	eh	eh	INTJ
fnp-2639	154	11	,	,	PUNCT
fnp-2639	154	12	cairns	cairns	PROPN
fnp-2639	154	13	nj	nj	PROPN
fnp-2639	154	14	,	,	PUNCT
fnp-2639	154	15	alafuzoff	alafuzoff	NOUN
fnp-2639	155	1	i	i	PRON
fnp-2639	155	2	,	,	PUNCT
fnp-2639	155	3	kril	kril	PROPN
fnp-2639	155	4	j	j	PROPN
fnp-2639	155	5	,	,	PUNCT
fnp-2639	155	6	et	et	PROPN
fnp-2639	155	7	al	al	PROPN
fnp-2639	155	8	.	.	PUNCT
fnp-2639	156	1	nomenclature	nomenclature	NOUN
fnp-2639	156	2	and	and	CCONJ
fnp-2639	156	3	nosology	nosology	NOUN
fnp-2639	156	4	for	for	ADP
fnp-2639	156	5	neuropathologic	neuropathologic	ADJ
fnp-2639	156	6	subtypes	subtype	NOUN
fnp-2639	156	7	of	of	ADP
fnp-2639	156	8	frontotemporal	frontotemporal	ADJ
fnp-2639	156	9	lobar	lobar	ADJ
fnp-2639	156	10	degeneration	degeneration	NOUN
fnp-2639	156	11	:	:	PUNCT
fnp-2639	156	12	an	an	DET
fnp-2639	156	13	update	update	NOUN
fnp-2639	156	14	.	.	PUNCT
fnp-2639	157	1	acta	acta	PROPN
fnp-2639	157	2	neuropathol	neuropathol	PROPN
fnp-2639	157	3	.	.	PUNCT
fnp-2639	158	1	2010;119(1):1	2010;119(1):1	X
fnp-2639	158	2	-	-	SYM
fnp-2639	158	3	4	4	NUM
fnp-2639	158	4	.	.	NOUN
fnp-2639	158	5	4	4	NUM
fnp-2639	158	6	.	.	X
fnp-2639	158	7	josephs	josephs	PROPN
fnp-2639	158	8	ka	ka	PROPN
fnp-2639	158	9	,	,	PUNCT
fnp-2639	158	10	lin	lin	PROPN
fnp-2639	158	11	wl	wl	PROPN
fnp-2639	158	12	,	,	PUNCT
fnp-2639	158	13	ahmed	ahmed	PROPN
fnp-2639	158	14	z	z	PROPN
fnp-2639	158	15	,	,	PUNCT
fnp-2639	158	16	stroh	stroh	PROPN
fnp-2639	158	17	da	da	PROPN
fnp-2639	158	18	,	,	PUNCT
fnp-2639	158	19	graff	graff	NOUN
fnp-2639	158	20	-	-	PUNCT
fnp-2639	158	21	radford	radford	PROPN
fnp-2639	158	22	nr	nr	PROPN
fnp-2639	158	23	,	,	PUNCT
fnp-2639	158	24	dickson	dickson	PROPN
fnp-2639	158	25	dw	dw	PROPN
fnp-2639	158	26	.	.	PROPN
fnp-2639	158	27	frontotemporal	frontotemporal	ADJ
fnp-2639	158	28	lobar	lobar	ADJ
fnp-2639	158	29	degeneration	degeneration	NOUN
fnp-2639	158	30	with	with	ADP
fnp-2639	158	31	ubiquitin	ubiquitin	ADJ
fnp-2639	158	32	-	-	ADJ
fnp-2639	158	33	positive	positive	ADJ
fnp-2639	158	34	,	,	PUNCT
fnp-2639	158	35	but	but	CCONJ
fnp-2639	158	36	tdp-43	tdp-43	NOUN
fnp-2639	158	37	-	-	PUNCT
fnp-2639	158	38	negative	negative	ADJ
fnp-2639	158	39	inclusions	inclusion	NOUN
fnp-2639	158	40	.	.	PUNCT
fnp-2639	159	1	acta	acta	PROPN
fnp-2639	159	2	neuropathol	neuropathol	PROPN
fnp-2639	159	3	.	.	PUNCT
fnp-2639	160	1	2008;116(2):159	2008;116(2):159	NUM
fnp-2639	160	2	-	-	SYM
fnp-2639	160	3	67	67	NUM
fnp-2639	160	4	.	.	PUNCT
fnp-2639	161	1	5	5	NUM
fnp-2639	161	2	.	.	X
fnp-2639	161	3	mackenzie	mackenzie	PROPN
fnp-2639	161	4	ir	ir	PROPN
fnp-2639	161	5	,	,	PUNCT
fnp-2639	161	6	foti	foti	PROPN
fnp-2639	161	7	d	d	PROPN
fnp-2639	161	8	,	,	PUNCT
fnp-2639	161	9	woulfe	woulfe	PROPN
fnp-2639	161	10	j	j	PROPN
fnp-2639	161	11	,	,	PUNCT
fnp-2639	161	12	hurwitz	hurwitz	PROPN
fnp-2639	161	13	ta	ta	PROPN
fnp-2639	161	14	.	.	PUNCT
fnp-2639	162	1	atypical	atypical	ADJ
fnp-2639	162	2	frontotemporal	frontotemporal	ADJ
fnp-2639	162	3	lobar	lobar	ADJ
fnp-2639	162	4	degeneration	degeneration	NOUN
fnp-2639	162	5	with	with	ADP
fnp-2639	162	6	ubiquitin	ubiquitin	ADJ
fnp-2639	162	7	-	-	ADJ
fnp-2639	162	8	positive	positive	ADJ
fnp-2639	162	9	,	,	PUNCT
fnp-2639	162	10	tdp-43	tdp-43	NOUN
fnp-2639	162	11	-	-	PUNCT
fnp-2639	162	12	negative	negative	ADJ
fnp-2639	162	13	neuronal	neuronal	ADJ
fnp-2639	162	14	inclusions	inclusion	NOUN
fnp-2639	162	15	.	.	PUNCT
fnp-2639	163	1	brain	brain	NOUN
fnp-2639	163	2	.	.	PUNCT
fnp-2639	164	1	2008;131(pt	2008;131(pt	NUM
fnp-2639	164	2	5):1282	5):1282	NUM
fnp-2639	164	3	-	-	SYM
fnp-2639	164	4	93	93	NUM
fnp-2639	164	5	.	.	PUNCT
fnp-2639	165	1	6	6	NUM
fnp-2639	165	2	.	.	X
fnp-2639	165	3	neumann	neumann	PROPN
fnp-2639	165	4	m	m	PROPN
fnp-2639	165	5	,	,	PUNCT
fnp-2639	165	6	rademakers	rademaker	NOUN
fnp-2639	165	7	r	r	NOUN
fnp-2639	165	8	,	,	PUNCT
fnp-2639	165	9	roeber	roeber	PROPN
fnp-2639	165	10	s	s	PROPN
fnp-2639	165	11	,	,	PUNCT
fnp-2639	165	12	baker	baker	PROPN
fnp-2639	165	13	m	m	PROPN
fnp-2639	165	14	,	,	PUNCT
fnp-2639	165	15	kretzschmar	kretzschmar	PROPN
fnp-2639	165	16	ha	ha	INTJ
fnp-2639	165	17	,	,	PUNCT
fnp-2639	165	18	mackenzie	mackenzie	PROPN
fnp-2639	165	19	ir	ir	PROPN
fnp-2639	165	20	.	.	PUNCT
fnp-2639	166	1	a	a	DET
fnp-2639	166	2	new	new	ADJ
fnp-2639	166	3	subtype	subtype	NOUN
fnp-2639	166	4	of	of	ADP
fnp-2639	166	5	frontotemporal	frontotemporal	ADJ
fnp-2639	166	6	lobar	lobar	ADJ
fnp-2639	166	7	degeneration	degeneration	NOUN
fnp-2639	166	8	with	with	ADP
fnp-2639	166	9	fus	fus	PROPN
fnp-2639	166	10	pathology	pathology	NOUN
fnp-2639	166	11	.	.	PUNCT
fnp-2639	167	1	brain	brain	NOUN
fnp-2639	167	2	.	.	PUNCT
fnp-2639	168	1	2009;132(pt	2009;132(pt	NUM
fnp-2639	168	2	11):2922	11):2922	NUM
fnp-2639	168	3	-	-	SYM
fnp-2639	168	4	31	31	NUM
fnp-2639	168	5	.	.	PUNCT
fnp-2639	169	1	7	7	X
fnp-2639	169	2	.	.	X
fnp-2639	169	3	neumann	neumann	PROPN
fnp-2639	169	4	m	m	PROPN
fnp-2639	169	5	,	,	PUNCT
fnp-2639	169	6	roeber	roeber	PROPN
fnp-2639	169	7	s	s	PROPN
fnp-2639	169	8	,	,	PUNCT
fnp-2639	169	9	kretzschmar	kretzschmar	PROPN
fnp-2639	169	10	ha	ha	INTJ
fnp-2639	169	11	,	,	PUNCT
fnp-2639	169	12	rademakers	rademaker	NOUN
fnp-2639	169	13	r	r	NOUN
fnp-2639	169	14	,	,	PUNCT
fnp-2639	169	15	baker	baker	PROPN
fnp-2639	169	16	m	m	PROPN
fnp-2639	169	17	,	,	PUNCT
fnp-2639	169	18	mackenzie	mackenzie	PROPN
fnp-2639	169	19	ir	ir	AUX
fnp-2639	169	20	.	.	PROPN
fnp-2639	169	21	abundant	abundant	PROPN
fnp-2639	169	22	fus	fus	PROPN
fnp-2639	169	23	-	-	PUNCT
fnp-2639	169	24	immunoreactive	immunoreactive	ADJ
fnp-2639	169	25	pathology	pathology	NOUN
fnp-2639	169	26	in	in	ADP
fnp-2639	169	27	neuronal	neuronal	ADJ
fnp-2639	169	28	intermediate	intermediate	ADJ
fnp-2639	169	29	filament	filament	NOUN
fnp-2639	169	30	inclusion	inclusion	NOUN
fnp-2639	169	31	disease	disease	NOUN
fnp-2639	169	32	.	.	PUNCT
fnp-2639	170	1	acta	acta	PROPN
fnp-2639	170	2	neuropathol	neuropathol	PROPN
fnp-2639	170	3	.	.	PUNCT
fnp-2639	171	1	2009;118(5):605	2009;118(5):605	NUM
fnp-2639	171	2	-	-	SYM
fnp-2639	171	3	16	16	NUM
fnp-2639	171	4	.	.	PUNCT
fnp-2639	172	1	8	8	NUM
fnp-2639	172	2	.	.	X
fnp-2639	172	3	munoz	munoz	PROPN
fnp-2639	172	4	dg	dg	PROPN
fnp-2639	172	5	,	,	PUNCT
fnp-2639	172	6	neumann	neumann	PROPN
fnp-2639	172	7	m	m	PROPN
fnp-2639	172	8	,	,	PUNCT
fnp-2639	172	9	kusaka	kusaka	PROPN
fnp-2639	172	10	h	h	PROPN
fnp-2639	172	11	,	,	PUNCT
fnp-2639	172	12	yokota	yokota	PROPN
fnp-2639	172	13	o	o	NOUN
fnp-2639	172	14	,	,	PUNCT
fnp-2639	172	15	ishihara	ishihara	PROPN
fnp-2639	172	16	k	k	PROPN
fnp-2639	172	17	,	,	PUNCT
fnp-2639	172	18	terada	terada	PROPN
fnp-2639	172	19	s	s	PROPN
fnp-2639	172	20	,	,	PUNCT
fnp-2639	172	21	et	et	PROPN
fnp-2639	172	22	al	al	PROPN
fnp-2639	172	23	.	.	PROPN
fnp-2639	173	1	fus	fus	PROPN
fnp-2639	173	2	pathology	pathology	NOUN
fnp-2639	173	3	in	in	ADP
fnp-2639	173	4	basophilic	basophilic	ADJ
fnp-2639	173	5	inclusion	inclusion	NOUN
fnp-2639	173	6	body	body	NOUN
fnp-2639	173	7	disease	disease	NOUN
fnp-2639	173	8	.	.	PUNCT
fnp-2639	174	1	acta	acta	PROPN
fnp-2639	174	2	neuropathol	neuropathol	PROPN
fnp-2639	174	3	.	.	PUNCT
fnp-2639	175	1	2009;118(5):617	2009;118(5):617	NUM
fnp-2639	175	2	-	-	SYM
fnp-2639	175	3	27	27	NUM
fnp-2639	175	4	.	.	PUNCT
fnp-2639	176	1	9	9	NUM
fnp-2639	176	2	.	.	X
fnp-2639	176	3	cairns	cairns	PROPN
fnp-2639	176	4	nj	nj	PROPN
fnp-2639	176	5	,	,	PUNCT
fnp-2639	176	6	zhukareva	zhukareva	PROPN
fnp-2639	176	7	v	v	PROPN
fnp-2639	176	8	,	,	PUNCT
fnp-2639	176	9	uryu	uryu	PROPN
fnp-2639	176	10	k	k	PROPN
fnp-2639	176	11	,	,	PUNCT
fnp-2639	176	12	zhang	zhang	PROPN
fnp-2639	176	13	b	b	PROPN
fnp-2639	176	14	,	,	PUNCT
fnp-2639	176	15	bigio	bigio	NOUN
fnp-2639	176	16	e	e	NOUN
fnp-2639	176	17	,	,	PUNCT
fnp-2639	176	18	mackenzie	mackenzie	PROPN
fnp-2639	176	19	ir	ir	PROPN
fnp-2639	176	20	,	,	PUNCT
fnp-2639	176	21	et	et	PROPN
fnp-2639	176	22	al	al	PROPN
fnp-2639	176	23	.	.	PUNCT
fnp-2639	177	1	alpha	alpha	PROPN
fnp-2639	177	2	-	-	PUNCT
fnp-2639	177	3	internexin	internexin	PROPN
fnp-2639	177	4	is	be	AUX
fnp-2639	177	5	present	present	ADJ
fnp-2639	177	6	in	in	ADP
fnp-2639	177	7	the	the	DET
fnp-2639	177	8	pathological	pathological	ADJ
fnp-2639	177	9	inclusions	inclusion	NOUN
fnp-2639	177	10	of	of	ADP
fnp-2639	177	11	neuronal	neuronal	ADJ
fnp-2639	177	12	intermediate	intermediate	ADJ
fnp-2639	177	13	filament	filament	NOUN
fnp-2639	177	14	inclusion	inclusion	NOUN
fnp-2639	177	15	disease	disease	NOUN
fnp-2639	177	16	.	.	PUNCT
fnp-2639	178	1	am	be	AUX
fnp-2639	178	2	j	j	PROPN
fnp-2639	178	3	pathol	pathol	NOUN
fnp-2639	178	4	.	.	PUNCT
fnp-2639	179	1	2004;164(6):2153	2004;164(6):2153	NUM
fnp-2639	179	2	-	-	SYM
fnp-2639	179	3	61	61	NUM
fnp-2639	179	4	.	.	PUNCT
fnp-2639	180	1	10	10	NUM
fnp-2639	180	2	.	.	PUNCT
fnp-2639	181	1	josephs	josephs	PROPN
fnp-2639	181	2	ka	ka	PROPN
fnp-2639	181	3	,	,	PUNCT
fnp-2639	181	4	holton	holton	PROPN
fnp-2639	181	5	jl	jl	PROPN
fnp-2639	181	6	,	,	PUNCT
fnp-2639	181	7	rossor	rossor	PROPN
fnp-2639	181	8	mn	mn	PROPN
fnp-2639	181	9	,	,	PUNCT
fnp-2639	181	10	braendgaard	braendgaard	ADJ
fnp-2639	181	11	h	h	PROPN
fnp-2639	181	12	,	,	PUNCT
fnp-2639	181	13	ozawa	ozawa	PROPN
fnp-2639	181	14	t	t	PROPN
fnp-2639	181	15	,	,	PUNCT
fnp-2639	181	16	fox	fox	PROPN
fnp-2639	181	17	nc	nc	PROPN
fnp-2639	181	18	,	,	PUNCT
fnp-2639	181	19	et	et	PROPN
fnp-2639	181	20	al	al	PROPN
fnp-2639	181	21	.	.	PROPN
fnp-2639	181	22	neurofilament	neurofilament	PROPN
fnp-2639	181	23	inclusion	inclusion	NOUN
fnp-2639	181	24	body	body	NOUN
fnp-2639	181	25	disease	disease	NOUN
fnp-2639	181	26	:	:	PUNCT
fnp-2639	181	27	a	a	DET
fnp-2639	181	28	new	new	ADJ
fnp-2639	181	29	proteinopathy	proteinopathy	ADJ
fnp-2639	181	30	?	?	PUNCT
fnp-2639	182	1	brain	brain	NOUN
fnp-2639	182	2	.	.	PUNCT
fnp-2639	183	1	2003;126(pt	2003;126(pt	PROPN
fnp-2639	183	2	10):2291	10):2291	NUM
fnp-2639	183	3	-	-	SYM
fnp-2639	183	4	303	303	NUM
fnp-2639	183	5	.	.	PUNCT
fnp-2639	183	6	11	11	NUM
fnp-2639	183	7	.	.	PUNCT
fnp-2639	184	1	yokota	yokota	PROPN
fnp-2639	184	2	o	o	PROPN
fnp-2639	184	3	,	,	PUNCT
fnp-2639	184	4	tsuchiya	tsuchiya	PROPN
fnp-2639	185	1	k	k	PROPN
fnp-2639	185	2	,	,	PUNCT
fnp-2639	185	3	terada	terada	PROPN
fnp-2639	185	4	s	s	PROPN
fnp-2639	185	5	,	,	PUNCT
fnp-2639	185	6	ishizu	ishizu	NOUN
fnp-2639	185	7	h	h	PROPN
fnp-2639	185	8	,	,	PUNCT
fnp-2639	185	9	uchikado	uchikado	ADJ
fnp-2639	185	10	h	h	NOUN
fnp-2639	185	11	,	,	PUNCT
fnp-2639	185	12	ikeda	ikeda	PROPN
fnp-2639	185	13	m	m	PROPN
fnp-2639	185	14	,	,	PUNCT
fnp-2639	185	15	et	et	PROPN
fnp-2639	185	16	al	al	PROPN
fnp-2639	185	17	.	.	PUNCT
fnp-2639	185	18	basophilic	basophilic	ADJ
fnp-2639	185	19	inclusion	inclusion	NOUN
fnp-2639	185	20	body	body	NOUN
fnp-2639	185	21	disease	disease	NOUN
fnp-2639	185	22	and	and	CCONJ
fnp-2639	185	23	neuronal	neuronal	ADJ
fnp-2639	185	24	intermediate	intermediate	ADJ
fnp-2639	185	25	filament	filament	NOUN
fnp-2639	185	26	inclusion	inclusion	NOUN
fnp-2639	185	27	disease	disease	NOUN
fnp-2639	185	28	:	:	PUNCT
fnp-2639	185	29	a	a	DET
fnp-2639	185	30	comparative	comparative	ADJ
fnp-2639	185	31	clinicopathological	clinicopathological	ADJ
fnp-2639	185	32	study	study	NOUN
fnp-2639	185	33	.	.	PUNCT
fnp-2639	186	1	acta	acta	PROPN
fnp-2639	186	2	neuropathol	neuropathol	PROPN
fnp-2639	186	3	.	.	PUNCT
fnp-2639	187	1	2008;115(5):561	2008;115(5):561	NUM
fnp-2639	187	2	-	-	SYM
fnp-2639	187	3	75	75	NUM
fnp-2639	187	4	.	.	PUNCT
fnp-2639	188	1	12	12	NUM
fnp-2639	188	2	.	.	PUNCT
fnp-2639	189	1	munoz	munoz	PROPN
fnp-2639	189	2	-	-	PUNCT
fnp-2639	189	3	garcia	garcia	PROPN
fnp-2639	189	4	d	d	PROPN
fnp-2639	189	5	,	,	PUNCT
fnp-2639	189	6	ludwin	ludwin	NOUN
fnp-2639	189	7	sk	sk	PROPN
fnp-2639	189	8	.	.	PROPN
fnp-2639	189	9	classic	classic	ADJ
fnp-2639	189	10	and	and	CCONJ
fnp-2639	189	11	generalized	generalized	ADJ
fnp-2639	189	12	variants	variant	NOUN
fnp-2639	189	13	of	of	ADP
fnp-2639	189	14	pick	pick	PROPN
fnp-2639	189	15	's	's	PART
fnp-2639	189	16	disease	disease	NOUN
fnp-2639	189	17	:	:	PUNCT
fnp-2639	189	18	a	a	DET
fnp-2639	189	19	clinicopathological	clinicopathological	ADJ
fnp-2639	189	20	,	,	PUNCT
fnp-2639	189	21	ultrastructural	ultrastructural	ADJ
fnp-2639	189	22	,	,	PUNCT
fnp-2639	189	23	and	and	CCONJ
fnp-2639	189	24	immunocytochemical	immunocytochemical	ADJ
fnp-2639	189	25	comparative	comparative	ADJ
fnp-2639	189	26	study	study	NOUN
fnp-2639	189	27	.	.	PUNCT
fnp-2639	190	1	ann	ann	PROPN
fnp-2639	190	2	neurol	neurol	PROPN
fnp-2639	190	3	.	.	PUNCT
fnp-2639	191	1	1984;16(4):467	1984;16(4):467	NUM
fnp-2639	191	2	-	-	SYM
fnp-2639	191	3	80	80	NUM
fnp-2639	191	4	.	.	PUNCT
fnp-2639	191	5	13	13	NUM
fnp-2639	191	6	.	.	PUNCT
fnp-2639	192	1	josephs	josephs	PROPN
fnp-2639	192	2	ka	ka	PROPN
fnp-2639	192	3	,	,	PUNCT
fnp-2639	192	4	hodges	hodges	PROPN
fnp-2639	192	5	jr	jr	PROPN
fnp-2639	192	6	,	,	PUNCT
fnp-2639	192	7	snowden	snowden	PROPN
fnp-2639	192	8	js	js	PROPN
fnp-2639	192	9	,	,	PUNCT
fnp-2639	192	10	mackenzie	mackenzie	PROPN
fnp-2639	192	11	ir	ir	PROPN
fnp-2639	192	12	,	,	PUNCT
fnp-2639	192	13	neumann	neumann	PROPN
fnp-2639	192	14	m	m	PROPN
fnp-2639	192	15	,	,	PUNCT
fnp-2639	192	16	mann	mann	PROPN
fnp-2639	192	17	dm	dm	PROPN
fnp-2639	192	18	,	,	PUNCT
fnp-2639	192	19	et	et	PROPN
fnp-2639	192	20	al	al	PROPN
fnp-2639	192	21	.	.	PUNCT
fnp-2639	193	1	neuropathological	neuropathological	ADJ
fnp-2639	193	2	background	background	NOUN
fnp-2639	193	3	of	of	ADP
fnp-2639	193	4	phenotypical	phenotypical	ADJ
fnp-2639	193	5	variability	variability	NOUN
fnp-2639	193	6	in	in	ADP
fnp-2639	193	7	frontotemporal	frontotemporal	ADJ
fnp-2639	193	8	dementia	dementia	NOUN
fnp-2639	193	9	.	.	PUNCT
fnp-2639	194	1	acta	acta	PROPN
fnp-2639	194	2	neuropathol	neuropathol	PROPN
fnp-2639	194	3	.	.	PUNCT
fnp-2639	195	1	2011;122(2):137	2011;122(2):137	NUM
fnp-2639	195	2	-	-	SYM
fnp-2639	195	3	53	53	NUM
fnp-2639	195	4	.	.	PUNCT
fnp-2639	196	1	14	14	NUM
fnp-2639	196	2	.	.	PUNCT
fnp-2639	197	1	urwin	urwin	PROPN
fnp-2639	197	2	h	h	PROPN
fnp-2639	197	3	,	,	PUNCT
fnp-2639	197	4	josephs	josephs	PROPN
fnp-2639	197	5	ka	ka	PROPN
fnp-2639	197	6	,	,	PUNCT
fnp-2639	197	7	rohrer	rohrer	PROPN
fnp-2639	197	8	jd	jd	PROPN
fnp-2639	197	9	,	,	PUNCT
fnp-2639	197	10	mackenzie	mackenzie	PROPN
fnp-2639	197	11	ir	ir	PROPN
fnp-2639	197	12	,	,	PUNCT
fnp-2639	197	13	neumann	neumann	PROPN
fnp-2639	197	14	m	m	PROPN
fnp-2639	197	15	,	,	PUNCT
fnp-2639	197	16	authier	authier	PROPN
fnp-2639	197	17	a	a	NOUN
fnp-2639	197	18	,	,	PUNCT
fnp-2639	197	19	et	et	PROPN
fnp-2639	197	20	al	al	PROPN
fnp-2639	197	21	.	.	PROPN
fnp-2639	198	1	fus	fus	PROPN
fnp-2639	198	2	pathology	pathology	NOUN
fnp-2639	198	3	defines	define	VERB
fnp-2639	198	4	the	the	DET
fnp-2639	198	5	majority	majority	NOUN
fnp-2639	198	6	of	of	ADP
fnp-2639	198	7	tauand	tauand	NOUN
fnp-2639	198	8	tdp-43	tdp-43	PROPN
fnp-2639	198	9	-	-	PUNCT
fnp-2639	198	10	negative	negative	ADJ
fnp-2639	198	11	frontotemporal	frontotemporal	ADJ
fnp-2639	198	12	lobar	lobar	ADJ
fnp-2639	198	13	degeneration	degeneration	NOUN
fnp-2639	198	14	.	.	PUNCT
fnp-2639	199	1	acta	acta	PROPN
fnp-2639	199	2	neuropathol	neuropathol	PROPN
fnp-2639	199	3	.	.	PUNCT
fnp-2639	200	1	2010;120(1):33	2010;120(1):33	NUM
fnp-2639	200	2	-	-	SYM
fnp-2639	200	3	41	41	NUM
fnp-2639	200	4	.	.	PUNCT
fnp-2639	200	5	15	15	NUM
fnp-2639	200	6	.	.	PUNCT
fnp-2639	201	1	snowden	snowden	PROPN
fnp-2639	201	2	js	js	PROPN
fnp-2639	201	3	,	,	PUNCT
fnp-2639	201	4	hu	hu	PROPN
fnp-2639	201	5	q	q	PROPN
fnp-2639	201	6	,	,	PUNCT
fnp-2639	201	7	rollinson	rollinson	NOUN
fnp-2639	201	8	s	s	PROPN
fnp-2639	201	9	,	,	PUNCT
fnp-2639	201	10	halliwell	halliwell	PROPN
fnp-2639	201	11	n	n	CCONJ
fnp-2639	201	12	,	,	PUNCT
fnp-2639	201	13	robinson	robinson	PROPN
fnp-2639	201	14	a	a	PROPN
fnp-2639	201	15	,	,	PUNCT
fnp-2639	201	16	davidson	davidson	NOUN
fnp-2639	201	17	ys	ys	NOUN
fnp-2639	201	18	,	,	PUNCT
fnp-2639	201	19	et	et	PROPN
fnp-2639	201	20	al	al	PROPN
fnp-2639	201	21	.	.	PUNCT
fnp-2639	202	1	the	the	DET
fnp-2639	202	2	most	most	ADV
fnp-2639	202	3	common	common	ADJ
fnp-2639	202	4	type	type	NOUN
fnp-2639	202	5	of	of	ADP
fnp-2639	202	6	ftld	ftld	NOUN
fnp-2639	202	7	-	-	PUNCT
fnp-2639	202	8	fus	fus	NOUN
fnp-2639	202	9	(	(	PUNCT
fnp-2639	202	10	aftld	aftld	NOUN
fnp-2639	202	11	-	-	PUNCT
fnp-2639	202	12	u	u	NOUN
fnp-2639	202	13	)	)	PUNCT
fnp-2639	202	14	is	be	AUX
fnp-2639	202	15	associated	associate	VERB
fnp-2639	202	16	with	with	ADP
fnp-2639	202	17	a	a	DET
fnp-2639	202	18	distinct	distinct	ADJ
fnp-2639	202	19	clinical	clinical	ADJ
fnp-2639	202	20	form	form	NOUN
fnp-2639	202	21	of	of	ADP
fnp-2639	202	22	frontotemporal	frontotemporal	ADJ
fnp-2639	202	23	dementia	dementia	NOUN
fnp-2639	202	24	but	but	CCONJ
fnp-2639	202	25	is	be	AUX
fnp-2639	202	26	not	not	PART
fnp-2639	202	27	related	relate	VERB
fnp-2639	202	28	to	to	ADP
fnp-2639	202	29	mutations	mutation	NOUN
fnp-2639	202	30	in	in	ADP
fnp-2639	202	31	the	the	DET
fnp-2639	202	32	fus	fus	PROPN
fnp-2639	202	33	gene	gene	NOUN
fnp-2639	202	34	.	.	PUNCT
fnp-2639	203	1	acta	acta	PROPN
fnp-2639	203	2	neuropathol	neuropathol	PROPN
fnp-2639	203	3	.	.	PUNCT
fnp-2639	204	1	2011;122(1):99	2011;122(1):99	NUM
fnp-2639	204	2	-	-	SYM
fnp-2639	204	3	110	110	NUM
fnp-2639	204	4	.	.	PUNCT
fnp-2639	205	1	16	16	NUM
fnp-2639	205	2	.	.	PUNCT
fnp-2639	206	1	matsumoto	matsumoto	PROPN
fnp-2639	206	2	s	s	PROPN
fnp-2639	206	3	,	,	PUNCT
fnp-2639	206	4	kusaka	kusaka	PROPN
fnp-2639	206	5	h	h	PROPN
fnp-2639	206	6	,	,	PUNCT
fnp-2639	206	7	murakami	murakami	NOUN
fnp-2639	206	8	n	n	CCONJ
fnp-2639	206	9	,	,	PUNCT
fnp-2639	206	10	hashizume	hashizume	PROPN
fnp-2639	206	11	y	y	PROPN
fnp-2639	206	12	,	,	PUNCT
fnp-2639	206	13	okazaki	okazaki	PROPN
fnp-2639	206	14	h	h	PROPN
fnp-2639	206	15	,	,	PUNCT
fnp-2639	206	16	hirano	hirano	PROPN
fnp-2639	206	17	a.	a.	PROPN
fnp-2639	206	18	basophilic	basophilic	PROPN
fnp-2639	206	19	inclusions	inclusion	NOUN
fnp-2639	206	20	in	in	ADP
fnp-2639	206	21	sporadic	sporadic	ADJ
fnp-2639	206	22	juvenile	juvenile	ADJ
fnp-2639	206	23	amyotrophic	amyotrophic	ADJ
fnp-2639	206	24	lateral	lateral	ADJ
fnp-2639	206	25	sclerosis	sclerosis	NOUN
fnp-2639	206	26	:	:	PUNCT
fnp-2639	206	27	an	an	DET
fnp-2639	206	28	immunocytochemical	immunocytochemical	ADJ
fnp-2639	206	29	and	and	CCONJ
fnp-2639	206	30	ultrastructural	ultrastructural	ADJ
fnp-2639	206	31	study	study	NOUN
fnp-2639	206	32	.	.	PUNCT
fnp-2639	207	1	acta	acta	PROPN
fnp-2639	207	2	neuropathol	neuropathol	PROPN
fnp-2639	207	3	.	.	PUNCT
fnp-2639	208	1	1992;83(6):579	1992;83(6):579	NUM
fnp-2639	208	2	-	-	PUNCT
fnp-2639	208	3	83	83	NUM
fnp-2639	208	4	.	.	PUNCT
fnp-2639	208	5	17	17	NUM
fnp-2639	208	6	.	.	PUNCT
fnp-2639	209	1	josephs	josephs	PROPN
fnp-2639	209	2	ka	ka	PROPN
fnp-2639	209	3	,	,	PUNCT
fnp-2639	209	4	whitwell	whitwell	PROPN
fnp-2639	209	5	jl	jl	PROPN
fnp-2639	209	6	,	,	PUNCT
fnp-2639	209	7	parisi	parisi	PROPN
fnp-2639	209	8	je	je	PROPN
fnp-2639	209	9	,	,	PUNCT
fnp-2639	209	10	petersen	petersen	PROPN
fnp-2639	209	11	rc	rc	PROPN
fnp-2639	209	12	,	,	PUNCT
fnp-2639	209	13	boeve	boeve	PROPN
fnp-2639	209	14	bf	bf	PROPN
fnp-2639	209	15	,	,	PUNCT
fnp-2639	209	16	jack	jack	PROPN
fnp-2639	209	17	cr	cr	PROPN
fnp-2639	209	18	,	,	PUNCT
fnp-2639	209	19	jr	jr	PROPN
fnp-2639	209	20	.	.	PROPN
fnp-2639	209	21	,	,	PUNCT
fnp-2639	209	22	et	et	PROPN
fnp-2639	209	23	al	al	PROPN
fnp-2639	209	24	.	.	PUNCT
fnp-2639	210	1	caudate	caudate	ADJ
fnp-2639	210	2	atrophy	atrophy	NOUN
fnp-2639	210	3	on	on	ADP
fnp-2639	210	4	mri	mri	NOUN
fnp-2639	210	5	is	be	AUX
fnp-2639	210	6	a	a	DET
fnp-2639	210	7	characteristic	characteristic	ADJ
fnp-2639	210	8	feature	feature	NOUN
fnp-2639	210	9	of	of	ADP
fnp-2639	210	10	ftld	ftld	ADJ
fnp-2639	210	11	-	-	PUNCT
fnp-2639	210	12	fus	fus	NOUN
fnp-2639	210	13	.	.	PUNCT
fnp-2639	211	1	eur	eur	PROPN
fnp-2639	211	2	j	j	PROPN
fnp-2639	211	3	neurol	neurol	NOUN
fnp-2639	211	4	.	.	PUNCT
fnp-2639	212	1	2010;17(7):969	2010;17(7):969	NOUN
fnp-2639	212	2	-	-	SYM
fnp-2639	212	3	75	75	NUM
fnp-2639	212	4	.	.	PUNCT
fnp-2639	212	5	18	18	NUM
fnp-2639	212	6	.	.	PUNCT
fnp-2639	212	7	seelaar	seelaar	PROPN
fnp-2639	212	8	h	h	PROPN
fnp-2639	212	9	,	,	PUNCT
fnp-2639	212	10	klijnsma	klijnsma	PROPN
fnp-2639	212	11	ky	ky	PROPN
fnp-2639	212	12	,	,	PUNCT
fnp-2639	212	13	de	de	PROPN
fnp-2639	212	14	koning	koning	PROPN
fnp-2639	212	15	i	i	PRON
fnp-2639	212	16	,	,	PUNCT
fnp-2639	212	17	van	van	PROPN
fnp-2639	212	18	der	der	PROPN
fnp-2639	212	19	lugt	lugt	PROPN
fnp-2639	212	20	a	a	PRON
fnp-2639	212	21	,	,	PUNCT
fnp-2639	212	22	chiu	chiu	PROPN
fnp-2639	212	23	wz	wz	PROPN
fnp-2639	212	24	,	,	PUNCT
fnp-2639	212	25	azmani	azmani	VERB
fnp-2639	212	26	a	a	PRON
fnp-2639	212	27	,	,	PUNCT
fnp-2639	212	28	et	et	PROPN
fnp-2639	212	29	al	al	PROPN
fnp-2639	212	30	.	.	PROPN
fnp-2639	212	31	frequency	frequency	PROPN
fnp-2639	212	32	of	of	ADP
fnp-2639	212	33	ubiquitin	ubiquitin	NOUN
fnp-2639	212	34	and	and	CCONJ
fnp-2639	212	35	fus	fus	ADJ
fnp-2639	212	36	-	-	PUNCT
fnp-2639	212	37	positive	positive	ADJ
fnp-2639	212	38	,	,	PUNCT
fnp-2639	212	39	tdp-43	tdp-43	NOUN
fnp-2639	212	40	-	-	PUNCT
fnp-2639	212	41	negative	negative	ADJ
fnp-2639	212	42	frontotemporal	frontotemporal	ADJ
fnp-2639	212	43	lobar	lobar	ADJ
fnp-2639	212	44	degeneration	degeneration	NOUN
fnp-2639	212	45	.	.	PUNCT
fnp-2639	213	1	j	j	PROPN
fnp-2639	213	2	neurol	neurol	PROPN
fnp-2639	213	3	.	.	PUNCT
fnp-2639	214	1	2010;257(5):747	2010;257(5):747	NUM
fnp-2639	214	2	-	-	SYM
fnp-2639	214	3	53	53	NUM
fnp-2639	214	4	.	.	NOUN
fnp-2639	214	5	19	19	NUM
fnp-2639	214	6	.	.	X
fnp-2639	214	7	lashley	lashley	PROPN
fnp-2639	214	8	t	t	PROPN
fnp-2639	214	9	,	,	PUNCT
fnp-2639	214	10	rohrer	rohrer	PROPN
fnp-2639	214	11	jd	jd	PROPN
fnp-2639	214	12	,	,	PUNCT
fnp-2639	214	13	bandopadhyay	bandopadhyay	PROPN
fnp-2639	214	14	r	r	PROPN
fnp-2639	214	15	,	,	PUNCT
fnp-2639	214	16	fry	fry	NOUN
fnp-2639	214	17	c	c	PROPN
fnp-2639	214	18	,	,	PUNCT
fnp-2639	214	19	ahmed	ahmed	PROPN
fnp-2639	214	20	z	z	PROPN
fnp-2639	214	21	,	,	PUNCT
fnp-2639	214	22	isaacs	isaacs	PROPN
fnp-2639	214	23	am	be	AUX
fnp-2639	214	24	,	,	PUNCT
fnp-2639	214	25	et	et	PROPN
fnp-2639	214	26	al	al	PROPN
fnp-2639	214	27	.	.	PUNCT
fnp-2639	215	1	a	a	DET
fnp-2639	215	2	comparative	comparative	ADJ
fnp-2639	215	3	clinical	clinical	ADJ
fnp-2639	215	4	,	,	PUNCT
fnp-2639	215	5	pathological	pathological	ADJ
fnp-2639	215	6	,	,	PUNCT
fnp-2639	215	7	biochemical	biochemical	ADJ
fnp-2639	215	8	and	and	CCONJ
fnp-2639	215	9	genetic	genetic	ADJ
fnp-2639	215	10	study	study	NOUN
fnp-2639	215	11	of	of	ADP
fnp-2639	215	12	fused	fuse	VERB
fnp-2639	215	13	in	in	ADP
fnp-2639	215	14	sarcoma	sarcoma	NOUN
fnp-2639	215	15	proteinopathies	proteinopathie	NOUN
fnp-2639	215	16	.	.	PUNCT
fnp-2639	216	1	brain	brain	NOUN
fnp-2639	216	2	.	.	PUNCT
fnp-2639	217	1	2011;134(pt	2011;134(pt	NUM
fnp-2639	217	2	9):2548	9):2548	NOUN
fnp-2639	217	3	-	-	PUNCT
fnp-2639	217	4	64	64	NUM
fnp-2639	217	5	.	.	PUNCT
fnp-2639	218	1	20	20	NUM
fnp-2639	218	2	.	.	PUNCT
fnp-2639	219	1	dickson	dickson	PROPN
fnp-2639	219	2	dw	dw	PROPN
fnp-2639	219	3	,	,	PUNCT
fnp-2639	219	4	wertkin	wertkin	VERB
fnp-2639	219	5	a	a	X
fnp-2639	219	6	,	,	PUNCT
fnp-2639	219	7	mattiace	mattiace	NOUN
fnp-2639	219	8	la	la	PROPN
fnp-2639	219	9	,	,	PUNCT
fnp-2639	219	10	fier	fier	X
fnp-2639	219	11	e	e	NOUN
fnp-2639	219	12	,	,	PUNCT
fnp-2639	219	13	kress	kress	PROPN
fnp-2639	219	14	y	y	PROPN
fnp-2639	219	15	,	,	PUNCT
fnp-2639	219	16	davies	davy	NOUN
fnp-2639	219	17	p	p	X
fnp-2639	219	18	,	,	PUNCT
fnp-2639	219	19	et	et	PROPN
fnp-2639	219	20	al	al	PROPN
fnp-2639	219	21	.	.	PROPN
fnp-2639	220	1	ubiquitin	ubiquitin	VERB
fnp-2639	220	2	immunoelectron	immunoelectron	ADJ
fnp-2639	220	3	microscopy	microscopy	NOUN
fnp-2639	220	4	of	of	ADP
fnp-2639	220	5	dystrophic	dystrophic	ADJ
fnp-2639	220	6	neurites	neurite	NOUN
fnp-2639	220	7	in	in	ADP
fnp-2639	220	8	cerebellar	cerebellar	ADJ
fnp-2639	220	9	senile	senile	ADJ
fnp-2639	220	10	plaques	plaque	NOUN
fnp-2639	220	11	of	of	ADP
fnp-2639	220	12	alzheimer	alzheimer	PROPN
fnp-2639	220	13	's	's	PART
fnp-2639	220	14	disease	disease	NOUN
fnp-2639	220	15	.	.	PUNCT
fnp-2639	221	1	acta	acta	PROPN
fnp-2639	221	2	neuropathol	neuropathol	PROPN
fnp-2639	221	3	.	.	PUNCT
fnp-2639	222	1	1990;79(5):486	1990;79(5):486	NUM
fnp-2639	222	2	-	-	SYM
fnp-2639	222	3	93	93	NUM
fnp-2639	222	4	.	.	PUNCT
fnp-2639	223	1	21	21	NUM
fnp-2639	223	2	.	.	PUNCT
fnp-2639	224	1	lee	lee	PROPN
fnp-2639	224	2	s	s	PROPN
fnp-2639	224	3	,	,	PUNCT
fnp-2639	224	4	park	park	NOUN
fnp-2639	224	5	yd	yd	PROPN
fnp-2639	224	6	,	,	PUNCT
fnp-2639	224	7	yen	yen	NOUN
fnp-2639	224	8	sh	sh	PROPN
fnp-2639	224	9	,	,	PUNCT
fnp-2639	224	10	ksiezak	ksiezak	NOUN
fnp-2639	224	11	-	-	PUNCT
fnp-2639	224	12	reding	rede	VERB
fnp-2639	224	13	h	h	NOUN
fnp-2639	224	14	,	,	PUNCT
fnp-2639	224	15	goldman	goldman	PROPN
fnp-2639	224	16	je	je	PROPN
fnp-2639	224	17	,	,	PUNCT
fnp-2639	224	18	dickson	dickson	PROPN
fnp-2639	224	19	dw	dw	PROPN
fnp-2639	224	20	.	.	PUNCT
fnp-2639	225	1	a	a	DET
fnp-2639	225	2	study	study	NOUN
fnp-2639	225	3	of	of	ADP
fnp-2639	225	4	infantile	infantile	ADJ
fnp-2639	225	5	motor	motor	NOUN
fnp-2639	225	6	neuron	neuron	NOUN
fnp-2639	225	7	disease	disease	NOUN
fnp-2639	225	8	with	with	ADP
fnp-2639	225	9	neurofilament	neurofilament	NOUN
fnp-2639	225	10	and	and	CCONJ
fnp-2639	225	11	ubiquitin	ubiquitin	ADJ
fnp-2639	225	12	immunocytochemistry	immunocytochemistry	PROPN
fnp-2639	225	13	.	.	PUNCT
fnp-2639	226	1	neuropediatrics	neuropediatrics	PROPN
fnp-2639	226	2	.	.	PUNCT
fnp-2639	227	1	1989;20(2):107	1989;20(2):107	PROPN
fnp-2639	227	2	-	-	SYM
fnp-2639	227	3	11	11	NUM
fnp-2639	227	4	.	.	PUNCT
fnp-2639	228	1	22	22	NUM
fnp-2639	228	2	.	.	PUNCT
fnp-2639	229	1	gwinn	gwinn	NOUN
fnp-2639	229	2	-	-	PUNCT
fnp-2639	229	3	hardy	hardy	PROPN
fnp-2639	229	4	k	k	PROPN
fnp-2639	229	5	,	,	PUNCT
fnp-2639	229	6	mehta	mehta	PROPN
fnp-2639	229	7	nd	nd	PROPN
fnp-2639	229	8	,	,	PUNCT
fnp-2639	229	9	farrer	farrer	PROPN
fnp-2639	229	10	m	m	PROPN
fnp-2639	229	11	,	,	PUNCT
fnp-2639	229	12	maraganore	maraganore	NOUN
fnp-2639	229	13	d	d	NOUN
fnp-2639	229	14	,	,	PUNCT
fnp-2639	229	15	muenter	muenter	NOUN
fnp-2639	229	16	m	m	PROPN
fnp-2639	229	17	,	,	PUNCT
fnp-2639	229	18	yen	yen	PROPN
fnp-2639	229	19	sh	sh	PROPN
fnp-2639	229	20	,	,	PUNCT
fnp-2639	229	21	et	et	PROPN
fnp-2639	229	22	al	al	PROPN
fnp-2639	229	23	.	.	PROPN
fnp-2639	229	24	distinctive	distinctive	ADJ
fnp-2639	229	25	neuropathology	neuropathology	NOUN
fnp-2639	229	26	revealed	reveal	VERB
fnp-2639	229	27	by	by	ADP
fnp-2639	229	28	alpha	alpha	NOUN
fnp-2639	229	29	-	-	PUNCT
fnp-2639	229	30	synuclein	synuclein	NOUN
fnp-2639	229	31	antibodies	antibodie	VERB
fnp-2639	229	32	in	in	ADP
fnp-2639	229	33	hereditary	hereditary	ADJ
fnp-2639	229	34	parkinsonism	parkinsonism	NOUN
fnp-2639	229	35	and	and	CCONJ
fnp-2639	229	36	dementia	dementia	NOUN
fnp-2639	229	37	linked	link	VERB
fnp-2639	229	38	to	to	PART
fnp-2639	229	39	chromosome	chromosome	VERB
fnp-2639	229	40	4p	4p	NUM
fnp-2639	229	41	.	.	PUNCT
fnp-2639	230	1	acta	acta	PROPN
fnp-2639	230	2	neuropathol	neuropathol	PROPN
fnp-2639	230	3	.	.	PUNCT
fnp-2639	231	1	2000;99(6):663	2000;99(6):663	NUM
fnp-2639	231	2	-	-	SYM
fnp-2639	231	3	72	72	NUM
fnp-2639	231	4	.	.	PUNCT
fnp-2639	231	5	23	23	NUM
fnp-2639	231	6	.	.	PUNCT
fnp-2639	232	1	josephs	josephs	PROPN
fnp-2639	232	2	ka	ka	PROPN
fnp-2639	232	3	,	,	PUNCT
fnp-2639	232	4	parisi	parisi	PROPN
fnp-2639	232	5	je	je	PROPN
fnp-2639	232	6	,	,	PUNCT
fnp-2639	232	7	knopman	knopman	NOUN
fnp-2639	232	8	ds	ds	PROPN
fnp-2639	232	9	,	,	PUNCT
fnp-2639	232	10	boeve	boeve	NOUN
fnp-2639	232	11	bf	bf	NOUN
fnp-2639	232	12	,	,	PUNCT
fnp-2639	232	13	petersen	petersen	PROPN
fnp-2639	232	14	rc	rc	PROPN
fnp-2639	232	15	,	,	PUNCT
fnp-2639	232	16	dickson	dickson	PROPN
fnp-2639	232	17	dw	dw	PROPN
fnp-2639	232	18	.	.	PROPN
fnp-2639	232	19	clinically	clinically	ADV
fnp-2639	232	20	undetected	undetecte	VERB
fnp-2639	232	21	motor	motor	NOUN
fnp-2639	232	22	neuron	neuron	NOUN
fnp-2639	232	23	disease	disease	NOUN
fnp-2639	232	24	in	in	ADP
fnp-2639	232	25	pathologically	pathologically	ADV
fnp-2639	232	26	proven	prove	VERB
fnp-2639	232	27	frontotemporal	frontotemporal	ADJ
fnp-2639	232	28	lobar	lobar	ADJ
fnp-2639	232	29	degeneration	degeneration	NOUN
fnp-2639	232	30	with	with	ADP
fnp-2639	232	31	motor	motor	PROPN
fnp-2639	232	32	neuron	neuron	PROPN
fnp-2639	232	33	disease	disease	PROPN
fnp-2639	232	34	.	.	PUNCT
fnp-2639	233	1	arch	arch	ADJ
fnp-2639	233	2	neurol	neurol	NOUN
fnp-2639	233	3	.	.	PUNCT
fnp-2639	234	1	2006;63(4):506	2006;63(4):506	NUM
fnp-2639	234	2	-	-	PUNCT
fnp-2639	234	3	12	12	NUM
fnp-2639	234	4	.	.	PUNCT
fnp-2639	235	1	24	24	NUM
fnp-2639	235	2	.	.	PUNCT
fnp-2639	236	1	neary	neary	PROPN
fnp-2639	236	2	d	d	PROPN
fnp-2639	236	3	,	,	PUNCT
fnp-2639	236	4	snowden	snowden	PROPN
fnp-2639	236	5	js	js	PROPN
fnp-2639	236	6	,	,	PUNCT
fnp-2639	236	7	gustafson	gustafson	PROPN
fnp-2639	236	8	l	l	PROPN
fnp-2639	236	9	,	,	PUNCT
fnp-2639	236	10	passant	passant	ADJ
fnp-2639	236	11	u	u	NOUN
fnp-2639	236	12	,	,	PUNCT
fnp-2639	236	13	stuss	stuss	ADJ
fnp-2639	236	14	d	d	PROPN
fnp-2639	236	15	,	,	PUNCT
fnp-2639	236	16	black	black	PROPN
fnp-2639	236	17	s	s	PROPN
fnp-2639	236	18	,	,	PUNCT
fnp-2639	236	19	et	et	PROPN
fnp-2639	236	20	al	al	PROPN
fnp-2639	236	21	.	.	PUNCT
fnp-2639	236	22	frontotemporal	frontotemporal	ADJ
fnp-2639	236	23	lobar	lobar	ADJ
fnp-2639	236	24	degeneration	degeneration	NOUN
fnp-2639	236	25	:	:	PUNCT
fnp-2639	236	26	a	a	DET
fnp-2639	236	27	consensus	consensus	NOUN
fnp-2639	236	28	on	on	ADP
fnp-2639	236	29	clinical	clinical	ADJ
fnp-2639	236	30	diagnostic	diagnostic	ADJ
fnp-2639	236	31	criteria	criterion	NOUN
fnp-2639	236	32	.	.	PUNCT
fnp-2639	237	1	neurology	neurology	NOUN
fnp-2639	237	2	.	.	PUNCT
fnp-2639	238	1	1998;51(6):1546	1998;51(6):1546	NUM
fnp-2639	238	2	-	-	SYM
fnp-2639	238	3	54	54	NUM
fnp-2639	238	4	.	.	PUNCT
fnp-2639	239	1	25	25	NUM
fnp-2639	239	2	.	.	PUNCT
fnp-2639	240	1	boeve	boeve	PROPN
fnp-2639	240	2	bf	bf	PROPN
fnp-2639	240	3	,	,	PUNCT
fnp-2639	240	4	lang	lang	PROPN
fnp-2639	240	5	ae	ae	PROPN
fnp-2639	240	6	,	,	PUNCT
fnp-2639	240	7	litvan	litvan	PROPN
fnp-2639	240	8	i.	i.	PROPN
fnp-2639	240	9	corticobasal	corticobasal	PROPN
fnp-2639	240	10	degeneration	degeneration	NOUN
fnp-2639	240	11	and	and	CCONJ
fnp-2639	240	12	its	its	PRON
fnp-2639	240	13	relationship	relationship	NOUN
fnp-2639	240	14	to	to	PART
fnp-2639	240	15	progressive	progressive	ADJ
fnp-2639	240	16	supranuclear	supranuclear	ADJ
fnp-2639	240	17	palsy	palsy	ADJ
fnp-2639	240	18	and	and	CCONJ
fnp-2639	240	19	frontotemporal	frontotemporal	ADJ
fnp-2639	240	20	dementia	dementia	NOUN
fnp-2639	240	21	.	.	PUNCT
fnp-2639	241	1	ann	ann	PROPN
fnp-2639	241	2	neurol	neurol	PROPN
fnp-2639	241	3	.	.	PUNCT
fnp-2639	242	1	2003;54	2003;54	NUM
fnp-2639	242	2	suppl	suppl	ADJ
fnp-2639	242	3	5	5	NUM
fnp-2639	242	4	:	:	PUNCT
fnp-2639	242	5	s15	s15	PROPN
fnp-2639	242	6	-	-	PUNCT
fnp-2639	242	7	9	9	NUM
fnp-2639	242	8	.	.	NOUN
fnp-2639	242	9	26	26	NUM
fnp-2639	242	10	.	.	PUNCT
fnp-2639	243	1	litvan	litvan	PROPN
fnp-2639	243	2	i	i	PRON
fnp-2639	243	3	,	,	PUNCT
fnp-2639	243	4	agid	agid	PROPN
fnp-2639	243	5	y	y	PROPN
fnp-2639	243	6	,	,	PUNCT
fnp-2639	243	7	calne	calne	PROPN
fnp-2639	243	8	d	d	PROPN
fnp-2639	243	9	,	,	PUNCT
fnp-2639	243	10	campbell	campbell	PROPN
fnp-2639	243	11	g	g	PROPN
fnp-2639	243	12	,	,	PUNCT
fnp-2639	243	13	dubois	dubois	PROPN
fnp-2639	243	14	b	b	PROPN
fnp-2639	243	15	,	,	PUNCT
fnp-2639	243	16	duvoisin	duvoisin	PROPN
fnp-2639	243	17	rc	rc	PROPN
fnp-2639	243	18	,	,	PUNCT
fnp-2639	243	19	et	et	PROPN
fnp-2639	243	20	al	al	PROPN
fnp-2639	243	21	.	.	PROPN
fnp-2639	244	1	clinical	clinical	ADJ
fnp-2639	244	2	research	research	NOUN
fnp-2639	244	3	criteria	criterion	NOUN
fnp-2639	244	4	for	for	ADP
fnp-2639	244	5	the	the	DET
fnp-2639	244	6	diagnosis	diagnosis	NOUN
fnp-2639	244	7	of	of	ADP
fnp-2639	244	8	progressive	progressive	ADJ
fnp-2639	244	9	supranuclear	supranuclear	ADJ
fnp-2639	244	10	palsy	palsy	ADJ
fnp-2639	244	11	(	(	PUNCT
fnp-2639	244	12	steele	steele	PROPN
fnp-2639	244	13	-	-	PUNCT
fnp-2639	244	14	richardson	richardson	PROPN
fnp-2639	244	15	-	-	PUNCT
fnp-2639	244	16	olszewski	olszewski	ADJ
fnp-2639	244	17	syndrome	syndrome	NOUN
fnp-2639	244	18	):	):	PUNCT
fnp-2639	244	19	report	report	NOUN
fnp-2639	244	20	of	of	ADP
fnp-2639	244	21	the	the	DET
fnp-2639	244	22	ninds	nind	NOUN
fnp-2639	244	23	-	-	PUNCT
fnp-2639	244	24	spsp	spsp	NOUN
fnp-2639	244	25	international	international	ADJ
fnp-2639	244	26	workshop	workshop	NOUN
fnp-2639	244	27	.	.	PUNCT
fnp-2639	245	1	neurology	neurology	NOUN
fnp-2639	245	2	.	.	PUNCT
fnp-2639	246	1	1996;47(1):1	1996;47(1):1	NUM
fnp-2639	246	2	-	-	SYM
fnp-2639	246	3	9	9	NUM
fnp-2639	246	4	.	.	NOUN
fnp-2639	246	5	27	27	NUM
fnp-2639	246	6	.	.	PUNCT
fnp-2639	247	1	zhai	zhai	PROPN
fnp-2639	247	2	p	p	X
fnp-2639	247	3	,	,	PUNCT
fnp-2639	247	4	pagan	pagan	ADJ
fnp-2639	247	5	f	f	NOUN
fnp-2639	247	6	,	,	PUNCT
fnp-2639	247	7	statland	statland	PROPN
fnp-2639	247	8	j	j	PROPN
fnp-2639	247	9	,	,	PUNCT
fnp-2639	247	10	butman	butman	PROPN
fnp-2639	247	11	ja	ja	PROPN
fnp-2639	247	12	,	,	PUNCT
fnp-2639	247	13	floeter	floeter	PROPN
fnp-2639	247	14	mk	mk	PROPN
fnp-2639	247	15	.	.	PUNCT
fnp-2639	248	1	primary	primary	ADJ
fnp-2639	248	2	lateral	lateral	ADJ
fnp-2639	248	3	sclerosis	sclerosis	NOUN
fnp-2639	248	4	:	:	PUNCT
fnp-2639	248	5	a	a	DET
fnp-2639	248	6	heterogeneous	heterogeneous	ADJ
fnp-2639	248	7	disorder	disorder	NOUN
fnp-2639	248	8	composed	compose	VERB
fnp-2639	248	9	of	of	ADP
fnp-2639	248	10	different	different	ADJ
fnp-2639	248	11	subtypes	subtype	NOUN
fnp-2639	248	12	?	?	PUNCT
fnp-2639	249	1	neurology	neurology	NOUN
fnp-2639	249	2	.	.	PUNCT
fnp-2639	250	1	2003;60(8):1258	2003;60(8):1258	PROPN
fnp-2639	250	2	-	-	SYM
fnp-2639	250	3	65	65	NUM
fnp-2639	250	4	.	.	PUNCT
fnp-2639	250	5	28	28	NUM
fnp-2639	250	6	.	.	PUNCT
fnp-2639	251	1	papp	papp	PROPN
fnp-2639	251	2	mi	mi	PROPN
fnp-2639	251	3	,	,	PUNCT
fnp-2639	251	4	kahn	kahn	PROPN
fnp-2639	251	5	je	je	PROPN
fnp-2639	251	6	,	,	PUNCT
fnp-2639	251	7	lantos	lantos	PROPN
fnp-2639	251	8	pl	pl	PROPN
fnp-2639	251	9	.	.	PROPN
fnp-2639	251	10	glial	glial	ADJ
fnp-2639	251	11	cytoplasmic	cytoplasmic	ADJ
fnp-2639	251	12	inclusions	inclusion	NOUN
fnp-2639	251	13	in	in	ADP
fnp-2639	251	14	the	the	DET
fnp-2639	251	15	cns	cns	NOUN
fnp-2639	251	16	of	of	ADP
fnp-2639	251	17	patients	patient	NOUN
fnp-2639	251	18	with	with	ADP
fnp-2639	251	19	multiple	multiple	ADJ
fnp-2639	251	20	system	system	NOUN
fnp-2639	251	21	atrophy	atrophy	NOUN
fnp-2639	251	22	(	(	PUNCT
fnp-2639	251	23	striatonigral	striatonigral	ADJ
fnp-2639	251	24	degeneration	degeneration	NOUN
fnp-2639	251	25	,	,	PUNCT
fnp-2639	251	26	olivopontocerebellar	olivopontocerebellar	ADJ
fnp-2639	251	27	atrophy	atrophy	NOUN
fnp-2639	251	28	and	and	CCONJ
fnp-2639	251	29	shy	shy	ADJ
fnp-2639	251	30	-	-	PUNCT
fnp-2639	251	31	drager	drager	NOUN
fnp-2639	251	32	syndrome	syndrome	NOUN
fnp-2639	251	33	)	)	PUNCT
fnp-2639	251	34	.	.	PUNCT
fnp-2639	252	1	j	j	PROPN
fnp-2639	252	2	neurol	neurol	PROPN
fnp-2639	252	3	sci	sci	PROPN
fnp-2639	252	4	.	.	PUNCT
fnp-2639	253	1	1989;94(1	1989;94(1	NUM
fnp-2639	253	2	-	-	PUNCT
fnp-2639	253	3	3):79	3):79	NUM
fnp-2639	253	4	-	-	PUNCT
fnp-2639	253	5	100	100	NUM
fnp-2639	253	6	.	.	PUNCT
fnp-2639	254	1	29	29	NUM
fnp-2639	254	2	.	.	PUNCT
fnp-2639	255	1	uchikado	uchikado	PROPN
fnp-2639	255	2	h	h	PROPN
fnp-2639	255	3	,	,	PUNCT
fnp-2639	255	4	li	li	PROPN
fnp-2639	255	5	a	a	PROPN
fnp-2639	255	6	,	,	PUNCT
fnp-2639	255	7	lin	lin	PROPN
fnp-2639	255	8	wl	wl	PROPN
fnp-2639	255	9	,	,	PUNCT
fnp-2639	255	10	dickson	dickson	PROPN
fnp-2639	255	11	dw	dw	PROPN
fnp-2639	255	12	.	.	PROPN
fnp-2639	255	13	heterogeneous	heterogeneous	ADJ
fnp-2639	255	14	inclusions	inclusion	NOUN
fnp-2639	255	15	in	in	ADP
fnp-2639	255	16	neurofilament	neurofilament	ADJ
fnp-2639	255	17	inclusion	inclusion	NOUN
fnp-2639	255	18	disease	disease	NOUN
fnp-2639	255	19	.	.	PUNCT
fnp-2639	256	1	neuropathology	neuropathology	NOUN
fnp-2639	256	2	.	.	PUNCT
fnp-2639	257	1	2006;26(5):417	2006;26(5):417	NUM
fnp-2639	257	2	-	-	SYM
fnp-2639	257	3	21	21	NUM
fnp-2639	257	4	.	.	PUNCT
fnp-2639	257	5	30	30	NUM
fnp-2639	257	6	.	.	PUNCT
fnp-2639	258	1	rohrer	rohrer	PROPN
fnp-2639	258	2	jd	jd	PROPN
fnp-2639	258	3	,	,	PUNCT
fnp-2639	258	4	lashley	lashley	PROPN
fnp-2639	258	5	t	t	PROPN
fnp-2639	258	6	,	,	PUNCT
fnp-2639	258	7	schott	schott	PROPN
fnp-2639	258	8	jm	jm	PROPN
fnp-2639	258	9	,	,	PUNCT
fnp-2639	258	10	warren	warren	PROPN
fnp-2639	258	11	je	je	PROPN
fnp-2639	258	12	,	,	PUNCT
fnp-2639	258	13	mead	mead	PROPN
fnp-2639	258	14	s	s	PROPN
fnp-2639	258	15	,	,	PUNCT
fnp-2639	258	16	isaacs	isaacs	PROPN
fnp-2639	258	17	am	be	AUX
fnp-2639	258	18	,	,	PUNCT
fnp-2639	258	19	et	et	PROPN
fnp-2639	258	20	al	al	PROPN
fnp-2639	258	21	.	.	PROPN
fnp-2639	259	1	clinical	clinical	ADJ
fnp-2639	259	2	and	and	CCONJ
fnp-2639	259	3	neuroanatomical	neuroanatomical	ADJ
fnp-2639	259	4	signatures	signature	NOUN
fnp-2639	259	5	of	of	ADP
fnp-2639	259	6	tissue	tissue	NOUN
fnp-2639	259	7	pathology	pathology	NOUN
fnp-2639	259	8	in	in	ADP
fnp-2639	259	9	frontotemporal	frontotemporal	ADJ
fnp-2639	259	10	lobar	lobar	ADJ
fnp-2639	259	11	degeneration	degeneration	NOUN
fnp-2639	259	12	.	.	PUNCT
fnp-2639	260	1	brain	brain	NOUN
fnp-2639	260	2	.	.	PUNCT
fnp-2639	261	1	2011;134(pt	2011;134(pt	NUM
fnp-2639	261	2	9):2565	9):2565	NUM
fnp-2639	261	3	-	-	PUNCT
fnp-2639	261	4	81	81	NUM
fnp-2639	261	5	.	.	PUNCT
fnp-2639	262	1	31	31	NUM
fnp-2639	262	2	.	.	PUNCT
fnp-2639	263	1	bigio	bigio	NOUN
fnp-2639	263	2	eh	eh	INTJ
fnp-2639	263	3	,	,	PUNCT
fnp-2639	263	4	lipton	lipton	PROPN
fnp-2639	263	5	am	am	PROPN
fnp-2639	263	6	,	,	PUNCT
fnp-2639	263	7	white	white	ADJ
fnp-2639	263	8	cl	cl	NOUN
fnp-2639	263	9	,	,	PUNCT
fnp-2639	263	10	3rd	3rd	NOUN
fnp-2639	263	11	,	,	PUNCT
fnp-2639	263	12	dickson	dickson	PROPN
fnp-2639	263	13	dw	dw	PROPN
fnp-2639	263	14	,	,	PUNCT
fnp-2639	263	15	hirano	hirano	PROPN
fnp-2639	263	16	a.	a.	PROPN
fnp-2639	263	17	frontotemporal	frontotemporal	PROPN
fnp-2639	263	18	and	and	CCONJ
fnp-2639	263	19	motor	motor	NOUN
fnp-2639	263	20	neurone	neurone	NOUN
fnp-2639	263	21	degeneration	degeneration	NOUN
fnp-2639	263	22	with	with	ADP
fnp-2639	263	23	neurofilament	neurofilament	ADJ
fnp-2639	263	24	inclusion	inclusion	NOUN
fnp-2639	263	25	bodies	body	NOUN
fnp-2639	263	26	:	:	PUNCT
fnp-2639	263	27	additional	additional	ADJ
fnp-2639	263	28	evidence	evidence	NOUN
fnp-2639	263	29	for	for	ADP
fnp-2639	263	30	overlap	overlap	NOUN
fnp-2639	263	31	between	between	ADP
fnp-2639	263	32	ftd	ftd	PROPN
fnp-2639	263	33	and	and	CCONJ
fnp-2639	263	34	als	al	NOUN
fnp-2639	263	35	.	.	PUNCT
fnp-2639	264	1	neuropathol	neuropathol	PROPN
fnp-2639	264	2	appl	appl	PROPN
fnp-2639	264	3	neurobiol	neurobiol	PROPN
fnp-2639	264	4	.	.	PUNCT
fnp-2639	265	1	2003;29(3):239	2003;29(3):239	NUM
fnp-2639	265	2	-	-	SYM
fnp-2639	265	3	53	53	NUM
fnp-2639	265	4	.	.	PUNCT
fnp-2639	265	5	32	32	NUM
fnp-2639	265	6	.	.	PUNCT
fnp-2639	266	1	cairns	cairns	PROPN
fnp-2639	266	2	nj	nj	PROPN
fnp-2639	266	3	,	,	PUNCT
fnp-2639	266	4	grossman	grossman	PROPN
fnp-2639	266	5	m	m	PROPN
fnp-2639	266	6	,	,	PUNCT
fnp-2639	266	7	arnold	arnold	PROPN
fnp-2639	266	8	se	se	PROPN
fnp-2639	266	9	,	,	PUNCT
fnp-2639	266	10	burn	burn	VERB
fnp-2639	266	11	dj	dj	NOUN
fnp-2639	266	12	,	,	PUNCT
fnp-2639	266	13	jaros	jaros	PROPN
fnp-2639	266	14	e	e	NOUN
fnp-2639	266	15	,	,	PUNCT
fnp-2639	266	16	perry	perry	PROPN
fnp-2639	266	17	rh	rh	PROPN
fnp-2639	266	18	,	,	PUNCT
fnp-2639	266	19	et	et	PROPN
fnp-2639	266	20	al	al	PROPN
fnp-2639	266	21	.	.	PROPN
fnp-2639	267	1	clinical	clinical	ADJ
fnp-2639	267	2	and	and	CCONJ
fnp-2639	267	3	neuropathologic	neuropathologic	ADJ
fnp-2639	267	4	variation	variation	NOUN
fnp-2639	267	5	in	in	ADP
fnp-2639	267	6	neuronal	neuronal	ADJ
fnp-2639	267	7	intermediate	intermediate	ADJ
fnp-2639	267	8	filament	filament	NOUN
fnp-2639	267	9	inclusion	inclusion	NOUN
fnp-2639	267	10	disease	disease	NOUN
fnp-2639	267	11	.	.	PUNCT
fnp-2639	268	1	neurology	neurology	NOUN
fnp-2639	268	2	.	.	PUNCT
fnp-2639	269	1	2004;63(8):1376	2004;63(8):1376	NUM
fnp-2639	269	2	-	-	SYM
fnp-2639	269	3	84	84	NUM
fnp-2639	269	4	.	.	PUNCT
fnp-2639	270	1	33	33	NUM
fnp-2639	270	2	.	.	PUNCT
fnp-2639	271	1	josephs	josephs	PROPN
fnp-2639	271	2	ka	ka	PROPN
fnp-2639	271	3	,	,	PUNCT
fnp-2639	271	4	uchikado	uchikado	ADJ
fnp-2639	271	5	h	h	PROPN
fnp-2639	271	6	,	,	PUNCT
fnp-2639	271	7	mccomb	mccomb	PROPN
fnp-2639	271	8	rd	rd	PROPN
fnp-2639	271	9	,	,	PUNCT
fnp-2639	271	10	bashir	bashir	PROPN
fnp-2639	271	11	r	r	PROPN
fnp-2639	271	12	,	,	PUNCT
fnp-2639	271	13	wszolek	wszolek	VERB
fnp-2639	271	14	z	z	NOUN
fnp-2639	271	15	,	,	PUNCT
fnp-2639	271	16	swanson	swanson	PROPN
fnp-2639	271	17	j	j	PROPN
fnp-2639	271	18	,	,	PUNCT
fnp-2639	271	19	et	et	PROPN
fnp-2639	271	20	al	al	PROPN
fnp-2639	271	21	.	.	PUNCT
fnp-2639	272	1	extending	extend	VERB
fnp-2639	272	2	the	the	DET
fnp-2639	272	3	clinicopathological	clinicopathological	ADJ
fnp-2639	272	4	spectrum	spectrum	NOUN
fnp-2639	272	5	of	of	ADP
fnp-2639	272	6	neurofilament	neurofilament	ADJ
fnp-2639	272	7	inclusion	inclusion	NOUN
fnp-2639	272	8	disease	disease	NOUN
fnp-2639	272	9	.	.	PUNCT
fnp-2639	273	1	acta	acta	PROPN
fnp-2639	273	2	neuropathol	neuropathol	PROPN
fnp-2639	273	3	.	.	PUNCT
fnp-2639	274	1	2005;109(4):427	2005;109(4):427	NUM
fnp-2639	274	2	-	-	SYM
fnp-2639	274	3	32	32	NUM
fnp-2639	274	4	.	.	PUNCT
fnp-2639	275	1	34	34	NUM
fnp-2639	275	2	.	.	PUNCT
fnp-2639	276	1	uchikado	uchikado	PROPN
fnp-2639	276	2	h	h	PROPN
fnp-2639	276	3	,	,	PUNCT
fnp-2639	276	4	shaw	shaw	PROPN
fnp-2639	276	5	g	g	PROPN
fnp-2639	276	6	,	,	PUNCT
fnp-2639	276	7	wang	wang	PROPN
fnp-2639	276	8	ds	ds	PROPN
fnp-2639	276	9	,	,	PUNCT
fnp-2639	276	10	dickson	dickson	PROPN
fnp-2639	276	11	dw	dw	PROPN
fnp-2639	276	12	.	.	PROPN
fnp-2639	276	13	screening	screen	VERB
fnp-2639	276	14	for	for	ADP
fnp-2639	276	15	neurofilament	neurofilament	ADJ
fnp-2639	276	16	inclusion	inclusion	NOUN
fnp-2639	276	17	disease	disease	NOUN
fnp-2639	276	18	using	use	VERB
fnp-2639	276	19	alpha	alpha	NOUN
fnp-2639	276	20	-	-	PUNCT
fnp-2639	276	21	internexin	internexin	PROPN
fnp-2639	276	22	immunohistochemistry	immunohistochemistry	NOUN
fnp-2639	276	23	.	.	PUNCT
fnp-2639	277	1	neurology	neurology	NOUN
fnp-2639	277	2	.	.	PUNCT
fnp-2639	278	1	2005;64(9):1658	2005;64(9):1658	NUM
fnp-2639	278	2	-	-	SYM
fnp-2639	278	3	9	9	NUM
fnp-2639	278	4	.	.	NOUN
fnp-2639	278	5	35	35	NUM
fnp-2639	278	6	.	.	PUNCT
fnp-2639	279	1	armstrong	armstrong	PROPN
fnp-2639	279	2	ra	ra	PROPN
fnp-2639	279	3	,	,	PUNCT
fnp-2639	279	4	gearing	gear	VERB
fnp-2639	279	5	m	m	PRON
fnp-2639	279	6	,	,	PUNCT
fnp-2639	279	7	bigio	bigio	NOUN
fnp-2639	279	8	eh	eh	INTJ
fnp-2639	279	9	,	,	PUNCT
fnp-2639	279	10	cruz	cruz	PROPN
fnp-2639	279	11	-	-	PUNCT
fnp-2639	279	12	sanchez	sanchez	PROPN
fnp-2639	279	13	ff	ff	NOUN
fnp-2639	279	14	,	,	PUNCT
fnp-2639	279	15	duyckaerts	duyckaert	NOUN
fnp-2639	279	16	c	c	PROPN
fnp-2639	279	17	,	,	PUNCT
fnp-2639	279	18	mackenzie	mackenzie	PROPN
fnp-2639	279	19	ir	ir	PROPN
fnp-2639	279	20	,	,	PUNCT
fnp-2639	279	21	et	et	PROPN
fnp-2639	279	22	al	al	PROPN
fnp-2639	279	23	.	.	PUNCT
fnp-2639	280	1	the	the	DET
fnp-2639	280	2	spectrum	spectrum	NOUN
fnp-2639	280	3	and	and	CCONJ
fnp-2639	280	4	severity	severity	NOUN
fnp-2639	280	5	of	of	ADP
fnp-2639	280	6	fus	fus	PROPN
fnp-2639	280	7	-	-	PUNCT
fnp-2639	280	8	immunoreactive	immunoreactive	ADJ
fnp-2639	280	9	inclusions	inclusion	NOUN
fnp-2639	280	10	in	in	ADP
fnp-2639	280	11	the	the	DET
fnp-2639	280	12	frontal	frontal	ADJ
fnp-2639	280	13	and	and	CCONJ
fnp-2639	280	14	temporal	temporal	ADJ
fnp-2639	280	15	lobes	lobe	NOUN
fnp-2639	280	16	of	of	ADP
fnp-2639	280	17	ten	ten	NUM
fnp-2639	280	18	cases	case	NOUN
fnp-2639	280	19	of	of	ADP
fnp-2639	280	20	neuronal	neuronal	ADJ
fnp-2639	280	21	intermediate	intermediate	ADJ
fnp-2639	280	22	filament	filament	NOUN
fnp-2639	280	23	inclusion	inclusion	NOUN
fnp-2639	280	24	disease	disease	NOUN
fnp-2639	280	25	.	.	PUNCT
fnp-2639	281	1	acta	acta	PROPN
fnp-2639	281	2	neuropathol	neuropathol	PROPN
fnp-2639	281	3	.	.	PUNCT
fnp-2639	282	1	2011;121(2):219	2011;121(2):219	NUM
fnp-2639	282	2	-	-	SYM
fnp-2639	282	3	28	28	NUM
fnp-2639	282	4	.	.	PUNCT
fnp-2639	283	1	36	36	NUM
fnp-2639	283	2	.	.	PUNCT
fnp-2639	284	1	mackenzie	mackenzie	PROPN
fnp-2639	284	2	ir	ir	PROPN
fnp-2639	284	3	,	,	PUNCT
fnp-2639	284	4	munoz	munoz	PROPN
fnp-2639	284	5	dg	dg	PROPN
fnp-2639	284	6	,	,	PUNCT
fnp-2639	284	7	kusaka	kusaka	PROPN
fnp-2639	284	8	h	h	PROPN
fnp-2639	284	9	,	,	PUNCT
fnp-2639	284	10	yokota	yokota	PROPN
fnp-2639	284	11	o	o	NOUN
fnp-2639	284	12	,	,	PUNCT
fnp-2639	284	13	ishihara	ishihara	PROPN
fnp-2639	284	14	k	k	PROPN
fnp-2639	284	15	,	,	PUNCT
fnp-2639	284	16	roeber	roeber	PROPN
fnp-2639	284	17	s	s	PROPN
fnp-2639	284	18	,	,	PUNCT
fnp-2639	284	19	et	et	PROPN
fnp-2639	284	20	al	al	PROPN
fnp-2639	284	21	.	.	PROPN
fnp-2639	285	1	distinct	distinct	ADJ
fnp-2639	285	2	pathological	pathological	ADJ
fnp-2639	285	3	subtypes	subtype	NOUN
fnp-2639	285	4	of	of	ADP
fnp-2639	285	5	ftld	ftld	ADJ
fnp-2639	285	6	-	-	PUNCT
fnp-2639	285	7	fus	fus	NOUN
fnp-2639	285	8	.	.	PUNCT
fnp-2639	286	1	acta	acta	PROPN
fnp-2639	286	2	neuropathol	neuropathol	PROPN
fnp-2639	286	3	.	.	PUNCT
fnp-2639	287	1	2011;121(2):207	2011;121(2):207	NOUN
fnp-2639	287	2	-	-	SYM
fnp-2639	287	3	18	18	NUM
fnp-2639	287	4	.	.	PUNCT
fnp-2639	288	1	37	37	NUM
fnp-2639	288	2	.	.	PUNCT
fnp-2639	289	1	lin	lin	PROPN
fnp-2639	289	2	wl	wl	PROPN
fnp-2639	289	3	,	,	PUNCT
fnp-2639	289	4	dickson	dickson	PROPN
fnp-2639	289	5	dw	dw	PROPN
fnp-2639	289	6	.	.	PROPN
fnp-2639	289	7	ultrastructural	ultrastructural	ADJ
fnp-2639	289	8	localization	localization	NOUN
fnp-2639	289	9	of	of	ADP
fnp-2639	289	10	tdp-43	tdp-43	PROPN
fnp-2639	289	11	in	in	ADP
fnp-2639	289	12	filamentous	filamentous	ADJ
fnp-2639	289	13	neuronal	neuronal	ADJ
fnp-2639	289	14	inclusions	inclusion	NOUN
fnp-2639	289	15	in	in	ADP
fnp-2639	289	16	various	various	ADJ
fnp-2639	289	17	neurodegenerative	neurodegenerative	ADJ
fnp-2639	289	18	diseases	disease	NOUN
fnp-2639	289	19	.	.	PUNCT
fnp-2639	290	1	acta	acta	PROPN
fnp-2639	290	2	neuropathol	neuropathol	PROPN
fnp-2639	290	3	.	.	PUNCT
fnp-2639	291	1	2008;116(2):205	2008;116(2):205	X
fnp-2639	291	2	-	-	SYM
fnp-2639	291	3	13	13	NUM
fnp-2639	291	4	.	.	PUNCT
fnp-2639	292	1	38	38	NUM
fnp-2639	292	2	.	.	PUNCT
fnp-2639	293	1	josephs	josephs	PROPN
fnp-2639	293	2	ka	ka	PROPN
fnp-2639	293	3	,	,	PUNCT
fnp-2639	293	4	mackenzie	mackenzie	PROPN
fnp-2639	293	5	i	i	PROPN
fnp-2639	293	6	,	,	PUNCT
fnp-2639	293	7	frosch	frosch	PROPN
fnp-2639	293	8	mp	mp	PROPN
fnp-2639	293	9	,	,	PUNCT
fnp-2639	293	10	bigio	bigio	NOUN
fnp-2639	293	11	eh	eh	INTJ
fnp-2639	293	12	,	,	PUNCT
fnp-2639	293	13	neumann	neumann	PROPN
fnp-2639	293	14	m	m	PROPN
fnp-2639	293	15	,	,	PUNCT
fnp-2639	293	16	arai	arai	PROPN
fnp-2639	293	17	t	t	PROPN
fnp-2639	293	18	,	,	PUNCT
fnp-2639	293	19	et	et	PROPN
fnp-2639	293	20	al	al	PROPN
fnp-2639	293	21	.	.	PUNCT
fnp-2639	294	1	late	late	ADV
fnp-2639	294	2	to	to	ADP
fnp-2639	294	3	the	the	DET
fnp-2639	294	4	part	part	ADJ
fnp-2639	294	5	-	-	PUNCT
fnp-2639	294	6	y.	y.	ADJ
fnp-2639	294	7	brain	brain	NOUN
fnp-2639	294	8	.	.	PUNCT
fnp-2639	295	1	2019;142(9):e47	2019;142(9):e47	PROPN
fnp-2639	295	2	.	.	PUNCT
fnp-2639	296	1	39	39	NUM
fnp-2639	296	2	.	.	PUNCT
fnp-2639	297	1	deng	deng	PROPN
fnp-2639	297	2	hx	hx	PROPN
fnp-2639	297	3	,	,	PUNCT
fnp-2639	297	4	zhai	zhai	PROPN
fnp-2639	297	5	h	h	PROPN
fnp-2639	297	6	,	,	PUNCT
fnp-2639	297	7	bigio	bigio	NOUN
fnp-2639	297	8	eh	eh	INTJ
fnp-2639	297	9	,	,	PUNCT
fnp-2639	297	10	yan	yan	PROPN
fnp-2639	297	11	j	j	PROPN
fnp-2639	297	12	,	,	PUNCT
fnp-2639	297	13	fecto	fecto	PROPN
fnp-2639	297	14	f	f	PROPN
fnp-2639	297	15	,	,	PUNCT
fnp-2639	297	16	ajroud	ajroud	NOUN
fnp-2639	297	17	k	k	PROPN
fnp-2639	297	18	,	,	PUNCT
fnp-2639	297	19	et	et	PROPN
fnp-2639	297	20	al	al	PROPN
fnp-2639	297	21	.	.	PROPN
fnp-2639	297	22	fus	fus	PROPN
fnp-2639	297	23	-	-	PUNCT
fnp-2639	297	24	immunoreactive	immunoreactive	ADJ
fnp-2639	297	25	inclusions	inclusion	NOUN
fnp-2639	297	26	are	be	AUX
fnp-2639	297	27	a	a	DET
fnp-2639	297	28	common	common	ADJ
fnp-2639	297	29	feature	feature	NOUN
fnp-2639	297	30	in	in	ADP
fnp-2639	297	31	sporadic	sporadic	ADJ
fnp-2639	297	32	and	and	CCONJ
fnp-2639	297	33	non	non	ADJ
fnp-2639	297	34	-	-	ADJ
fnp-2639	297	35	sod1	sod1	ADJ
fnp-2639	297	36	familial	familial	ADJ
fnp-2639	297	37	amyotrophic	amyotrophic	ADJ
fnp-2639	297	38	lateral	lateral	ADJ
fnp-2639	297	39	sclerosis	sclerosis	NOUN
fnp-2639	297	40	.	.	PUNCT
fnp-2639	298	1	ann	ann	PROPN
fnp-2639	298	2	neurol	neurol	PROPN
fnp-2639	298	3	.	.	PUNCT
fnp-2639	299	1	2010;67(6):739	2010;67(6):739	NUM
fnp-2639	299	2	-	-	SYM
fnp-2639	299	3	48	48	NUM
fnp-2639	299	4	.	.	PUNCT
fnp-2639	300	1	40	40	NUM
fnp-2639	300	2	.	.	PUNCT
fnp-2639	301	1	nakamura	nakamura	PROPN
fnp-2639	301	2	m	m	PROPN
fnp-2639	301	3	,	,	PUNCT
fnp-2639	301	4	bieniek	bieniek	PROPN
fnp-2639	301	5	kf	kf	PROPN
fnp-2639	301	6	,	,	PUNCT
fnp-2639	301	7	lin	lin	PROPN
fnp-2639	301	8	wl	wl	PROPN
fnp-2639	301	9	,	,	PUNCT
fnp-2639	301	10	graff	graff	PROPN
fnp-2639	301	11	-	-	PUNCT
fnp-2639	301	12	radford	radford	PROPN
fnp-2639	301	13	nr	nr	PROPN
fnp-2639	301	14	,	,	PUNCT
fnp-2639	301	15	murray	murray	VERB
fnp-2639	301	16	me	i	PRON
fnp-2639	301	17	,	,	PUNCT
fnp-2639	301	18	castanedes	castanedes	PROPN
fnp-2639	301	19	-	-	PUNCT
fnp-2639	301	20	casey	casey	PROPN
fnp-2639	301	21	m	m	PROPN
fnp-2639	301	22	,	,	PUNCT
fnp-2639	301	23	et	et	PROPN
fnp-2639	301	24	al	al	PROPN
fnp-2639	301	25	.	.	PUNCT
fnp-2639	302	1	a	a	DET
fnp-2639	302	2	truncating	truncate	VERB
fnp-2639	302	3	sod1	sod1	ADJ
fnp-2639	302	4	mutation	mutation	NOUN
fnp-2639	302	5	,	,	PUNCT
fnp-2639	302	6	p.gly141x	p.gly141x	VERB
fnp-2639	302	7	,	,	PUNCT
fnp-2639	302	8	is	be	AUX
fnp-2639	302	9	associated	associate	VERB
fnp-2639	302	10	with	with	ADP
fnp-2639	302	11	clinical	clinical	ADJ
fnp-2639	302	12	and	and	CCONJ
fnp-2639	302	13	pathologic	pathologic	ADJ
fnp-2639	302	14	heterogeneity	heterogeneity	NOUN
fnp-2639	302	15	,	,	PUNCT
fnp-2639	302	16	including	include	VERB
fnp-2639	302	17	frontotemporal	frontotemporal	ADJ
fnp-2639	302	18	lobar	lobar	ADJ
fnp-2639	302	19	degeneration	degeneration	NOUN
fnp-2639	302	20	.	.	PUNCT
fnp-2639	303	1	acta	acta	PROPN
fnp-2639	303	2	neuropathol	neuropathol	PROPN
fnp-2639	303	3	.	.	PUNCT
fnp-2639	304	1	2015;130(1):145	2015;130(1):145	NUM
fnp-2639	304	2	-	-	SYM
fnp-2639	304	3	57	57	NUM
fnp-2639	304	4	.	.	PUNCT
fnp-2639	305	1	41	41	NUM
fnp-2639	305	2	.	.	PUNCT
fnp-2639	306	1	neumann	neumann	PROPN
fnp-2639	306	2	m	m	PROPN
fnp-2639	306	3	,	,	PUNCT
fnp-2639	306	4	bentmann	bentmann	PROPN
fnp-2639	306	5	e	e	NOUN
fnp-2639	306	6	,	,	PUNCT
fnp-2639	306	7	dormann	dormann	PROPN
fnp-2639	306	8	d	d	PROPN
fnp-2639	306	9	,	,	PUNCT
fnp-2639	306	10	jawaid	jawaid	VERB
fnp-2639	306	11	a	a	PRON
fnp-2639	306	12	,	,	PUNCT
fnp-2639	306	13	dejesus	dejesus	PROPN
fnp-2639	306	14	-	-	PUNCT
fnp-2639	306	15	hernandez	hernandez	PROPN
fnp-2639	306	16	m	m	PROPN
fnp-2639	306	17	,	,	PUNCT
fnp-2639	306	18	ansorge	ansorge	ADJ
fnp-2639	306	19	o	o	NOUN
fnp-2639	306	20	,	,	PUNCT
fnp-2639	307	1	et	et	PROPN
fnp-2639	307	2	al	al	PROPN
fnp-2639	307	3	.	.	PUNCT
fnp-2639	307	4	fet	fet	PROPN
fnp-2639	307	5	proteins	protein	NOUN
fnp-2639	307	6	taf15	taf15	PROPN
fnp-2639	307	7	and	and	CCONJ
fnp-2639	307	8	ews	ews	PROPN
fnp-2639	307	9	are	be	AUX
fnp-2639	307	10	selective	selective	ADJ
fnp-2639	307	11	markers	marker	NOUN
fnp-2639	307	12	that	that	PRON
fnp-2639	307	13	distinguish	distinguish	VERB
fnp-2639	307	14	ftld	ftld	NOUN
fnp-2639	307	15	with	with	ADP
fnp-2639	307	16	fus	fus	PROPN
fnp-2639	307	17	pathology	pathology	NOUN
fnp-2639	307	18	from	from	ADP
fnp-2639	307	19	amyotrophic	amyotrophic	ADJ
fnp-2639	307	20	lateral	lateral	ADJ
fnp-2639	307	21	sclerosis	sclerosis	NOUN
fnp-2639	307	22	with	with	ADP
fnp-2639	307	23	fus	fus	PROPN
fnp-2639	307	24	mutations	mutation	NOUN
fnp-2639	307	25	.	.	PUNCT
fnp-2639	308	1	brain	brain	NOUN
fnp-2639	308	2	.	.	PUNCT
fnp-2639	309	1	2011;134(pt	2011;134(pt	NUM
fnp-2639	309	2	9):2595	9):2595	NUM
fnp-2639	309	3	-	-	SYM
fnp-2639	309	4	609	609	NUM
fnp-2639	309	5	.	.	PUNCT
fnp-2639	310	1	42	42	NUM
fnp-2639	310	2	.	.	PUNCT
fnp-2639	311	1	brelstaff	brelstaff	PROPN
fnp-2639	311	2	j	j	PROPN
fnp-2639	311	3	,	,	PUNCT
fnp-2639	311	4	lashley	lashley	PROPN
fnp-2639	311	5	t	t	PROPN
fnp-2639	311	6	,	,	PUNCT
fnp-2639	311	7	holton	holton	PROPN
fnp-2639	311	8	jl	jl	PROPN
fnp-2639	311	9	,	,	PUNCT
fnp-2639	311	10	lees	lee	NOUN
fnp-2639	311	11	aj	aj	PROPN
fnp-2639	311	12	,	,	PUNCT
fnp-2639	311	13	rossor	rossor	PROPN
fnp-2639	311	14	mn	mn	PROPN
fnp-2639	311	15	,	,	PUNCT
fnp-2639	311	16	bandopadhyay	bandopadhyay	PROPN
fnp-2639	311	17	r	r	PROPN
fnp-2639	311	18	,	,	PUNCT
fnp-2639	311	19	et	et	PROPN
fnp-2639	311	20	al	al	PROPN
fnp-2639	311	21	.	.	PUNCT
fnp-2639	312	1	transportin1	transportin1	PROPN
fnp-2639	312	2	:	:	PUNCT
fnp-2639	312	3	a	a	DET
fnp-2639	312	4	marker	marker	NOUN
fnp-2639	312	5	of	of	ADP
fnp-2639	312	6	ftld	ftld	ADJ
fnp-2639	312	7	-	-	PUNCT
fnp-2639	312	8	fus	fus	NOUN
fnp-2639	312	9	.	.	PUNCT
fnp-2639	313	1	acta	acta	PROPN
fnp-2639	313	2	neuropathol	neuropathol	PROPN
fnp-2639	313	3	.	.	PUNCT
fnp-2639	314	1	2011;122(5):591	2011;122(5):591	NUM
fnp-2639	314	2	-	-	SYM
fnp-2639	314	3	600	600	NUM
fnp-2639	314	4	.	.	PUNCT
fnp-2639	315	1	copyright	copyright	NOUN
fnp-2639	315	2	:	:	PUNCT
fnp-2639	315	3	©	©	PROPN
fnp-2639	315	4	2020	2020	NUM
fnp-2639	315	5	the	the	DET
fnp-2639	315	6	author(s	author(s	NOUN
fnp-2639	315	7	)	)	PUNCT
fnp-2639	315	8	.	.	PUNCT
fnp-2639	316	1	this	this	PRON
fnp-2639	316	2	is	be	AUX
fnp-2639	316	3	an	an	DET
fnp-2639	316	4	open	open	ADJ
fnp-2639	316	5	access	access	NOUN
fnp-2639	316	6	article	article	NOUN
fnp-2639	316	7	distributed	distribute	VERB
fnp-2639	316	8	under	under	ADP
fnp-2639	316	9	the	the	DET
fnp-2639	316	10	terms	term	NOUN
fnp-2639	316	11	of	of	ADP
fnp-2639	316	12	the	the	DET
fnp-2639	316	13	creative	creative	ADJ
fnp-2639	316	14	commons	common	NOUN
fnp-2639	316	15	attribution	attribution	NOUN
fnp-2639	316	16	4.0	4.0	NUM
fnp-2639	316	17	international	international	ADJ
fnp-2639	316	18	license	license	NOUN
fnp-2639	316	19	(	(	PUNCT
fnp-2639	316	20	https://creativecommons.org/licenses/by/4.0/	https://creativecommons.org/licenses/by/4.0/	PROPN
fnp-2639	316	21	)	)	PUNCT
fnp-2639	316	22	,	,	PUNCT
fnp-2639	316	23	which	which	PRON
fnp-2639	316	24	permits	permit	VERB
fnp-2639	316	25	unrestricted	unrestricted	ADJ
fnp-2639	316	26	use	use	NOUN
fnp-2639	316	27	,	,	PUNCT
fnp-2639	316	28	distribution	distribution	NOUN
fnp-2639	316	29	,	,	PUNCT
fnp-2639	316	30	and	and	CCONJ
fnp-2639	316	31	reproduction	reproduction	NOUN
fnp-2639	316	32	in	in	ADP
fnp-2639	316	33	any	any	DET
fnp-2639	316	34	medium	medium	NOUN
fnp-2639	316	35	,	,	PUNCT
fnp-2639	316	36	provided	provide	VERB
fnp-2639	316	37	the	the	DET
fnp-2639	316	38	original	original	ADJ
fnp-2639	316	39	author	author	NOUN
fnp-2639	316	40	and	and	CCONJ
fnp-2639	316	41	source	source	NOUN
fnp-2639	316	42	are	be	AUX
fnp-2639	316	43	credited	credit	VERB
fnp-2639	316	44	,	,	PUNCT
fnp-2639	316	45	a	a	DET
fnp-2639	316	46	link	link	NOUN
fnp-2639	316	47	to	to	ADP
fnp-2639	316	48	the	the	DET
fnp-2639	316	49	creative	creative	ADJ
fnp-2639	316	50	commons	common	NOUN
fnp-2639	316	51	license	license	NOUN
fnp-2639	316	52	is	be	AUX
fnp-2639	316	53	provided	provide	VERB
fnp-2639	316	54	,	,	PUNCT
fnp-2639	316	55	and	and	CCONJ
fnp-2639	316	56	any	any	DET
fnp-2639	316	57	changes	change	NOUN
fnp-2639	316	58	are	be	AUX
fnp-2639	316	59	indicated	indicate	VERB
fnp-2639	316	60	.	.	PUNCT
fnp-2639	317	1	the	the	DET
fnp-2639	317	2	creative	creative	ADJ
fnp-2639	317	3	commons	common	NOUN
fnp-2639	317	4	public	public	ADJ
fnp-2639	317	5	domain	domain	NOUN
fnp-2639	317	6	dedication	dedication	NOUN
fnp-2639	317	7	waiver	waiver	NOUN
fnp-2639	317	8	(	(	PUNCT
fnp-2639	317	9	https://creativecommons.org/publicdomain/zero/1.0/	https://creativecommons.org/publicdomain/zero/1.0/	PROPN
fnp-2639	317	10	)	)	PUNCT
fnp-2639	317	11	applies	apply	VERB
fnp-2639	317	12	to	to	ADP
fnp-2639	317	13	the	the	DET
fnp-2639	317	14	data	datum	NOUN
fnp-2639	317	15	made	make	VERB
fnp-2639	317	16	available	available	ADJ
fnp-2639	317	17	in	in	ADP
fnp-2639	317	18	this	this	DET
fnp-2639	317	19	article	article	NOUN
fnp-2639	317	20	,	,	PUNCT
fnp-2639	317	21	unless	unless	SCONJ
fnp-2639	317	22	otherwise	otherwise	ADV
fnp-2639	317	23	stated	state	VERB
fnp-2639	317	24	.	.	PUNCT